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Abstract 
 
Despite years of use, the enamel demineralisation inhibitory mechanisms of 
topical treatments with silver compounds remain obscure. This study aimed to 
investigate the effects of topical treatments with silver compounds, including 
AgNO
3
, AgF and Ag[NH3]2F (silver diammine fluoride; SDF), on demineralisation 
of hydroxyapatite (HAP) discs and human enamel. Further, the dose-response 
effects of these silver compounds on demineralisation of human enamel were 
also investigated. 
The dose-response effect of Ag+ in solution on demineralisation was 
investigated using scanning microradiography (SMR). The effects of topical 
treatments with AgNO
3
, AgF and Ag[NH3]2F on demineralisation of  HAP discs 
and human enamel were investigated using real-time Ca2+, Ag+ and F- ion 
selective electrodes (ISEs), scanning electron microscopy (SEM), energy 
dispersive X-ray analysis (EDX), and 31P and 19F magic angle spinning-nuclear 
magnetic resonance (MAS-NMR). 
    The results from this study suggest that the inhibitory mechanism of topical 
treatment with AgNO3 is associated with the formation of a Ag3PO4 protective 
barrier. Whereas, the inhibitory mechanism of topical treatment with AgF or 
Ag[NH3]2F is associated with the F- released from topically treated sample 
surfaces and the formation of a protective barrier composed of Ag3PO4, CaF2 and 
FHA. Further, the inhibitory efficacy of topical treatment with AgNO3 decreased 
with increasing concentration, whereas, the inhibitory efficacy of topical treatment 
with AgF or Ag[NH3]2F increased with increasing concentration. 
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PART I: LITERATURE REVIEW, 
AIMS AND OBJECTIVES 
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Chapter 1 INTRODUCTION OF DENTAL MINERAL  
 
1.1 Human Tooth Structure 
 
The human tooth is composed of enamel, dentine and cementum as mineralised 
hard tissues, and dental pulp as soft tissue (Fig. 1.1) (Douglass, 2003). In the 
crown, enamel is the hardest tissue in the human body (He and Swain, 2007), 
covering a thick dentinal layer comprising the bulk of tooth, and in the root, 
dentine is surrounded by cementum (Turp and Alt, 1998). Enamel contains the 
highest apatite mineral (96 wt%), followed by dentine (70 wt%), while cementum 
(65 wt%) is similar to bone (Driessens, 1980; Curzon and Featherstone, 1983). 
As enamel is the outermost dental mineral of the tooth exposed to acid challenges, 
it is discussed in this section. 
 
 
Figure 1.1 - Structure of tooth (From Douglass, 2003). 
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1.2 Human Enamel 
 
Enamel is acellular, non-sensitive and cannot be cellularly regenerated once lost. 
The structure comprises prismatic units with a hierarchical construction (Boyde, 
1964). Enamel is thickest at the cusps (2.5 mm) and thinnest at the cervical 
margins. Due to its high mineral density, the porosity of enamel is extremely low 
(Berkovitz, 2011). 
    Incipient caries always starts from enamel, as it is the first surface suffering the 
acid attacks from organic acids. These acids diffuse through the enamel pores, 
and selectively dissolve components with higher solubility, and gradually 
penetrate into underlying dentine. Remineralisation of the demineralised lesion is 
possible under certain conditions (Featherstone, 2008). 
 
1.2.1 Composition of Human Enamel 
 
The mineral component of human enamel is a calcium-deficient carbonated 
hydroxyapatite (LeGeros, 1991; Weatherell, 1975). Mature human enamel is 
composed of hydroxyapatite (HAP) (92 ~ 96 wt%), water (2 ~ 3 wt%), carbonate 
(2 ~ 3 wt%), trace elements (sodium, chloride, magnesium, potassium and zinc, 
1 wt%), fluoride (0.01 ~ 0.05 wt%) and proteins and lipids (< 1 wt%) (Hicks et al., 
2004; LeGeros, 1991). Generally, the concentration of F- is highest (thousands 
of ppm) in the surface and decreases toward EDJ (Enamel-Dentine junction), 
whereas, the concentration gradients of CO32- and Mg2+ are reverse (Robinson 
et al., 2000). The organic components and water are mainly located in the inter-
prismatic regions of enamel (Berkovitz, 2011; Boyde, 1964). As the distributions 
of these components in enamel are not homogeneous, the response of enamel 
to physical and chemical challenges varies in different regions (He and Swain, 
2008; Simmer et al., 2010; Zhang et al., 2014). 
Developmental processes in enamel can profoundly affect the resultant 
composition by ion substitution. CO32- can replace OH- or PO43- groups, which 
depends on the pCO2 during the amelogenesis. Further, Ca2+ can also be partially 
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replaced by Mg2+ up to 0.3 % (Robinson et al., 2000). As both CO32- and Mg2+ 
are destabilising agents, the regions with higher concentrations of these ions, 
such as the core of enamel prism (Boyde, 1979), tend to dissolve faster under 
demineralisation (Robinson et al., 1995). On the other hand, F- is a stabilising 
agent. As FAP (or FHA) has stronger hydrogen bonds within the lattice than HAP, 
which stabilises the structure of fluoridated enamel, it is more acid-resistant than 
HAP (Garcia-Godoy and Hicks, 2008; Hicks et al., 2003; Robinson, 2009). F- can 
replace the OH- of the enamel during post-eruption maturation, or after contact 
between enamel and topical fluoride supplements, to form fluorapatite (FAP) or 
fluorohydroxyapatite (FHA) (Hicks et al., 2003). The incorporation of F- into 
enamel can be up to a depth of 100 μm (Arends and Christoffersen, 1990; Lynch, 
2013), whose amounts vary with the fluoride supplements that the enamel is 
exposed to (Schamschula et al., 1982). The difference in the F- concentration in 
the enamel surfaces between non-fluoridated areas and fluoridated areas could 
be up to 1000 ppm (Weatherell et al., 1977).  
 
1.2.2 Mineral Structure of Human Enamel 
 
Fig. 1.2 shows the projected crystal structure of stoichiometric HAP in human 
enamel viewed down the c-axis OH- column (Robinson et al., 2000). The ion 
arrangement is shown as one OH- surrounded by three Ca2+ (Ca II), with three 
PO43- outside these ions compassing them. These ions are enclosed by six Ca2+ 
(Ca I) arranged in a hexagon, called the hexagonal HAP unit cell.  
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Figure 1.2 - Hexagonal unit structure of HAP in human enamel (Adapted from Robinson et al., 
2000). 
 
A hexagonal enamel crystallite (50 nm in width and 25 nm in thickness), 
composed of millions of hexagonal HAP unit cells (Robinson et al., 2000; Lu et 
al., 2011), is the basic structural element (level 0) of enamel mineral (Yilmaz et 
al., 2015). During amelogenesis, hexagonal enamel crystallites are aligned along 
the c-axis under the guidance of proteins (Berkovitz, 2011; Robinson et al., 2000) 
and bundled into prisms (5 µm in diameter) and inter-prismatic matrix (level 1). 
The crystallites in the central part of a rod are aligned with the longitudinal axis of 
the prism, whereas, those at the sides are aligned in a divergent angle (nearly 
600) to the longitudinal axis of the prisms (He and Swain, 2007; He and Swain, 
2008). The arrangement of multiple prisms (level 2) in cross-section appears as 
“keyholes”, whereas, in the longitudinal view, the layout is more parallel. These 
arrangements (level 3) can be categorised as radial enamel in the outer layers 
and decussating enamel in the inner layers. Finally, different arrangements of 
enamel constitute the hierarchical structure of enamel (enamel pattern, level 4) 
to meet the mechanical and physical requirements of mastication in an oral 
environment (Fig. 1.3) (Berkovitz, 2011; Cui and Ge, 2007; Yilmaz et al., 2015). 
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Figure 1.3 - Microstructure of enamel showing hierarchical levels (From Yilmaz et al., 2015). 
 
1.3 Hydroxyapatite Discs as a Model System for Human enamel  
 
As hydroxyapatite (HAP) is the main constituent of human enamel (LeGeros, 
1991; Busch et al., 2001), compressed HAP discs have been used in many 
studies to simulate the demineralisation of human enamel (e.g., Anderson et al., 
2004a; do Amaral et al., 2016; Jones et al., 2013; Kosoric et al., 2010). HAP discs 
exhibit similar demineralisation kinetics to that of human enamel and can be used 
as a model for human enamel in order to understand the formation of in vivo 
dental caries or erosion (Shellis et al., 2010). 
The major difference between human enamel mineral and HAP is the presence 
of about 3 wt% carbonate (Mukundan et al., 1999), which leads to faster 
dissolution of human enamel than HAP discs (Anderson et al., 2004b; Shellis et 
al., 2010). Further, HAP discs do not have the complex biological structures (see 
Section 1.2.2) of human enamel (Anderson et al., 2004b; Yilmaz et al., 2015). 
However, as HAP discs are easy to obtain and have homogeneous chemical 
composition and structure, compared to human enamel minerals (Elliott, 1994; 
Lingawi, 2012), they have been accepted as suitable analogues for dental enamel 
mineral. 
Hierarchical order of enamel
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Chapter 2 DENTAL CARIES AND EROSION  
 
2.1 Enamel Demineralisation 
 
Enamel demineralisation results from two dental diseases, dental caries and 
erosion (Abou Neel et al., 2016). The source of acids in caries is from bacterial 
metabolism, while erosion is from acids without bacterial involvement (Selwitz et 
al., 2007; Ren, 2011). The difference between caries and erosion is seen in the 
structure of each. Caries is characterised by subsurface demineralisation 
resulting from the exposure to pH 4.5 ~ 6.5 organic acids following fermentation 
in the plaque. Whereas, erosion is characterised by surface softening resulting 
from exposure to pH 2.0 ~ 4.0 acidic diet, leading to the destruction of weakened 
inter-prismatic regions (Arends and ten Cate, 1981).  
Despite the differences between dental caries and erosion mentioned above, 
the development of these two dental lesions follows the same chemical reaction 
(Lussi, 2006a). As the pH decreases, trivalent phosphate ions (PO43-) and 
hydroxyl ions (OH-) of the enamel HAP will be protonated to divalent phosphate 
ions (HPO42-) and water (H2O), respectively. This transformation results in the 
formation of more soluble dicalcium phosphate dihydrate (CaHPO4 · 2H2O), so-
called brushite, and later causes the weakening of the bonding between PO43- 
and Ca2+. The consequent Ca2+ loss from enamel leads to enamel 
demineralisation (Robinson et al., 1995). 
 
2.2 Dental Caries  
 
Dental caries is the most common chronic disease worldwide (Moreira, 2012). It 
is characterised by localised subsurface destruction of enamel arising from 
organic acids generated by bacterial metabolism within the biofilm (Newbrun, 
1982; Selwitz et al., 2007).  
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2.2.1 Aetiology of Dental Caries 
 
Caries is a multifactorial disease (Hunter, 1988), whose development involves 
cariogenic microorganisms, environmental triggers and a susceptible host 
(Anderson, 2002; Marsh, 2009). Streptococcus mutans (S.m.), Streptococcus 
sobrinus and Lactobacillus acidophilus are the major cariogenic bacteria (Kidd, 
2005). They rapidly produce organic acids such as lactic and acetic acids by the 
fermentation of ingested carbohydrate (Bowen, 2013; Distler and Kroncke, 1980; 
Sheiham, 2001). Modern refined foods contain a high amount of sugars, 
especially sucrose, and can promote the production of these organic acids. 
Therefore, the constant intake of sugary food is a risk factor of dental caries 
(Marsh, 2009). Defects in tooth structure is also a risk factor, as they make the 
tooth more susceptible to acid challenge (Selwitz et al., 2007). The progression 
of caries is associated with time. The longer the time period that the tooth is in 
acidic conditions, the more destructive the dental lesion will be (Maya et al., 2015) 
(Fig. 2.1).  
 
 
Figure 2.1 – Aetiology of dental caries (Adapted from Selwitz et al., 2007). 
 
Host
DietBacteria
Behaviors, education
Saliva
Time
Socio-economic status
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As saliva has sufficient mineral concentrations to keep the fluid saturated with 
respect to the dental mineral, the integrity of enamel in contact with saliva is 
maintained (Garcia-Godoy and Hicks, 2008). Further, as the presence of F- in 
saliva is beneficial for the formation of less soluble FAP on the enamel surface 
(mainly HAP), the dental mineral can be further protected (Robinson, 2009; Miura 
et al., 1993). Therefore, the presence of saliva is a protective factor of dental 
caries, and the decrease in secretion of saliva is a risk factor. Other factors such 
as behaviour, socio-economic status and education level can also affect the risk 
of dental caries (Fig. 2.1) (Fejerskov, 2004; Selwitz et al., 2007). 
 
 
Figure 2.2 - Caries balance (Adapted from Garcia-Godoy and Hicks, 2008). 
 
Consequently, a caries balance can be established (Fig 2.2) based on the 
interaction between pathological and protective factors (Featherstone, 2004; 
Garcia-Godoy and Hicks, 2008). On one side, it is the pathological factors such 
as acidogenic bacteria, impaired salivary function and frequent carbohydrate 
consumption, resulting in enamel demineralisation. On the other side, it is the 
protective factors such as saliva flow, antibacterial effects, fluoride supplements 
and sufficient mineral concentrations, resulting in enamel remineralisation. The 
dynamic equilibrium between the pathological and protective factors determines 
No Caries Caries
Protective Factors Pathological Factors
Reduced salivary 
function
Cariogenic bacteria: 
Streptococcus mutans, 
Lactobacilli 
Carbohydrates
Salivary flow, proteins 
and antibacterial 
components
Fluoride, calcium and 
phosphate
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the final outcome of the carious lesion, which may be progression, reversal, or 
maintenance (Featherstone, 2004). 
 
2.2.2 Chemistry of Dental Caries 
 
The solubility of enamel mineral (mainly HAP, Ca10(PO4)6(OH)2) increases 10 
times with a decrease of 1 pH unit in the solution (Buzalaf et al., 2011). In the oral 
cavity, whenever the acidity of saliva is below the critical pH of HAP, it becomes 
under-saturated with respect to enamel mineral, leading to dental 
demineralisation (Dawes, 2003; Ehrlich et al., 2009). However, whenever the 
saliva acidity is above the critical pH, remineralisation of the dental mineral occurs 
(Fig. 2.3) (Anderson et al., 2001). Even though the generally recognised critical 
pH is 5.5, the actual value depends on the concentrations (activities) of OH-, Ca2+ 
and PO43- in the solution (Anderson et al., 2001; Dawes, 2003). With sufficient 
supply of Ca2+, enamel will not dissolve even under low pH, as long as the ion 
product (Ip) is equal or greater than the solubility product constant (Ksp) of HAP 
(suggested to be pKsp = 117.2) (Anderson et al., 2001; Dawes, 2003; Miura et al., 
1993). 
 
 
Figure 2.3 - Solubility isotherm of HAP. O: normal intra-oral condition (From Anderson et al., 
2001). 
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Before bacterially generated organic acids become in contact with the tooth, 
the acids diffuse through the dental plaque into the defects on the enamel surface, 
followed by demineralisation of the underlying mineral structure (Rosin-Grget et 
al., 2013). The carious lesion is usually initiated in the most accessible and 
soluble periphery and cores of the prisms (Featherstone, 1977). This is due to 
the loose arrangements of the crystals and the high content of soluble 
substitutions like CO32- and Mg2+ in these areas (Boyde, 1979). Next, the acid 
then penetrates via cross-striations and pores to the prism body and inter-
prismatic area (Featherstone, 2008; Marshall and Lawless, 1981; Robinson et al., 
2000).  
However, the development of a carious lesion is not only about the 
advancement of the acid, but also about the diffusion of dissolved Ca2+ and PO43- 
back to the surface region, which induces the formation of a surface zone by 
mineral re-deposition (Hicks et al., 2004; Moreno and Zahradnik, 1979; Rosin-
Grget et al., 2013). There are four zones that can be observed under the 
inspection of caries using polarising light microscopy; translucent zone, dark zone, 
body of lesion and surface zone (Fig 2.4) (Moreno and Zahradnik, 1979; 
Robinson et al., 2000; Silverstone, 1981). 
 
 
Figure 2.4 - Schematic diagrams of enamel caries (Adapted from Robinson et al., 2000). 
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2.2.2.1 Translucent zone 
 
The translucent zone is the first sign of caries lesion which can be detected by 
visual examination. It contains few but large pores with 1 ~ 2 % mineral loss. 
Preliminarily, the organic matrix is decomposed followed by the dissolution of the 
mineral material, which mostly takes place at inter-crystalline and inter-prismatic 
regions leading to the formation of channels for ion diffusion (Robinson et al., 
2000). 
 
2.2.2.2 Dark zone 
 
Dark zone is characterised by the smaller pores in addition to the big ones. There 
is an increased porosity of 5 ~ 10 % in the area. It has been postulated that those 
smaller pores are the consequence of slight remineralisation narrowing the large 
pores. Therefore, it implies that both demineralisation and remineralisation occur 
at the same time during the process of caries (Robinson et al., 2000). 
 
2.2.2.3 Body of lesion 
 
In the body of lesion, there is a higher porosity up to 25 ~ 50 %. It represents the 
final stage of the enamel demineralisation after the continuous enlargement of 
pores which ends up with cavitation. The concentrations of CO32- and Mg2+ are 
lower, whilst that of F- is higher in this zone, which facilitates the lateral 
enlargement of crystallites. This phenomenon further indicates that 
remineralisation happens during the carious process (Pearce et al., 1995; 
Robinson et al., 2000). 
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2.2.2.4 Surface zone 
 
The surface zone remains relatively intact much longer than the other zones 
under demineralisation, which means that it might be preserved or benefited from 
the re-deposition process. The porosity of this zone is 1 ~ 2 % which is similar to 
that of the sound enamel (Anderson et al., 2004a; Robinson et al., 2000). It has 
been proposed that due to the higher content of F- in superficial area of enamel, 
and the covering of pellicle which retards the mineral loss, the acid may penetrate 
into the deeper layers of enamel to preferentially dissolve more soluble 
subsurface substances (Matinlinna, 2015; Robinson et al., 1995). 
Subsurface lesions may be attributed to the re-deposition of mineral from the 
deeper dissolved regions (Moreno and Zahradnik, 1974). Together with 
components from the plaque, three solid phases including HAP, dicalcium 
phosphate dihydrate (DCPD), and FAP can achieve an equilibrium with the 
aqueous phase in the pores, leading to remineralisation at the surface zone (Fig. 
2.4) (Moreno and Zahradnik, 1974). Supersaturation of oral fluids with respect to 
FAP (pKsp = 121.2) is crucial for the maintenance of the surface zone (Buzalaf et 
al., 2011; Miura et al., 1993), and more supersaturated the solution with respect 
to FAP, thicker the surface layer will be (Kidd, 2005). A natural enamel carious 
lesion has been reported to have a surface layer with a thickness of surface zone 
in the range of 35 ~ 130 µm (Cochrane et al., 2012). 
 
2.2.3 Epidemiology of Dental Caries  
 
It has been reported that, in 2012, 60 ~ 90 % of children in school and almost 100 
% of adults experience dental cavitation worldwide (Moreira, 2012). Further, 
approximately 92 % of the adults aged 20 to 64 have been reported to have dental 
decay in the permanent teeth, while 42 % of the children with age 2 to 11 had 
caries in their deciduous teeth (NIH, 2014). The worldwide average of DMFT 
(number of permanent teeth decayed, missing and filled teeth) is 2.11+ 1.32 
(Moreira, 2012). Even though there has been a dramatic decline in DMFT number 
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and prevalence for the past several decades (Moreira, 2012), dental caries is still 
a prevalent oral disease in several countries including USA, UK, China, Brazil, 
Mexico, Norway, Argentina and Taiwan (Bagramian et al., 2009).  
 
2.3 Dental Erosion  
 
Dental erosion is defined as the loss of dental hard tissue through chemical 
dissolution by acids of non-bacterial origin (Amaechi and Higham, 2005; Lussi, 
2006b; Magalhaes et al., 2009a). It is a surface phenomenon showing bulk 
substance loss, together with a smaller softened surface layer (Magalhaes et al., 
2011).  
 
2.3.1 Aetiology of Dental Erosion 
 
Dental erosion is a multi-factorial disease, whose development involves the direct 
interaction between the tooth surface and the erosive solution (Lussi, 2006a). 
Further, personal habits and lifestyles can affect the development of dental 
erosion (Lussi, 2006a; Donovan, 2011; Magalhaes et al., 2009b; Gupta et al., 
2009). It has been proposed that the determinant factors of the dental erosion 
progression include chemical, biological and behaviour factors, while physiologic 
health, educational level and socio-economic status are the modifying factors 
(Fig 2.5) (Donovan, 2011; Magalhaes et al., 2009b; Meurman and ten Cate, 
1996). In this section, the chemical factors are discussed.  
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Figure 2.5 - Causal factors of erosion (Adapted from Magalhaes et al., 2009b). 
 
2.3.2 Chemistry of Dental Erosion  
 
 
Figure 2.6 - Degree of saturation plotted against pH with respect to HAP and FAP at certain 
salivary concentration. FAP can still be formed under carious condition while neither HAP or FAP 
can be formed under erosive pH (Adapted from Meurman and ten Cate, 1996). 
 
Dental erosion is caused by much lower pH of acids than caries, below the critical 
pH of FAP (= 4.5) (Fig. 2.6) (Magalhaes et al., 2009b; Meurman and ten Cate, 
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1996). Therefore, as the erosive lesion is developed in a solution under-saturated 
with respect to both HAP and FAP, no surface layer can be formed in the erosive 
lesion (Fig. 2.7) (Arends and ten Cate, 1981; Larsen, 1974; Larsen, 1990). After 
erosive acid comes into contact with enamel, the dissociated H+ dissolves enamel 
crystals, initially from the enamel sheath area to prism core, and subsequently 
diffuses to the inter-prismatic area (Donovan, 2011; Lussi, 2006a). This results in 
a “honeycomb” appearance in prismatic enamel (Fig. 2.8) (Lussi, 2006b; Wang 
et al., 2006). 
 
a   
b  
Figure 2.7 - (a) Schematic of erosive lesion: O = outer surface; S = sound enamel. (b) Schematic 
of carious lesion: SL = surface layer; L: lesion; P: prisms (Adapted from Arends and ten Cate, 
1981). 
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Figure 2.8 – Honeycomb erosion lesion (From Wang et al., 2006). 
 
Erosive acids can be categorised into extrinsic acids such as fresh fruits, fruit 
juice, soft drinks, acidic mouth rinse, acidic drugs and acidic industrial vapour 
(Linnett and Seow, 2001; Richards, 2016; Shaw and Smith, 1999; Ren, 2011), 
and intrinsic acids such as gastric contents (Linnett and Seow, 2001; Shaw and 
Smith, 1999). Fruits commonly have carboxylic and citric acids, and vinegar has 
acetic acid, while carbonic and phosphoric acids are usually present in soft drinks 
(Abou Neel et al., 2016; White et al., 2001). It has been proposed that the pH of 
extrinsic acids varies between 2.5 ~ 4.0, while that of gastric acid is about 1.2 
(Magalhaes et al., 2009b). However, pH is not the only indicator of erosive 
potential, factors like type of acid, titratable acidity (buffering capacity), Ca2+, 
PO43- and F- concentrations, and chelating properties are all elements for erosive 
potential (Lussi, 2006b; ten Cate and Imfeld, 1996).  
Titratable acidity represents the amount of the actual H+ concentration 
available to interact with the dental mineral. The greater titratable acidity is, the 
harder for saliva to neutralise the pH (Linnett and Seow, 2001; Singh and Jindal, 
2010). Different from pH measuring only the dissociated ions in a solution, 
titratable acidity also measures the erosive potential of bound compounds, giving 
a more comprehensive view of the potential acidity of a solution (Cairns et al., 
2002; Shellis et al., 2014).  
After acids dissociate into H+ and acid anions, the combination of CO32- and 
PO43- with H+ in conjunction with the complexation of Ca2+ with anions lead to the 
softening of an enamel surface (Shellis et al., 2014). The strength of acids is 
determined by the acid dissociation constant (Ka), describing how complete the 
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acids dissociate. Whereas, the strength of anion-calcium interaction is 
determined by stability constant (K), describing how strong the binding 
established between anion and calcium (i.e., chelating ability) (Lussi, 2006a; 
Shellis et al., 2014). Every acid has different strengths of these properties. For 
acetic acid, it has lower erosive potential than lactic acid, as lactic acid dissociates 
more readily to release more H+, and the lactate-calcium interaction is stronger 
than acetate-calcium interaction, leading to a stronger chelating effect (Lussi et 
al., 1993; Shellis et al., 2014). 
The other chemical factor associated with erosive potential is the degree of 
saturation with respect to the enamel mineral. This factor is associated with the 
concentrations of Ca2+, PO43- and F- in the solution. For example, soft drinks 
enriched with calcium and phosphate salts have been shown to have a protective 
effect against dental erosion on the teeth (Hara and Zero, 2008; Lussi, 2006b). 
 
2.3.3 Epidemiology of Dental Erosion 
 
Dental erosion is a common oral disease and a serious public health issue, which 
is widespread in developed countries such as United Kingdom, Sweden, Canada 
and the United States (Higham, 2014; Ren, 2011). Several studies have 
suggested that preschool children between 2 ~ 5 years old had a prevalence of 
erosion of 6 ~ 50 %, while school-aged children had a prevalence of 20 ~ 100 %, 
and adults aged between 18 and 88 years had a prevalence of 4 % ~ 82 % (Lussi, 
2006b; Higham, 2014). In the UK, 77 % of 20 ~ 25-year-olds have been reported 
to have erosion (Abou Neel et al., 2016). 
It has been reported that both the prevalence and the incidence of dental 
erosion, especially in adolescences, has increased recently (Donovan, 2011; 
Gupta et al., 2009; Linnett and Seow, 2001; Shaw and Smith, 1999), which might 
arise from the increasing consumption of acidic diets such as soft drinks and fruit 
juices, and the growing number of people suffering from reflux of gastric content 
(Donovan, 2011; Lussi, 2006a; ten Cate and Imfeld, 1996). In 2010, a Chinese 
study reported that dental erosion in 12 to 13-year-old school children is 
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becoming a significant problem, which is in need of an effective solution (Wang 
et al., 2010). 
 
2.4 Role of Fluoride in Enamel Demineralisation 
 
Fluoride was introduced into dentistry almost 80 years ago and is considered to 
be the major reason for the drastic decline in the caries prevalence for the past 
decades (Bratthall et al., 1996; ten Cate, 2013). Multiple fluoride supplements 
have been used for more than 70 years and can be found in various forms, 
including drinking water (0.5 ~ 1 ppm), dentifrices (100 ~ 1500 ppm), 
mouthwashes (250 ~ 500 ppm), and gels and varnishes (> 5000 ppm) (Buzalaf 
et al., 2011; Hellwig and Lennon, 2004; Li et al., 2014; Mohammed et al., 2014a; 
ten Cate et al., 2008; Twetman et al., 2003). 
  The inhibitory mechanism of F- on demineralisation of HAP involves three 
modes of interactions (Rosin-Grget et al., 2013): 
 
1) Ionic exchange: 
Ca10(PO4)6(OH)2 + 2F-          Ca10(PO4)6F2 + 2OH-                                        (Eq. 2.1) 
2) Crystal growth:  
10Ca2+ + 6PO43- + 2F-         Ca10(PO4)6F2                                                       (Eq. 2.2) 
3) HAP reaction with F- resulting in CaF2 formation:  
Ca10(PO4)6(OH)2 + 20F-        10CaF2 + 6PO43- + 2OH-                                 (Eq. 2.3) 
 
It has been suggested that the Eq. 2.1 and Eq. 2.2 take place following long-term 
exposure to low concentrations of fluoride solution (0.01 ~ 100 ppm), while crystal 
growth will occur when the solution is supersaturated with FAP (Ksp = 10-121). Both 
systemic and topical fluoride sources can lead to these two processes (Cury and 
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Tenuta, 2009; Rosin-Grget and Lincir, 2001). On the other hand, the formation of 
CaF2 (Ksp = 3 X 10-10.4) (Eq. 2.3) takes place in solution with higher concentrations 
of fluoride (> 100 ppm at pH 5.0; > 300 ppm at pH 7.2) (McCann, 1968; ten Cate, 
1997), which usually results from topical fluoride sources (Mohammed et al., 2013; 
Rosin-Grget et al., 2013; ten Cate and Featherstone, 1991). At the higher fluoride 
concentrations, Eq. 2.1 and Eq. 2.2 play minor roles, while Eq. 2.3 accounts for 
the major reaction (Rosin-Grget et al., 2013; Yamaga et al., 1972). An in vitro 
study found that, under a pH 4.0 acid challenge, when [F-] was below 45 ppm, 
FAP (or FHA) was predominantly formed in enamel surface, whereas CaF2 was 
predominantly formed only when the [F-] was above 135 ppm (Mohammed et al., 
2013).  
Both incorporated fluorides (e.g., fluorapatite; FAP and fluorohydroxyapatite; 
FHA), and deposited fluorides (e.g., CaF2), can contribute to the inhibition of 
enamel demineralisation (Rosin-Grget et al., 2013; ten Cate, 1997; White and 
Nancollas, 1990). As F- has a better “fit” into the HAP lattice compared to the 
larger asymmetric OH-, FAP (or FHA) has higher thermal and chemical stability 
than HAP (Robinson et al., 2004). Therefore, FAP (or FHA) formed in the enamel 
surface is acid-resistant (Robinson, 2009). As the formation of pure FAP is 
difficult in a clinical situation, FHA formation is usually more likely (Mei et al., 
2018).  
On the other hand, CaF2 formed on the enamel surface can inhibit the acid 
attack as a protective barrier (Magalhaes et al., 2011). The formation of CaF2 
requires slight dissolution of the enamel surface in order to provide the necessary 
Ca2+, followed by the reaction with F- (Buzalaf et al., 2011). The CaF2 formed 
following interaction between fluoride and enamel (mainly HAP) is granular due 
to the adsorption of HPO42- around CaF2 (Barbier et al., 2010; Rolla, 1988). This 
granular CaF2 is called “CaF2-like globule”, which is less soluble and dissolves 
more slowly than pure CaF2 during acid attacks (White and Nancollas, 1990). 
Therefore, CaF2 (or CaF2-like globule) can also act as a pH-driven reservoir of F-, 
which favours the formation of FAP (or FHA) (ten Cate, 2013; Vogel, 2011). It has 
been proposed that under an acid challenge, F- in enamel fluid, dissolved from 
CaF2, can be adsorbed onto the enamel surface (Featherstone, 1999). These 
adsorbed F- attract Ca2+ and PO43- from oral fluids to form FAP (or FHA), which 
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protects the mineral of a tooth (Fig. 2.9) (Arends and Christoffersen, 1990; 
Featherstone, 2008).  
 
 
Figure 2.9 – Schematic representation of F- absorb onto enamel surface, which attract Ca2+ and 
PO43-, to form an insoluble FAP (or FHA) veneer (From Featherstone, 2008). 
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Chapter 3 TOPICAL TREATMENTS WITH SILVER 
COMPOUNDS FOR PROTECTION AGAINST ENAMEL 
DEMINERALISATION 
 
3.1 Use of Silver Compounds in Dentistry 
 
Minimal Intervention Dentistry (MID) has been advocated since the early 1990s, 
in order to keep the teeth functional for a whole lifetime. In contrast to traditional 
clinical treatment, the aim of MID is to reduce the need of tissue cutting and save 
as much healthy tissue as possible by enhancement of cariostatic effect, and by 
minimally invasive restoration (Frencken et al., 2012; Murdoch-Kinch and 
McLean, 2003; Wilson, 2007). Even though fluoride has pronounced 
remineralisation ability and is still the cornerstone of MID for dental caries 
management (Hellwig and Lennon, 2004), the fluoride concentration in the oral 
cavity is not enough to inhibit cariogenic bacterial activities (Tenuta and Cury, 
2010). Recently, the use of silver compounds for dental caries has been a 
growing trend in dentistry due to their anti-bacterial properties and non-invasive 
ways of applications (Horst et al., 2016; Wilson, 2007). Common silver products 
used in dentistry include silver nitrate (AgNO3), silver fluoride (AgF) and SDF 
(Ag[NH3]2F) (Peng et al., 2012). Ag[NH3]2F has been the most popular silver 
compound used in the clinical practice lately, whose treatment is effective in 
arresting and preventing dental caries both in deciduous and permanent 
dentitions (Peng et al., 2012; Yamaga et al., 1972).  
In terms of cariostatic mechanisms of silver compounds, their anti-bacterial 
mechanisms have been extensively investigated (Lansdown, 2002; Lansdown, 
2006; Russell and Hugo, 1994; Thibodeau et al., 1978). However, even though 
numerous studies have investigated the effects of silver compounds on dental 
minerals (Green, 1989; Liu et al., 2012b; Lou et al., 2011; Mei et al., 2017; Miller, 
1905; Punyanirun et al., 2018), the inhibitory mechanisms of topical treatments 
with AgNO3, AgF and Ag[NH3]2F on demineralisation of dental mineral remain 
obscure.  
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In clinical practice, treatments with silver compounds are topically applying the 
silver compounds on the lesions using a micro-brush for a certain application time 
(Horst et al., 2016). Therefore, to investigate the effects of the topical treatments 
with silver compounds on demineralisation of dental mineral in vitro, a real-time 
methodology able to allow “as if clinical” topical treatments with silver compounds 
on dental mineral, i.e., following a clinical protocol, needs to be developed. 
 
3.2 Topical Treatments with Silver Nitrate for Protection against 
Enamel Demineralisation 
 
Since the 1840s, silver nitrate (AgNO3) (pH 4.2) has been used to reduce the 
prevalence of caries in deciduous dentition (Peng et al., 2012; Lou et al., 2011). 
Other applications of AgNO3 include caries prevention in permanent dentition, 
and as a desensitising agent. In 1917, Howe developed ammoniacal silver nitrate 
(Ag[NH3]2NO3, so-called Howe’s solution), and this has been subsequently used 
in caries management (Rosenblatt et al., 2009).  
AgNO3 was one of the first silver compounds topically applied to manage dental 
caries due to its antibacterial property. It has been concluded that the major anti-
bacterial component of silver compounds was the Ag+ (Thibodeau et al., 1978). 
10 ~ 40 ppm of Ag+ has been shown to be able to destroy most of the pathogens 
(Lansdown, 2006). Further, it was found that 20 ppm Ag+ is lethal to 
Streptococcus mutans (S.m.) after contact of 3 to 4 h, while 200 ppm Ag+ is 
instantaneously lethal to S.m. (Thibodeau et al., 1978).  
Even though the antibacterial property of AgNO3 is well-understood, its effects 
on dental mineral are still unclear. The interaction between AgNO3 and enamel 
mineral has been suggested to be (Yamaga et al., 1972):  
 
Ca10(PO4)6(OH)2 + 20AgNO3     6Ag3PO4 + 10Ca(NO3)2 + Ag2O + H2O (Eq. 3.1) 
 
and shown diagrammatically in Fig 3.1: 
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Figure 3.1 – Reaction between AgNO3 and HAP. The PO43- released from demineralising enamel 
can be preserved by the formation of Ag3PO4 (Adapted from Yamaga et al., 1972). 
 
As the Ag3PO4 (yellow) is insoluble (solubility = 6.5 X 10-4 g/100 mL) (Lewis, 1920) 
(Eq 3.1 and Fig. 3.1), it has been proposed that the formation of a “protective 
barrier” composed of insoluble Ag3PO4 following treatment with AgNO3 can inhibit 
the demineralisation of dental mineral (Lou et al., 2011; Yamaga et al., 1972). On 
the other hand, the formation of soluble Ca(NO3)2 (solubility = 121.2 g/100 mL) 
has been proposed to result in the loss of Ca2+ from the treated dental mineral 
(Yamaga et al., 1972).  
A study found that following mixing HAP powders with AgNO3, the colour of the 
mixture changed from white to yellow immediately due to the formation of yellow 
Ag3PO4 particles (Lou et al., 2011). Gradually, these yellow particles turned black 
due to the chemical reduction of yellow Ag3PO4 to black metallic silver. The 
formation of black metallic silver is the cause of the black staining of lesions 
topically treated with silver compounds, which is the major disadvantage of silver 
compound treatments (Peng et al., 2012). However, even though Ag3PO4 was 
confirmed to be formed in the mixture of HAP powders with AgNO3, the formation 
of Ag3PO4 following the topical treatment with AgNO3 on enamel mineral using a 
micro-brush has not been confirmed. Further, any protective effect of the Ag3PO4 
has not been investigated. 
Other than the previously proposed protective effect from AgNO3 treatment  
(Yamaga et al., 1972), a study found that the Ca2+ in HAP could be substituted 
by Ag+ after immersion of HAP in AgNO3 (Ling Feng et al., 1998). Moreover, it 
has been reported that the solubility of the Ag+ substituted HAP disc under pH 
HAP + AgNO3 Ag3PO4 + Ca(NO3)2
Demineralising Enamel 
PO4
3-
preserved
Ca2+ loss
Ag3PO4
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4.2 acid attack increased with increasing incorporation of Ag+ in the HAP (Singh 
et al., 2011). This indicates that Ag+ substituted HAP was more susceptible to 
acid challenge than HAP. Further studies are required to see whether a similar 
dose-response effect of Ag+ can also occur, influencing the demineralisation of 
human enamel. 
 
3.3 Topical Treatments with Silver Fluoride for Protection 
Against Enamel Demineralisation 
 
Since the 1970s, silver fluoride (AgF) (pH 11.0) has been used to treat dental 
caries. AgF is a colourless solution comprising silver and fluoride. The 
applications of AgF can disturb the growth and metabolism of the bacteria in the 
biofilm (Shah et al., 2014). A series of clinical trials were carried out using 40 wt% 
(3.16 M) AgF followed by topical application of 10 wt% SnF2 as a reducing agent 
in an Australian school (Craig et al., 1981; Craig et al., 1987; Green, 1989). It was 
shown that this combination treatment was more effective than the treatment with 
10 wt% SnF2 alone, which could arrest proximal and occlusal caries in deciduous 
dentitions and prevent the development of caries in first permanent molars. It has 
been suggested that the application of AgF can facilitate the formation of both 
insoluble Ag3PO4 and CaF2 (solubility = 0.0015 g/ 100 mL), and therefore the loss 
of both PO43- and Ca2+ from enamel mineral can be inhibited (Peng et al., 2012; 
Yamaga et al., 1972). However, no study has been carried out to confirm this 
theoretical cariostatic mechanism.  
Unfortunately, many studies claiming to examine the effects of AgF, are 
actually using Ag[NH3]2F (Peng et al., 2012; Rosenblatt et al., 2009). 
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3.4 Topical Treatments with SDF for Protection Against Enamel 
Demineralisation 
 
As the storage of topical AgF agent for a long period is not easy due to 
photosensitivity of Ag+ (Liu et al., 2012c; Zhao et al., 2017a), Ag[NH3]2F (Silver 
Diammine Fluoride, SDF) was developed. The ammonia in SDF helps to stabilise 
Ag+ in the solution by forming a silverdiammine complex, [Ag(NH3)2]+, through 
reversible reaction (Liu et al., 2012b). Ag[NH3]2F is also a colourless solution 
comprising silver and fluoride but less alkaline (pH ~ 10.0) (Mei et al., 2013a).  
Since the 1970s, Ag[NH3]2F has been accepted as a therapeutic agent for anti-
caries function by the central Pharmaceutical Council of the Ministry of Health 
and Welfare in Japan (Yamaga et al., 1972). However, the applications of 
Ag[NH3]2F are not common in western countries (Gao et al., 2016). Recently, 
Ag[NH3]2F has drawn attention from dental researchers due to its profound 
effectiveness in preventing and arresting dental caries, and its non-invasive 
method of application (Frencken et al., 2012; Mei et al., 2017). In 2015, Ag[NH3]2F 
entered the US market shortly after being approved for clinical use by United 
State Food and Drug Administration (FDA) in 2014 (Horst et al., 2016). In 2016, 
a Current Dental Terminology (CDT) code was approved for Ag[NH3]2F  to be 
used in arresting dental caries (Horst et al., 2016).  
Ag[NH3]2F has been regarded as an efficient, affordable, effective and safe 
therapeutic agent across ages, whose application for caries control conforms to 
the World Health Organization’s Millennium Goals, and the US Institute of 
Medicine’s criteria for 21st Century medical care (Horst et al., 2016). Further, the 
low cost and the simplicity of Ag[NH3]2F treatment on dental caries make it 
appropriate to be used in children from low-income families living in 
underprivileged and remote areas (Chu and Lo, 2008b; Contreras et al., 2017; 
Fung et al., 2013). In terms of caries in permanent teeth of adults, Ag[NH3]2F can 
also be used for patients who cannot tolerate conventional treatments, or for 
patients with extreme risks of caries such as salivary dysfunction (Horst et al., 
2016).  
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It has been proposed that the use of Ag[NH3]2F is more effective in controlling 
carious lesions than other minimally invasive topical treatments such as fluoride 
varnish (Crystal and Niederman, 2016). However, similar to other silver 
compound treatments, the major disadvantage of topical treatment with 
Ag[NH3]2F is the black staining of the treated lesion (Fig. 3.2) (Horst et al., 2016; 
Mei et al., 2016). A new Ag[NH3]2F product, which is claimed to be able to treat 
lesions without the black staining has been issued by Riva Star (SDI Ltd, 
Australia). The product comprises a silver capsule containing 3.16 M Ag[NH3]2F, 
and a green capsule containing saturated solution of potassium iodine (SSKI). 
The concept is that the application of SSKI following treatment with Ag[NH3]2F 
will remove excessive Ag+ by forming white AgI, thereby eliminating the possibility 
of black staining (Ngo et al., 2002).  
 
 
Figure 3.2 – Black staining of Ag[NH3]2F treated teeth (From Mei et al., 2016). 
 
3.4.1. Clinical Effects of Topical Treatments with SDF on Enamel 
Caries  
 
Many Ag[NH3]2F studies have been carried out to investigate its effectiveness in 
clinical practice (Contreras et al., 2017). These studies cover a wide range from 
coronal caries in primary teeth and permanent teeth, to root caries (Appendix A). 
In this section, clinical studies of Ag[NH3]2F topical treatments on coronal caries 
are discussed. 
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Amongst all the different concentrations of Ag[NH3]2F available, including 12 
wt% (0.75 M), 38 wt% (2.36 M) and 50.9 wt% (3.16 M) Ag[NH3]2F (Fung et al., 
2013; SDI, 2016a), 38 wt% is the most commonly used (Horst et al., 2016). An 
annual application of 38 wt% Ag[NH3]2F has been reported to be able to prevent 
pit and fissure caries in permanent 1st molars (Liu et al., 2012a). Further, Llodra 
et al. found that a biannual 38 wt% Ag[NH3]2F application could reduce and 
prevent caries in both deciduous teeth and permanent 1st molars (Llodra et al., 
2005). Recently, a randomised controlled trial (RCT) concluded that the topical 
application of 38 wt% Ag[NH3]2F is effective and safe in arresting cavities in 
preschool children (Milgrom et al., 2018). Chu et al. reported a case about 
application of 38 wt% Ag[NH3]2F on rampant caries in permanent dentition (Chu 
et al., 2014); A 14-year-old boy with chronic oral graft versus host disease (GVHD) 
was in need of treatment of multiple cavitated caries. After topical application of 
38 wt% Ag[NH3]2F followed by restoration with temporary dental material, the 
prognosis was good without any pain perceived.  
However, despite the fact that there are multiple concentrations of Ag[NH3]2F 
products on the market, the does-response effects of these products have not 
been investigated. Further, even though the compositions of all the commercial 
Ag[NH3]2F products were provided in their safety data sheets (SDS), the 
manufacture processes of the products are market secrets. Therefore, studies 
can be done to compare the effects of the topical treatments with these products 
with the effects of the same concentration of laboratory-prepared Ag[NH3]2F on 
the demineralisation of dental mineral. 
 
3.4.2 Establishment of Standard Protocol for Topical Treatment with 
SDF 
 
Several studies have shown that Ag[NH3]2F is more effective in caries arrest at 
38 wt% (2.36 M) than 12 wt% (0.75 M) (Fung et al., 2016; Fung et al., 2018). 
Furthermore, randomised controlled trials (RCTs) have found that biannual 
application of 38 wt% Ag[NH3]2F application is more effective than annual and 
consecutive three weekly Ag[NH3]2F applications in caries arrest (Duangthip et 
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al., 2016; Fung et al., 2016; Fung et al., 2018; Yee et al., 2009; Zhi et al., 2012). 
Therefore, based on the current evidence (Duangthip et al., 2017; Fung et al., 
2016; Fung et al., 2018), the biannual application of 38 wt% Ag[NH3]2F is the 
most effective protocol.  
For Ag[NH3]2F application, application times from 10 sec to 3 min have been 
used in most of the clinical studies. In 2016, University of California San Francisco 
(UCSF) proposed that the application time of Ag[NH3]2F should be more than 1 
min for the optimal effectiveness (Horst et al., 2016). They also recommended 
that Ag[NH3]2F treated lesion should be rinsed. However, concerns have been 
expressed about losing effectiveness by rinsing (Horst, 2018). Another review 
suggested that a 30 ~ 60 sec Ag[NH3]2F application followed by air-drying 
provides the best results for caries arrest (Crystal and Niederman, 2016). Lately, 
in 2017, American Academy of Paediatric Dentistry (AAPD) announced a 
guideline of using 1 min 38 wt% Ag[NH3]2F application followed by gentle air-
drying in arresting carious primary teeth. Further, they expected similar cariostatic 
effectiveness of Ag[NH3]2F could be exerted on carious permanent teeth through 
the same protocol (Crystal et al., 2017). Therefore, 1 min application followed by 
air-drying should be the best procedure for Ag[NH3]2F treatment.  
 
3.4.3 Cariostatic Mechanisms of SDF 
 
Even though several possible cariostatic mechanisms of Ag[NH3]2F have been 
suggested (Mei et al., 2018; Zhao et al., 2017a), to date, its cariostatic 
mechanism is still unclear (Mei et al., 2017). It has been proposed that as fluoride 
in Ag[NH3]2F inhibits mineral loss, and silver in Ag[NH3]2F inhibits activities of 
cariogenic bacteria, the development of dental caries can be arrested (Rosenblatt 
et al., 2009). Actions of Ag[NH3]2F on dental mineral, cariogenic bacteria and 
dentinal organic content (Appendix A) have all been studied, and the action of 
Ag[NH3]2F on enamel mineral is discussed in this section.  
The interaction between Ag[NH3]2F and enamel mineral has been suggested 
to be (Yamaga et al., 1972):  
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Ca10(PO4)6(OH)2 + Ag[NH3]2F        CaF2 + Ag3PO4 + NH4OH                 (Eq. 3.2) 
 
and shown diagrammatically in Fig 3.3: 
 
Figure 3.3 –. Reaction between Ag[NH3]2F and HAP. The Ca2+ and PO43- released from 
demineralising enamel can be preserved by the formation of CaF2 and Ag3PO4, respectively 
(Adapted from Yamaga et al., 1972). 
 
As both insoluble CaF2 (solubility = 1.6 X 10-3 g/100 mL) and Ag3PO4 (solubility 
= 6.5 X 10-4 g/100 mL) are formed following Ag[NH3]2F application (Eq. 3.2), it 
has been proposed that both Ca2+ and PO43- released from dental mineral, can 
be preserved by the formation of a protective barrier composed of insoluble CaF2 
and Ag3PO4 (Fig. 3.3). Furthermore, the formed CaF2 has been proposed to act 
as a reservoir of F- for the formation of acid-resistant FAP (or FHA) (Yamaga et 
al., 1972).  
It has been reported that CaF2 and Ag3PO4 were formed in enamel powders 
mixed with Ag[NH3]2F (Zhao et al., 2017a). Further, an study found that the 
mineral density of incipient enamel caries in permanent premolars treated with 
Ag[NH3]2F was increased (Punyanirun et al., 2018). These findings suggest the 
ability of Ag[NH3]2F application in preserving both Ca2+ and PO43- of the treated 
dental mineral. However, it has been proposed that Ag3PO4 can be dissolved in 
ammonium (Firsching, 1961), which may affect the Ag3PO4 formation following 
Ag[NH3]2F topical treatment. Further, a study reported that following mixing HAP 
powders with Ag[NH3]2F, metallic silver rather than Ag3PO4 was found, and the 
CaF2-like globules disappeared after rinsing with water (Lou et al., 2011). 
Therefore, the formation of Ag3PO4 and the cariostatic efficacy of the formed 
CaF2 are questionable.  
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Recently, an in vitro study was carried out using calcium phosphate 
(Ca3(PO4)2) incubated with low concentrations of Ag[NH3]2F (2.36 X 10-3 ~ 2.36 
X 10-2 M), taking into account the salivary dilution after application (Mei et al., 
2017). After incubation at 37 0C for 24 h, fluorohydroxyapatite (FHA, a partially 
fluoride-substituted HAP) was found using X-ray diffraction (XRD). As a result, 
they proposed that acid-resistant FHA formation should be a more reasonable 
explanation for the cariostatic efficacy of treatment with Ag[NH3]2F (Mei et al., 
2017).  
However, Ca3(PO4)2 is stoichiometrically different from HAP and enamel 
mineral, and XRD is not a suitable technique to differentiate FHA from HAP due 
to the crystallographic similarity between these two compounds. Therefore, 
further studies are required to confirm the formation of FHA following topical 
treatment with Ag[NH3]2F on enamel mineral. 19F MAS-NMR is one of the few 
techniques capable of differentiating FHA from HAP, which can be used to 
identify FHA following Ag[NH3]2F topical treatment on dental mineral (Elsharkawy 
et al., 2018; Mohammed et al., 2013; White et al., 1994). 
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Chapter 4 AIMS AND OBJECTIVES 
 
4.1 Aims 
 
1. To develop a real-time methodology to investigate the effects of topical 
treatments with silver compounds on dental mineral. 
2. To investigate the dose-response effects of Ag+ in solution on demineralisation 
of human enamel. 
3. To understand the inhibitory mechanisms of topical treatments with silver 
compounds, including silver nitrate (AgNO3), silver fluoride (AgF) and SDF 
(Ag[NH3]2F), on demineralisation of hydroxyapatite (HAP) discs and human 
enamel. 
4. To investigate the dose-response effects of topical treatments with AgNO3, 
AgF and Ag[NH3]2F on demineralisation of human enamel. 
5. To compare the inhibitory efficacy and effects of topical treatment with a 
commercial Ag[NH3]2F product with laboratory-prepared Ag[NH3]2F on 
demineralisation of HAP discs and human enamel. 
 
4.2 Objectives 
 
1. Real-time Ca2+ ion selective electrodes (ISEs) will be used to monitor calcium 
loss of hydroxyapatite (HAP) discs before and after treatments with increasing F- 
and Zn2+ concentrations in order to validate the technique by comparison with the 
previously reported dose-response studies of demineralisation inhibition using 
Scanning Microradiography (SMR) (Chapter 6). 
2. Real-time scanning microradiograph (SMR) will be used to monitor mineral 
loss of human enamel under acid challenge in a demineralisation solution 
containing an increasing concentration of Ag+ (Chapter 7). 
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3. Ca2+, Ag+ and F- ISEs, scanning electron microscopy (SEM), energy dispersive 
X-ray analysis (EDX) and 31P and 19F MAS-NMR will be used to investigate the 
effects of topical treatments with 3.16 M AgNO3, 3.16 M AgF and 3.16 M 
Ag[NH3]2F on the demineralisation of HAP discs and human enamel (Chapter 8 
and 10). Also, a Knoop micro-hardness tester will be used to investigate the 
effects of topical treatments with 3.16 M AgNO3, 3.16 M AgF and 3.16 M 
Ag[NH3]2F on demineralisation of human enamel (Chapter 10). 
4. Ca2+, Ag+ and F- ISEs, SEM, EDX, 31P and 19F MAS-NMR and Knoop micro-
hardness tester will be used to investigate the effects of topical treatments with 
0.75 M, 2.36 M and 3.16 M of AgNO3, AgF and Ag[NH3]2F on the demineralisation 
of human enamel (Chapter 10). 
5. Ca2+, Ag+ and F- ISEs, SEM, EDX and 31P and 19F MAS-NMR will be used to 
investigate the effects of topical treatment with Silver Capsule of Riva Star (SDI 
Ltd, Australia) on the demineralisation of HAP discs and human enamel (Chapter 
8). Also, a Knoop micro-hardness tester will be used to investigate the effects of 
topical treatment with Silver Capsule of Riva Star on demineralisation of human 
enamel (Chapter 10). 
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PART II: INTRODUCTION OF 
TECHNIQUES USED IN THIS 
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Chapter 5 TECHNIQUES USED IN THIS STUDY 
 
5.1 Scanning Microradiography 
 
Scanning microradiography (SMR) is an X-ray attenuation technique, which can 
monitor the mineral mass of the specimen in real-time (Anderson and Elliott, 1993; 
Elliott et al., 1994). During the experiment, the specimen is contained in a SMR 
cell, which is mounted on the SMR stage. Next, the intensity of a 15 μm X-ray 
beam attenuated by passing through the specimen, is continually measured. The 
attenuated X-ray intensity is detected, and therefore the mineral mass of the 
specimen can be calculated by the computer system (Eq. 5.1) (Anderson and 
Elliott, 1993). The SMR cell allows the creation of strictly controlled condition for 
specific study. For example, by circulating acid through the SMR cell containing 
enamel or HAP sections (Fig. 5.1), many different demineralisation studies have 
been carried out (e.g., Anderson et al., 1998; Anderson et al., 2004a; Kosoric et 
al., 2010; Mohammed et al., 2014a; Mohammed et al., 2015).  
 
I = I0 X e-
μmM                                                                                             (Eq. 5.1) 
 
I = transmitted X-ray intensity 
I0 = incident X-ray intensity 
μm = mass absorption coefficient 
M = mass per unit area of the specimen (g/cm2) 
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Figure 5.1 – Schematic representation of a SMR cell containing a specimen. 
 
The SMR apparatus includes SMR cells, SMR stages, an X-ray generator, an 
X-ray detector and a computer (Anderson and Elliott, 1993). SMR cells are 
transparent boxes (4 cm X 5 cm X 6 mm) made of polymethyl methacrylate (Fig. 
5.1). In the centre of each SMR cell, there is a circular chamber, which contains 
the specimen. The SMR cell is mounted on the SMR stage with screws. The SMR 
apparatus has X and Y stages which allow the cell to move up to 600 mm 
horizontally in X-axis and up to 200 mm vertically in Y-axis. The X-ray generator 
includes a PANalytical®  X-ray tube to produce a stable 15 μm X-ray beam using 
a 15 μm aperture made up of 90 % gold and 10 % platinum. The attenuated X-
ray beam after passing through the specimen is then detected by the X-ray 
detector coupled with a digital spectrometer. Subsequently, the received signal 
is processed with a digital converter into a sequence of digital values, and the 
mineral mass of the tested specimen can be obtained (Fig. 5.2) (Anderson and 
Elliott, 1993). 
 
4 cm
5
cm
X-ray 
detector
Circulation of acid
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Figure 5.2 – Schematic representation of the SMR apparatus. 
 
5.2 Ion Selective Electrode 
 
An ion selective electrode (ISE) is a potentiometric sensor used as an analytic 
tool for the concentration (or activity) measurement of a selected free ion in 
solution (Rundle, 2000). The scientific applications of ISEs are diverse, including 
pollution monitoring, analysis of agriculture composition, measurement of salt 
contents in meat, examination of fluoridation of water, detection of corrosive 
effects in canned foods, determining the constituents of dairy products or 
preservatives, and laboratory research (Frant, 1994; Oesch et al., 1986). In 
dentistry, ISEs have been used for the measurement of Ca2+ activity in oral fluids 
to evaluate the Ca2+ concentrations in saliva, dental plaque and plaque fluid 
(Carey and Vogel, 2000). F- ISEs have been used for the detection of F- 
concentration in mineral and drinking water, mouthwashes, toothpastes, tea, food, 
and urine, in order to measure the F- concentrations, which is useful to prevent 
fluorosis development in humans (Adejumo et al., 2009; Bratovcic and Odobasic, 
2011; Frant and Ross, 1968; Itota et al., 2004; Kiliçel and Dağ, 2014; Malde et 
al., 2001; Ruiz-Payana et al., 2005; Villa et al., 2010).  
In this study, Ag+ ISEs were used to monitor the concentration of Ag+ in the 
solution. Ag+ ISEs have not previously been used in dental research. 
SMR cell with 
specimen
Computer
X-Y Stage
X-ray Source
X-ray Detector
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ISEs can deliver real-time information about the concentration variation of 
specific ions in complex samples by automatically measuring electronic voltages 
between two electrodes continuously. The relationship between ion concentration 
and the voltage reading is defined by the “Nernst equation” which states that this 
voltage is proportional to the logarithm of the concentration (or activity) (Eq 5.2) 
(Covington and Kenneth, 1979). Therefore, the ISE readings recorded can be 
converted into concentration units (Fig 5.3). 
 
Nernst equation: E = E0 + (
2.303RT
nF
) X Log(A)                                           (Eq 5.2) 
E = total potential in mV 
E0 = constant of a given ISE/reference pair 
2.303 = conversion factor 
R = gas constant (8.314joules/degree/mole) 
T = absolute temperature (Kelvin) 
n = the ionic charge 
F = Faraday constant (96500 coulombs) 
A = activity (effective ions) of the measured ion 
Slope = 2.303RT/nF (e.g., at 25 0C; Slope of Ca2+ ≈ 29.5 mV/dec, Ag+ ≈ 59.1 
mV/dec, F- ≈ -59.1 mV/dec) 
 
 
Figure 5.3 - An ISE calibration curve (From Wroblewski, 2005). 
 
Nernstian
Non-Nernstian
Non-Nernstian
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Overall, there are four types of conventional sensing ISEs including glass body 
electrode, solid state (crystalline membrane), liquid ion exchange (polymer 
membrane) and gas sensing type (Chen et al., 2011; Lakshminarayanaiah, 2012; 
Buhlmann and Chen, 2012; Srinivasan and Rechnitz, 1969; Yim et al., 1993). The 
basic ISE system comprises an indicator electrode, a reference electrode and a 
voltmeter (Rundle, 2000). The crucial part of the system required for the 
selectivity of the specific ion is the membrane of the indicator electrode which 
only allows that one specific ion to pass through (Wilson and Walker, 2000). 
In a potentiometric electrochemical cell, one half-cell provides a known 
reference potential and the potential of the other half-cell indicates the target ion 
concentration in the solution (Fig 5.4) (Harvey, 2016). Since the potential of the 
reference electrode is constant, it is the indicator electrode which possesses the 
analytical information. Therefore, by measuring the disparity of the indicator and 
reference electrode potentials the concentration (M) of the target ion in the 
solution can be measured (Rundle, 2000). 
 
 
Figure 5.4 - Schematic representation of an ISE system (From Harvey, 2016). 
 
  40   
5.2.1 Ion Activity and Ion Concentration: Two Different Measures 
 
The measurement of the ISE relies on the equilibrium of the concentrations of 
ions permitted across an ion-selective ISE membrane, and is directly associated 
with the total number of ions in dilute solution. However, in a solution with high 
concentrations of ions (both positively- and negatively-charged), the mobility of 
individual ions is reduced due to inter-ionic interactions. This leads to lower 
measured ISE readings (in mV), resulting in a lowered measurement of the target 
ion concentration (Rundle, 2000). The effective concentration measured by ISEs 
is the “activity” of the ion. Consequently, the calibration curve (Fig. 5.3) at higher 
concentrations curves away from linearity due to the disparity between the 
measured activity and the actual concentration. Therefore, it is more correct to 
state that the measured voltage is proportional to the logarithm of the activity of 
the target ion. The activity coefficient is the ratio of the ion activity divided by the 
ion concentration. This decreases with increasing ion concentration, and is 
determined by the total effect of all the ions in the solution (Ionic Strength, IS), 
calculated using Eq 5.3 (Rundle, 2000).  
 
IS = 0.5 X ∑cizi
2
                                                                                      (Eq 5.3) 
ci = concentration in Moles 
zi = valence 
 
5.2.2 Advantages of ISEs 
 
The use of ISE systems has several advantages. First, the apparatus is relatively 
inexpensive and simple to use compared to other analytic techniques. Secondly, 
the electrodes are robust which are suitable to use in nature or laboratory. In 
addition, the operation and reading of an ISE system is independent of the colour 
or turbidity of the test solution. Moreover, ISEs are able to measure both cations 
and anions (even though not all ions are measurable). Normally, the precision 
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level is of the order of + 2 or 3 % (Rundle, 2000). Continuous monitoring of the 
concentration variation in real-time is also possible. Many studies can only 
observe the sample before and after the intervention, whereas, real-time 
monitoring of the ion concentration is not interrupted by the topical treatments of 
the specimen, which is the most important feature of the ISE system with regard 
to this project. 
 
5.2.3 Limitations of ISEs 
 
1. ISEs can only detect dissolved ions in aqueous solutions, so insoluble 
compounds cannot be analysed using ISEs (Christian, 2004).  
2. The membranes may not be so specific to the target ion and may be slightly 
permeable to other ions existing in the test solution. There is no ideal membrane 
with the complete selective ability to rule out other ions’ interference, and the 
capacity depends on the selectivity coefficient (k) (Wroblewski, 2005). 
3. Operating ISEs above the higher limit of detection or below the lower limit of 
detection, i.e., out of the linearity range, will have the potential for error (Skoog et 
al., 1996). Generally, the range for linear (Nernstian) calibration curve is within 
0.1 ~ 10-5 M (Rundle, 2000).  
4. ISEs have a temperature range. Crystal-membrane types can be used in the 
range of 0 0C to 80 0C, whilst the range of PVC-membrane types is from 0 0C to 
50 0C (Rundle, 2000). Outside of these ranges, the membranes might be 
damaged resulting in errors of readings. 
 
5.2.4 The Effect of Temperature 
 
As temperature is one of the factors in the Nernst equation, it can affect ISE 
readings recorded during the study (Koryta and Štulík, 1983). The increase in 
temperature leads to a decrease in ISE reading. From the slope of the Nernst 
equation, it can be seen that the higher the temperature, the steeper the tendency 
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of the calibration line (Fig 5.5). Therefore, experiments should be conducted at 
the same temperature as that is used in the calibration (all-about-pH.com, 2017). 
According to the Nernst equation (Eq. 5.2), the change in the slope per degree is 
about 0.2 mV/dec. 
 
 
Figure 5.5 - Temperature effects on the slope of the calibration curve of a single charged ion 
(Adapted from all-about-pH.com, 2017). 
 
5.3 Effect of Data Sampling Frequency on Calculated Error in 
Gradient 
 
In the SMR results, the projected mineral mass of the specimen is plotted against 
the time period of the study. In the ISE results, the calcium loss of the specimen 
is plotted against over a time period of the ISE study. Subsequently, the trend of 
the change in the mineral mass or in the calcium loss can be illustrated by a 
trendline of these data. The more points in the data plot, the more accurate the 
trendline gradient will be to represent the change. 
For example, Fig. 5.6a ~ c shows the change in the projected HAP disc mineral 
mass content in acetic acid over 24 h with 100 %, 50 % and 10 % of sampling 
data (Lingawi, 2012). The standard error of the trendline increases as the number 
of points decreases. Further, the percentage increase in the standard error is 
equal to the square root of the percentage decrease in the data point number. 
For instance, the standard error of the 100 % sampling frequency (= 0.07 X 10-4) 
increases by the square root of 2 (= 100 % divided by 50 %) to the standard error 
of the 50 % sampling frequency (= 0.10 X 10-4). Therefore, as real-time SMR 
Slope = 74.1 mV/dec
Slope = 64.1 mV/dec
Slope = 54.4 mV/dec
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monitoring collects numerous data points, the gradient of change in the mineral 
mass of the specimen can be calculated with a low error value using SigmaPlot 
10.0 (Systat Software, California, USA). This applies equally to ISE data 
collecting constant direction of change.  
Fig. 5.7a shows the ISE measured calcium loss from an HAP disc in pH 4.0 
acetic acid, and Fig. 5.7b shows the calcium loss from the same HAP disc which 
is topically treated and re-immersed back into acetic acid. The gradients of the 
changes in the calcium loss before and after treatment are similar. However, the 
difference between the two calcium loss ISE data are still significant due to the 
numerous data points collected (Fig. 5.7c). 
For both SMR and ISE data, the error is improved by a factor of √𝑁, when N is 
the number of measurements.   
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a   
b   
c   
Figure 5.6 - Change in the projected HAP disc mineral mass content in pH 4.0 acetic acid over 
24 h with (a) 100 %, (b) 50 %) and (c) 10 % sampling frequency of data. Blue dots: one StdErr 
away from trendline; Green dots: two StdErr away from trendline; Yellow dots: three StdErr away 
from trendline (From Lingawi, 2012). 
Gradient = 3.32 X 10-4
SE = 0.07 X 10-4
R2 = 5.56E-01
Gradient = 3.33 X 10-4
SE = 0.10 X 10-4
R2 = 5.50E-01
Gradient = 3.25 X 10-4
SE = 0.24 X 10-4
R2 = 5.20E-01
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a    
b    
c    
Figure 5.7 – Change in the calcium loss from an HAP disc in pH 4.0 acetic acid (a) before (Blue 
dots) and (b) after (Red dots) topical treatment. The difference between the gradient of the two 
calcium loss trendlines (0.32 X 10-3) is detected (Green dots). 
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5.4 Scanning Electron Microscopy 
 
Scanning electron microscopy (SEM) is a non-destructive technique used to 
obtain a magnified image through interactions between thermo-ionically emitted 
electrons (electron beam) and the assessed sample surface (Vernon-Parry, 
2000). Before being inspected by SEM, non-conductive samples must be coated 
with an electrically conductive thin film (either gold or carbon in the order of 20 
nm thickness) to enable their imaging (Nixon, 1969).  
After electrons are emitted from the electron gun with significant amounts of 
kinetic energy, several electromagnetic condenser lenses focus the electron 
beam into a fine probe. Next, this energy is dissipated as a variety of signals 
produced by electron-sample interactions when the incident electrons are 
decelerated in the solid sample (Schweitzer, 2014; Swepp, 2017; Vernon-Parry, 
2000). The interactions between electrons and samples in a variety of ways, 
which produce secondary electrons (that produce SEM images) and 
characteristic X-rays (that are used for elemental analysis like energy-dispersive 
X-ray analysis, EDX) (Vernon-Parry, 2000). Production of secondary and low 
energy electrons are the main interactions for generation of topographic 
information as they can only escape from a very shallow, near-surface layer of 
the sample, and provide the highest spatial resolution (Vernon-Parry, 2000) (Fig. 
5.8).   
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Figure 5.8 - Schematic representation of SEM (From Schweitzer, 2014). 
 
5.5 Energy-Dispersive X-ray Analysis 
 
Energy Dispersive X-ray analysis (EDX) is a technique used for elemental 
analysis. As a focused beam of electrons bombards the sample to excite an 
electron in an inner shell, ejecting it from the shell, an electron from an outer, 
higher-energy shell then fills the electron-hole of the inner, lower-energy shell, 
and the emitted characteristic X-ray can be detected (Fig 5.9). As the magnitude 
of the signal is proportional to the energy of the X-ray, EDX spectrum can be 
illustrated as X-ray counts versus energy. That provides a means of rapidly 
evaluating the elemental constituents of a specimen and gives accurate 
quantitative analysis. Qualitative analysis involves the identification of the peaks 
in the spectrum to determine the elements present in the excited volume of the 
sample. Quantitative analysis (determination of the concentrations of the 
elements present) entails measuring line intensities for each element in the 
sample  (ACMAL, 2014; Peter, 2005; Middleton, 1999). 
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Figure 5.9 - Schematic representation of EDX (From ACMAL, 2014). 
 
5.6 Magic Angle Spinning – Nuclear Magnetic Resonance 
 
Nuclear magnetic resonance (NMR) is a non-destructive characteristic tool which 
can be used to determine the physical and chemical properties of atoms or 
molecules. Information including structure, reaction state and environment of the 
molecules can be obtained by interpreting the NMR spectrograms (Iggo, 2011).  
 
 
Figure 5.10 - Schematic representation of NMR apparatus (From Robert, 1959). 
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The apparatus comprises a magnet, a radio-frequency oscillator and a receiver 
(Fig 5.10). Under the particular magnetic field (B0), which defines the resonance 
frequency (or Larmor frequency; ν), the sample put in the magnet pole gap can 
absorb certain energy (∆E). After the “relaxation”, energy is emitted at a certain 
radio-frequency which can be detected and recorded by the receiver (Robert, 
1959). The resonance frequency (ν) is characteristic of a given nucleus of the 
inspected sample, which is affected by its chemical environment, called chemical 
shielding. Chemical shielding is associated with the interaction of the electrons 
surrounding the nucleus with the applied magnetic field (B0), whose magnitude 
can be measured as the “chemical shift (ẟ)” of the resonance line from that of a 
reference compound (Eq. 5.4) (Iggo, 2011). The characterisation of the sample 
is then achieved by measuring the positions of peaks of chemical shifts observed 
in NMR spectra, as they represent specific forms or states of the target nuclei 
(Robert, 1959). In contrast to aqueous phase NMR, solid-state NMR 
spectroscopy is affected by local nuclear interactions which result in broad 
spectra masking the chemical shift peaks. To overcome this problem in solid-
state NMR, the sample is spun at high speed at a magic angle (54.740) with 
respect to the magnet field in solid-state NMR. This is magic angle spinning 
(MAS), which averages the interactions, and consequently the peaks become 
narrower, and distinguishable spectra with better resolution are produced (Alia et 
al., 2009; Iggo, 2011).  
 
ẟ = (νobserved – νreference) / νreference                                                          (Eq. 5.4) 
 
However, not all nuclei are magnetically active. Only nuclei with odd numbers 
of protons and/or neutrons such as 31P and 19F can be applied in NMR 
characterisation (Iggo, 2011; Shoolery, 1954). Both 31P and 19F MAS-NMR have 
been used in dental research for decades. 31P MAS-NMR can identify numerous 
apatite species (Tsai and Chan, 2011), and 19F MAS-NMR is capable of 
differentiating FAP and FHA from HAP, and can distinguish between FAP, FHA 
and CaF2 (Elsharkawy et al., 2018; Mohammed et al., 2013; White et al., 1994). 
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Sometimes chemical shift peaks overlap with each other, which leads to a 
combined asymmetric peak. In this case, deconvolution of the spectrum, e.g., 
using DmFit (France), is required to identify each compound contributing to the 
peak (Fig. 5.11) (Gerth et al., 2007). 
 
 
Figure 5.11 – Deconvolution of a 19F MAS-NMR spectra of HAP, and of human enamel powders 
treated with amine fluoride (From Gerth et al., 2007).    
 
5.7 Knoop Micro-hardness Test  
 
5.7.1 Microscopic Photographs 
 
The microscope of the Knoop micro-hardness tester can be used to monitor the 
morphology of lesion sections. By attaching a camera to the microscope (Fig. 
5.12), these microscopic photographs of the lesion sections (Fig. 5.13) can be 
obtained. 
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Figure 5.12 – Taking the microscopic photographs through the microscope of the Knoop micro-
hardness tester using a camera. 
 
 
Figure 5.13 – Typical microscopic photographs of a tooth with Knoop indentations on a dentine 
specimen (From Chu and Lo, 2008a). 
 
5.7.2 Knoop Micro-hardness Indentation 
 
Micro-hardness testing refers to static indentations made with loads not 
exceeding 1 kgf. The indenter of the Knoop micro-hardness tester is a rhombic-
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based pyramidal-shaped diamond with edge angles of 172° 30' and 130° 0' (Fig 
5.14) (Davidson et al., 1974; England, 2013). The hardness assessment is 
conducted by forcing the indenter into the surface of the sample with a test force 
of between 1 gf and 1 kgf and then to measure the length of the indentation 
diagonal with a light microscope. Calculation of the Knoop hardness (KHN) is 
carried out via Eq 5.5 (ASTM, 2012; England, 2013).  
 
 
Figure 5.14 – Diagrams of the Knoop indenter (From England, 2013). 
 
KHN = 
𝐹
𝐴
 =  
𝐹
𝐶𝐿2
                                                                                          (Eq 5.5) 
F = applied load in kgf 
A = the unrecovered projected area of the indentation (mm2) 
L = measured the length of the long diagonal of indentation (mm) 
C = 0.07028 = Constant of indenter relating projected area of the indentation to 
the square of the length of the long diagonal.  
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Chapter 6 VALIDATION OF A REAL-TIME ISE METHODOLOGY 
TO QUANTIFY THE INFLUENCE OF INHIBITORS OF 
DEMINERALISATION KINETICS IN VITRO USING A 
HYDROXYAPATITE MODEL SYSTEM  
 
6.1 Introduction 
 
Numerous techniques have been used to investigate caries progression, such as 
profilometry, scanning electron microscopy, microradiography and micro-
indentation (Arends et al., 1987; Shellis et al., 2010). However, in addition to 
these static methodologies, real-time techniques have also been developed to 
monitor the dissolution process by periodic measurements of tissue loss or 
inspection of surface morphology (Shellis et al., 2010).  
For example, scanning micro-radiography (SMR) allows continuous 
observation of demineralisation in vitro and has been used in several dental 
researches (e.g., Kosoric et al., 2010; Mohammed et al., 2015; Shah et al., 2011). 
However, SMR is very technique sensitive and requires extensive protocols to 
ensure accurate measurement. As silver compounds are reduced to metallic 
silver over time due to the photosensitivity of Ag+ (Lin et al., 2015), the effect of 
topical treatments with silver compounds may be affected by application time. 
Therefore, the real-time SMR technique could not be applied in this study, as it 
requires time-consuming sample preparations following the topical treatments of 
the specimens. Thus, a novel real-time methodology allowing efficient topical 
treatment of the specimen was needed to investigate the effects of topical 
treatments with silver compounds on demineralisation. 
Ion selective electrodes (ISEs) are potentiometric sensors which can be used 
as analytic tools for measuring the effective concentration of selected ions in a 
solution and have been used in the dental area for many years (Bjorvatn and 
Morch, 1979; Covington and Kenneth, 1979). As dental caries and dental erosion 
are associated with Ca2+ loss from dental hard tissues
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(Abou Neel et al., 2016), the Ca2+ release from dental mineral can be regarded 
as a proxy for demineralisation. Therefore, the use of real-time Ca2+ ISE has the 
potential for demineralisation studies. Furthermore, real-time Ca2+ ISE study 
allows topical treatments of specimens during the experiment in an efficient way, 
which is required for the investigation of the effects of topical treatments with 
silver compounds on demineralisation. However, even though real-time ISEs 
have been used in many research areas other than dentistry (Chumbimuni-
Torres et al., 2009; Kim et al., 2005; Zeitchek and Anthony, 2013), cariostatic 
demineralisation studies using real-time Ca2+ ISE have not been reported 
The inhibitory effects of F- and of Zn2+ on enamel demineralisation in vitro have 
been studied previously using SMR (Mohammed et al., 2014a; Mohammed et al., 
2015). The results showed a log-linear relationship between mean percentage 
reduction in the rate of enamel mineral loss (PRMLenamel) with increasing F- 
concentration, and with increasing Zn2+ concentration. If similar results of the 
SMR studies can be replicated using real-time ISE, the technique can be 
validated to be used for quantifying the influence of inhibitors of demineralisation 
kinetics in vitro.  
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6.2 Aim 
 
The aim was to validate the use of Ca2+ ISEs for real-time monitoring of calcium 
loss of hydroxyapatite (HAP) discs by replicating the previous SMR studies 
exactly but using Ca2+ ISE. HAP discs were used in the present corroboration 
study to avoid the interference from inhomogeneities in human enamel such as 
individual variations in composition and biological structures (Section 1.2.1 and 
Section 1.2.2). 
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6.3 Materials and Methods 
 
6.3.1 Preparation of Samples  
 
 
Figure 6.1 – Half-varnished porous HAP discs. 
 
Forty-eight porous HAP circular discs (20% porosity, 12 mm in diameter, 2 mm 
in thickness; Plasma Biotal Ltd, UK) were varnished with red nail lacquer (KIKO, 
Italy) to expose only the upper face to the demineralisation solution (Fig 6.1). The 
varnished discs were then allocated into sixteen groups (n = 3 each) of increasing 
[Zn2+] or increasing [F-] as previously described (Mohammed et al., 2014a; 
Mohammed et al., 2015). 
 
6.3.2 Preparation of Demineralisation Solution 
 
A 0.1 M CH3COOH (Sigma-Aldrich, UK) demineralisation solution buffered by 
adding 1.0 M KOH (Sigma-Aldrich, UK) drop by drop up to pH 4.0 was prepared, 
as used previously (Mohammed et al., 2014a; Mohammed et al., 2015).  
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6.3.3 ISE Calibration 
 
A Ca2+ ISE paired with a double-junction lithium acetate reference electrode 
(ELIT 003n), was connected to an 8 channel ion analyser (attached to a computer) 
to record the mV output at specified time intervals. All ISE equipment used were 
products of Nico2000 (Nico2000 Ltd, UK). 
    ISEs are pH sensitive, so the ISE calibration solution was prepared with the 
demineralisation solution in the same pH as used in the main study. A 1 mM Ca2+ 
standard solution was made by adding 0.147 g CaCl2 · 2H2O into the 
demineralisation solution and made up to 1 L. The Ca2+ ISE was immersed in 50 
mL of demineralisation solution, and standard calcium solution was added drop-
wise to gradually increase the [Ca2+] up to about 0.5 mM. The calibration was 
performed at 23.0+1.0 0C using a temperature stabilised stirrer (Stuart 
UC152D/KIT, UK). Subsequently, the activity coefficients for each [Ca2+] were 
calculated with an ionic speciation program, Chemist (MicroMath, Missouri, USA). 
Next, the calibration curve was obtained by plotting the logarithm of calcium 
activity (mM) against ISE readings in mV.  
 
6.3.4 Demineralisation Study 
 
Each varnished HAP disc was immersed into 50 mL demineralisation solution 
(23.0+1.0 0C) for 1 h. The solution was continuously stirred using a magnetic 
stirrer (Stuart UC152D/KIT, UK). The Ca2+ ISE was used to monitor the increase 
in Ca2+ activity as demineralisation progressed, at intervals of 1 min (Fig 6.2). 
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Figure 6.2 – Two setups of the study ISE at room temperature. 
 
Then, 1 mL zinc acetate or sodium fluoride were added to the solutions to 
obtain concentrations of 0.1, 0.4, 1.8, 9.0, 36.0, 107.0, 356.0 or 1782.0 ppm Zn2+ , 
and 0.1, 0.5, 2.3, 11.3, 45.2, 135.7, 452.5 or 2262.4 ppm F- in each group for zinc 
and fluoride experiments, respectively, i.e., similar to those used in the previous 
studies (Mohammed et al., 2014a; Mohammed et al., 2015). Each disc was then 
demineralised for another 1 h, and the Ca2+ activity was monitored at 1 min 
intervals as before. The temperature was maintained at 23.0+1.0 oC as in the 
previously reported studies (Mohammed et al., 2014a; Mohammed et al., 2015).  
The Ca2+ ISE readings (mV) were converted to concentration units (mM) using 
the calibration curve, and the Ca2+ activity was plotted as a function of time (h) 
for each Zn2+ or F- addition. The activity of Ca2+ (mM) was plotted as a function 
of time (h) for each group, and the percentage reduction in the rate of calcium 
loss of HAP (PRCLHAP) for each Zn2+ and F- addition was calculated in a way 
similar to PRMLenamel, which was the ratio between the rate of Ca2+ release after 
the topical treatment (Ra) to the rate of Ca2+ release before the topical treatment 
(Rb) (Eq. 6.1). Thereafter, PRCLHAP could be used in the same way as PRMLenamel 
and was plotted as a function of [Zn2+] and [F-], similar to the previous studies 
(Mohammed et al., 2014a; Mohammed et al., 2015).  
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PRCL = (1 – 
𝑅𝑎
𝑅𝑏
) X 100%                                                                  (Eq. 6.1) 
PRCL = Percentage reduction in the rate of calcium loss 
Ra = The rate of Ca2+ release after the topical treatment 
Rb = The rate of Ca2+ release before the topical treatment 
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6.4 Results 
 
The calibration plot of the Ca2+ ISE (Fig. 6.3) shows a linear relationship between 
mV and log activity (R2 = 1.00) for Ca2+ activity greater than 0.023 mM (lower limit 
of detection, LLOD). A linear regression line was used to convert ISE mV to mM. 
Values below the linear Nernstian response region of the calibration curve were 
not used. The error of the gradient was calculated using SigmaPlot 10.0 (Systat 
Software, California, USA). 
 
  
Figure 6.3 - Calibration curve of Ca2+ ISE. LLOD = lower limit of detection. 
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Fig. 6.4a shows a typical plot of Ca2+ release from a demineralising HAP disc 
before and after addition of 1.8 ppm Zn2+. The Ca2+ release was approximately 
linear both before and after the addition of Zn2+. The rate of the Ca2+ release was 
≈ 0.081 mM/h before and ≈ 0.034 mM/h after the addition of Zn2+.  
Fig. 6.4b shows a typical plot of Ca2+ release from a demineralising HAP disc 
before and after addition of 107.0 ppm Zn2+. The Ca2+ release was approximately 
linear both before and after the addition of Zn2+. The rate of the Ca2+ release was 
≈ 0.101 mM/h before and ≈ 0.011 mM/h after the addition of Zn2+. The reduction 
in the rate of Ca2+ release after addition of 107.0 ppm Zn2+ was more than that 
after the addition of 1.8 ppm Zn2+.  
Similar plots were obtained for all Zn2+ additions, with a reduction in the rate of 
Ca2+ release increased with increasing [Zn2+] in the solutions.  
Table 6.1 shows the rates of calcium loss of HAP discs (RCLHAP) +/- standard 
error (SE) before and after addition of 1.8 ppm and 107 ppm Zn2+ of the Fig. 6.4. 
Errors of gradients were calculated using SigmaPlot 10.0 (Systat Software, 
California, USA). In each treatment group, the Ra was significantly different (p 
value < 0.05) from the Rb. 
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a   
b   
Figure 6.4 - Typical data collected from one HAP disc with additions of (a) 1.8 ppm Zn2+ and (b) 
107 ppm Zn2+ groups. 
 
Table 6.1 - RCLHAP before and after Zn2+ addition of the Fig. 6.4. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
1.8 ppm Zn2+ 81.02 + 0.70 33.94 + 0.20 < 0.01 
 107 ppm Zn2+ 100.90 + 0.30 11.15 + 0.30 < 0.01 
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Fig. 6.5a shows a typical plot of Ca2+ release from a demineralising HAP disc 
before and after addition of 2.3 ppm F-. The Ca2+ release was approximately 
linear both before and after the addition of F-. The rate of the Ca2+ release was 
≈ 0.055 mM/h before and ≈ 0.027 mM/h after addition of F-. 
Fig. 6.5b shows a typical plot of Ca2+ release from a demineralising HAP disc 
before and after addition of 45.2 ppm F-. The Ca2+ release was approximately 
linear both before and after the addition of F-. The rate of the Ca2+ release was 
≈ 0.070 mM/h before and ≈ 0.016 mM/h after addition of F-. The reduction in 
the rate of Ca2+ release after addition of 45.2 ppm F- was more than that after the 
addition of 2.3 ppm F-.  
Similar plots were obtained for all F- additions, with a reduction in the rate of 
Ca2+ release increased with increasing [F-] in the solutions. 
Table 6.2 shows the RCLHAP+/-SE before and after addition of 2.3 ppm and 
45.2 ppm F- of the Fig. 6.5. Errors of gradients were calculated using SigmaPlot 
10.0 (Systat Software, California, USA). In each treatment group, the Ra was 
significantly different (p value < 0.05) from the Rb. 
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a   
b  
Figure 6.5 - Typical data collected from one HAP disc with additions of (a) 2.3 ppm F- and (b) 
45.2 ppm F- groups. 
 
Table 6.2 - RCLHAP before and after F- addition of the Fig. 6.5. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
2.3 ppm F- 54.99 + 0.20 26.98 + 0.20 < 0.01 
 45.2 ppm F- 69.63 + 0.60 15.70 + 0.10 < 0.01 
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   Table 6.3 and Table 6.4 show the RCLHAP+/-SE (X 10-3 mM/h) and the 
PRCLHAP measured at increasing [Zn+] and [F-] in the solution. Every Ra (RCLHAP) 
measured at each [Zn+] and [F-] was significantly different (p < 0.05) from the Rb 
(RCLHAP). 
    The mean PRCLHAP (%) in both Zn2+ and F- experiments show that inhibitory 
efficacy on demineralisation of HAP discs increased with increasing [Zn+] and [F-]. 
Complete inhibition was achieved at 356 ppm Zn2+ and at 452.5 ppm F-, 
respectively.  
 
Table 6.3 – The RCLHAP and PRCLHAP of every HAP disc measured at each [Zn2+]. 
[Zn2+] HAP 
Disc 
Rb+/-SE (X 10-3 
mM/h) 
Ra+/-SE (X 10-3 
mM/h) 
PRCLHAP 
(%) 
0.1 ppm 1 37.63 + 0.20 2.39 + 0.88 36.5 
2 139.10 + 0.30 110.50 + 0.70 20.6 
3 97.54 + 0.40 72.38 + 0.40 25.8 
Average 91.42 + 29.45 68.93 + 25.06 27.6 + 4.7 
0.4 ppm 1 73.26 + 0.70 36.40 + 0.40 50.3 
2 74.17 + 1.80 44.60 + 1.50 39.9 
3 85.4 + 0.30 51.5 + 0.60 39.7 
Average 77.62 + 3.90 44.17 + 4.36 43.3 + 3.5 
1.8 ppm 1 52.83 + 0.10 27.91 + 0.30 47.2 
2 81.02 + 0.70 33.94 + 0.20 58.1 
3 29.07 + 0.80 10.40 + 0.50 64.2 
Average 54.31 + 15.01 24.09 + 7.06 56.5 + 5.0 
9 ppm 1 55.45 + 0.50 15.65 + 0.10 71.8 
2 66.85 + 0.60 14.82 + 0.20 77.8 
3 94.99 + 0.50 27.02 + 0.60 71.6 
Average 72.41 + 11.75 19.16 + 3.94 73.7 + 2.1 
36 ppm 1 46.55 + 0.40 9.73 + 0.10 79.1 
2 68.58 + 0.20 18.42 + 0.20 73.1 
3 46.20 + 0.20 10.49 + 0.08 77.3 
Average 53.78 + 7.40 12.88 + 2.78 76.5 + 1.8 
107 ppm 1 66.15 + 0.50 2.76 + 0.2 95.8 
2 100.90 + 0.30 11.15 + 0.30 88.9 
3 61.76 + 0.70 14.32 + 0.50 76.8 
Average 76.27 + 12.38 9.41 + 3.45 87.2 + 5.6 
356 ppm 1 44.17 + 0.50 -1.44 + 1.50 103.2 
2 149.50 + 0.50 0.80 + 1.20 94.8 
3 96.19 + 0.50 -2.85 + 0.70 103.0 
Average 96.62 + 30.41 1.17 + 3.34 100.0 + 2.8 
1782 
ppm 
1 103.10 + 0.10 -10.40 + 1.20 110.1 
2 118.10 + 0.30 2.33 + 1.10 98.1 
3 111.50 + 0.60 2.60 + 1.20 97.7 
Average 110.90 + 4.34 -1.82 + 4.29 100.0 + 4.1 
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Table 6.4 - The RCLHAP and PRCLHAP of every HAP disc measured at each [F-]. 
[F-] HAP Disc Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) PRCLHAP (%) 
0.1 ppm 1 74.69 + 0.20 62.54 + 0.30 16.3 
2 113.50 + 0.90 78.74 + 0.10 30.6 
3 52.50 + 0.20 41.19 + 0.40 21.5 
Average 80.23 + 17.83 60.82 + 10.87 22.8 + 4.2 
0.5 ppm 1 114.10 + 0.20 73.70 + 0.20 35.4 
2 58.64 + 0.10 33.41 + 0.20 43.0 
3 61.73 + 0.20 37.93 + 0.20 38.6 
Average 78.16 + 17.99 48.35 + 12.74 39.0 + 2.2 
2.3 ppm 1 71.77 + 0.30 30.40 + 0.30 57.6 
2 54.99 + 0.20 26.98 + 0.20 51.0 
3 71.23 + 0.40 28.69 + 0.10 59.7 
Average 66.00 + 5.10 28.69 + 0.99 56.1 + 2.7 
11.3 ppm 1 45.09 + 0.20 13.50 + 0.15 70.1 
2 117.70 + 0.60 34.42 + 0.20 70.8 
3 82.92 + 0.60 29.15 + 0.20 64.8 
Average 81.92 + 21.00 25.69 + 6.28 68.6 + 1.9 
45.2 ppm 1 65.57 + 0.20 11.48 + 0.10 82.5 
2 77.03 + 0.50 13.71 + 0.10 82.2 
3 69.63 + 0.60 15.70 + 0.10 77.5 
Average 70.74 + 3.35 13.63 + 1.22 80.7 + 1.2 
135.7 ppm 1 43.88 + 0.20 7.65 + 0.01 82.6 
2 110.40 + 0.50 22.25 + 0.30 79.8 
3 100.40 + 0.60 16.69 + 0.40 83.2 
Average 84.89 + 20.71 15.56 + 4.26 81.9 + 1.0 
452.5 ppm 1 51.75 + 0.10 3.32 + 1.50 93.6 
2 75.12 + 0.40 -7.01 + 1.20 109.3 
3 80.33 + 0.60 -4.92 + 1.40 106.1 
Average 69.07 + 8.79 -2.87 + 3.15 100.0 + 4.8 
2262.4 ppm 1 66.00 + 0.10 -15.95 + 1.40 124.2 
2 67.13 + 0.10 -11.58 + 2.20 117.3 
3 73.16 + 0.50 -16.95 + 2.60 123.2 
Average 68.76 + 2.22 -14.83 + 1.65 100.0 + 2.2 
 
Fig. 6.6a and Fig. 6.7a show the mean PRCLHAP plotted as the logarithm of 
[Zn2+] and [F-], both showing a log-linear relationship. Both PRCLHAP of Zn2+ and 
F- increased with increasing concentrations. The PRCLHAP of Zn2+ reached 100 
% at 356.0 ppm, and the PRCLHAP of F- reached 100 % at 452.5 ppm.  
Fig. 6.6b and Fig. 6.7b show the log-linear relationships between mean 
PRMLenamel of Zn2+ and F- and their concentrations reported by Mohammed et al. 
(2014a & 2015), which are similar to those reported in this study. 
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a  
b  
Figure 6.6 - (a) Log-linear relationship established between mean PRCLHAP and [Zn2+]. (b) Log-
linear relationship established between mean PRMLenamel and [Zn2+] (Replotted from Mohammed 
et al., 2015). Error bars show the standard errors.  
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a  
b  
Figure 6.7 – (a) Log-linear relationship established between mean PRCLHAP and [F-]. (b) Log-
linear relationship established between mean PRMLenamel and [F-] (Replotted from Mohammed et 
al., 2014a). Error bars show the standard errors.  
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6.5 Discussion 
 
The release of Ca2+, used in this study as a proxy for demineralisation, was linear 
during real-time monitoring both before, and after the additions of Zn2+ and F- 
(Fig. 6.4 and Fig. 6.5) for all inhibitor concentrations used. This is similar to the 
data reported in the previous SMR studies, although over a different time-scale 
(Mohammed et al., 2014a; Mohammed et al., 2015). This suggests that the 
cariostatic influence is immediate (within the time-frame of the methodology), with 
no accumulation of inhibitor action. The changes in slope immediately after 
inhibitor addition show the changes in rates of calcium loss by the effects of Zn2+ 
and F-. The log-linear relationships between mean PRCLHAP and inhibitor 
concentrations (Fig. 6.6a and Fig. 6.7a) are similar to those previously reported 
by Mohammed et al. (2014a & 2015) (Fig. 6.6b and Fig. 6.7b), confirming the 
validity of the ISE methodology. Further, although the underlying reasons for the 
log-linear dose-response remain uncertain, the fact that this is repeatable using 
both methodologies suggests that the log-linear dose-response is a function of 
the chemistry of the interaction between these inhibitor ions and the inhibition of 
demineralisation. It has been proposed that the log-linear dependency of 
inhibition of demineralisation on Zn2+ and F- may be due to the availability of fewer 
PO43- and Ca2+ sites with increasing [Zn2+] and [F-], and therefore more and more 
Zn2+ and F- are competing for a smaller number of these unoccupied sites on the 
HAP crystal surfaces (Mohammed et al., 2014a; Mohammed et al., 2015). 
In this study, HAP discs were utilised to simulate the demineralisation of human 
enamel under carious simulating condition, with or without the additions of 
inhibitors. The demineralisation process of HAP disc under carious or erosive 
challenge has been extensively investigated using different real-time monitoring 
techniques (Anderson et al., 2004a; do Amaral et al., 2016; Jones et al., 2013; 
Kosoric et al., 2010). Anderson et al. found that the mineral loss of HAP is linear 
with time for over 100 h using scanning micro-radiography (SMR) (Anderson et 
al., 2004a). As the rate of mineral mass loss is constant, the process should be 
controlled by the reaction taking place at the advancing front. Similarly, it has 
been reported that both dissolution rates of enamel and HAP were constant, while 
the former was faster than the latter due to structural and compositional 
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differences between them (Berkovitz, 2011; Bollet-Quivogne et al., 2005; Shellis 
et al., 2010) (Section 1.3). This indicated that the demineralisation process of 
HAP is qualitatively similar to enamel but is quantitatively different. Consequently, 
the preliminary demineralisation research using HAP is useful to understand a 
simplified reaction occurring between the solution and dental mineral, even 
though the confirmatory work on the dental hard tissue is still necessary. In the 
present study, mean PRCLHAP reached 100 % for [Zn2+] above 356.0 ppm and 
for [F-] above 452.5 ppm. 
As ISE measures the activity of Ca2+, representing the quantity of ion 
concentration corrected for interionic interactions, the data can be directly related 
to the chemical reactions occurring during the process (Rundle, 2000). This real-
time Ca2+ ISE methodology can be used in studies of Ca2+ loss such as teeth, 
bones or dental materials, which make it a potential analytic tool to be utilised in 
a broader scale (Jeffcoat, 1998; Kumar et al., 2013; Tezel et al., 2011). For 
examples, Ca2+ loss from teeth and bones can be investigated to study dental 
caries, dental erosion or osteoporosis (Jeffcoat, 1998; Kumar et al., 2013; Tezel 
et al., 2011). Further, the Ca2+ release from some Ca2+-containing dental 
materials such as casein phosphopeptide amorphous calcium phosphate (CPP-
ACP) can be investigated to study its therapeutic effect on enamel 
demineralisation (Somasundaram et al., 2013). 
This study reproduced the results of Mohammed et al. (2014a & 2015) 
demonstrating a similar log-relationship established between mean PRCLHAP and 
inhibitor concentration, which validated the use of real-time ISE as an effective in 
vitro method for monitoring demineralisation kinetics. Further, even though the 
real-time Ca2+ ISE system monitors the demineralisation indirectly from the 
solution, whereas, SMR monitors the demineralisation directly from the mineral 
mass of the specimen, the results showed that the values of PRCL and PRML 
(i.e., from the two different techniques) are similar.  
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6.6 Conclusion 
 
In conclusion, the demineralisation of dental mineral can be monitored by 
continuously recording the concentration of Ca2+ in the solution in contact with 
the dental mineral using real-time Ca2+ ISE measurements. 
    The technique can detect very small changes in rate because a large number 
of data points are measured before and after treatment. 
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PART IV: EXPERIMENTAL 
STUDIES 
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Chapter 7 A SMR STUDY OF THE DOSE-RESPONSE EFFECTS 
OF SILVER IONS IN SOLUTION ON DEMINERALISATION OF 
HUMAN ENAMEL 
 
7.1 Introduction 
 
The understanding of the effects of Ag+ (in solution) on demineralisation is crucial 
for the interpretation of the effects of topical treatments with silver compounds on 
demineralisation. It has been reported that following immersion of hydroxyapatite 
(HAP) in AgNO3, Ag+ can substitute for the Ca2+ in HAP, forming “Ca10-
xAgx(PO4)6(OH)2” (Ling Feng et al., 1998; Singh et al., 2011). Further, the 
susceptibility of the Ag+ substituted HAP to acid attack has been reported to 
increase with increasing incorporation of Ag+ in the HAP (Singh et al., 2011). 
Therefore, the Ag+ has an accelerating effect on demineralisation of HAP by the 
formation of a Ag+ substituted HAP. The chemical formula of Ag+ substituted HAP, 
Ca10-xAgx(PO4)6(OH)2, proposed in the previous study (Singh et al., 2011) does 
not have a balance in charge, as it requires two one-charged Ag+ to replace one 
two-charged Ca2+. Therefore, the correct stoichiometry for a Ag+ substituted HAP 
should be Ca10-xAg2x(PO4)6(OH)2. Further studies are required to confirm the 
stoichiometry. 
   The reaction between Ag+ and human enamel, mainly composed of HAP (Hicks 
et al., 2004), should be similar to that of HAP. This suggests that the 
demineralisation of human enamel would increase with increasing concentration 
of Ag+ in solution in contact with the human enamel, as reported by Singh et al. 
(2011). However, as human enamel has composition gradients and a hierarchical 
structure which are different from synthetic HAP discs (Section 1.3) (Robinson et 
al., 2000; Robinson, 2009; Yilmaz et al., 2015), a confirmatory study is still 
needed.  
Scanning microradiography (SMR) is a real-time technique which can monitor 
the mineral loss of a demineralising specimen in controlled conditions based on 
the attenuation of X-ray beams (Anderson and Elliott, 1993). Further, SMR has 
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been used in previous studies investigating the dose-response of other metal ions 
on demineralisation of human enamel (e.g., Zn2+) (Mohammed et al., 2015).  
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7.2 Aim 
 
The aim of this in vitro study was to investigate the dose-response effects of Ag+ 
in solution on demineralisation of a human enamel block using SMR. 
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7.3 Materials and Methods 
 
7.3.1 Preparation of Enamel Block 
 
An enamel block (5 mm X 5 mm with ~ 2mm in thickness) was sectioned from a 
caries-free permanent molar (QMREC 2011/99) using a cutting machine (Struers 
Accutom-5; USA). The dentine was polished away (300 LVAC, Kemet) with 
carbide papers with roughness up to P4000 under copious water cooling. 
Subsequently, the cut internal surface was coated with red nail lacquer (KIKO, 
Italy), and was put into a SMR environmental cell (volume = 2 cm3), leaving only 
the natural surface exposed (Fig 7.1). 
 
 
Figure 7.1 – The SMR environmental cell containing an enamel block. 
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7.3.2 Preparation of the Demineralisation Solution 
 
A 1 L, 0.1 M CH3COOH (Sigma-Aldrich, UK) demineralising solution buffered by 
adding 1.0 M KOH (Sigma-Aldrich, UK) drop by drop to pH 4.0 was prepared, as 
described in Section 6.3.2. 
 
7.3.3 SMR Area Scan of the Sample 
 
 
Figure 7.2 – Area scanning of an enamel block. The coloured scale (on right) represents the 
projected mineral mass (g*cm-2) in the sample. The white crosses show the three scan points. 
 
After the SMR cell containing the enamel sample was mounted on the SMR 
scanning stage, an SMR area scan of the enamel sample was performed. This 
provided an indication of the different projected mineral density levels of the 
sample and its exact location on the SMR stage (Fig. 7.2). Three scan points on 
the horizontal line, 0.5 mm apart, were chosen in the area with similar projected 
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mineral mass. The mineral masses of these points were then monitored 
throughout the demineralisation period.  
 
7.3.4 Demineralisation Study 
 
Throughout the demineralisation study, the demineralisation solution was 
circulated at 0.788 mL/min, during which the X-ray beam was targeted at the 
three selected scan points. Subsequently, AgNO3 (Sigma-Aldrich, UK) was 
added to the demineralisation solution to obtain concentrations of 0.0 ppm Ag+, 
0.1 ppm Ag+, 9.0 ppm Ag+ and 3565.0 ppm Ag+. These four concentrations were 
chosen from the range of concentrations used in the previous SMR study 
investigating the dose-response of Zn2+ on enamel demineralisation (Mohammed 
et al., 2015). Further, the range of [Ag+] in saliva following topical treatment with 
Ag[NH3]2F has been reported to be between 2.36 X 10-3 M and 2.36 X 10-2 M (= 
254.9 ppm and 2548.8 ppm Ag+) (Mei et al., 2017), which was covered by the 
[Ag+] range in the present study. 
Initially, demineralisation solution (without Ag+) was circulated through the 
SMR cell for a period around 30 h, whilst the mineral mass measurements of the 
three scan points were continuously monitored at 30 min intervals. After the initial 
demineralisation period, the SMR cell was circulated with the demineralisation 
solution containing 0.1 ppm Ag+, 9.0 ppm Ag+ and 3565.0 ppm Ag+ for a period 
around 30 h, respectively, whilst the mineral mass measurements of the three 
scan points were monitored throughout all the demineralisation periods. The 
study was carried out at 23.0+1.0 0C, as described in the previous Zn2+ study 
(Mohammed et al., 2015). 
    After the study, the mineral loss per unit area (g*cm-2) of each point measured 
at each [Ag+] was plotted as a function of time (h), and the rates of enamel mineral 
loss (RMLenamel) recorded at 0.1 ppm Ag+, 9.0 ppm Ag+ and 3565.0 ppm Ag+ were 
compared with that recorded during the initial demineralisation (without Ag+) for 
every scan point. Next, the percentage reduction in the rate of mineral loss of 
enamel (PRMLenamel) at each [Ag+] was calculated as the ratio of the RMLenamel at 
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that [Ag+] to the RMLenamel without Ag+ to assess the inhibitory efficacy of the Ag+. 
A positive value of PRMLenamel indicates the inhibition of enamel demineralisation, 
whereas, the negative value of PRMLenamel indicates the acceleration of enamel 
demineralisation.  
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7.4 Results 
 
Fig. 7.3 shows the trendlines of the mineral loss per unit area (g*cm-2) measured 
at the scan point 3 for 0.0 ppm Ag+ compared to that measured at the same scan 
point for (a) 0.1 ppm Ag+, (b) 9.0 ppm Ag+, and (c) 3565.0 ppm Ag+. The trendline 
observed for every [Ag+] was linear with time. Further, the RMLenamel (g*cm-2*h-1) 
increased with increasing [Ag+] in the solution. 
 
a   
b    
c    
Figure 7.3 – Trendlines of the mineral loss per unit area (g*cm-2) measured at the scan point 3 
for 0.0 ppm Ag+ compared to that measured at the same scan point for (a) 0.1 ppm Ag+, (b) 9.0 
ppm Ag+, and (c) 3565.0 ppm Ag+. 
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    Table 7.1 shows the RMLenamel+/-SE (X 10-4 g*cm-2*h-1) and PRMLenamel (%) 
measured at different scan points for increasing [Ag+] in the solution. The error of 
the gradient was calculated using SigmaPlot 10.0 (Systat Software, California, 
USA). PRMLenamel highlighted in red indicate that the RMLenamel measured at that 
[Ag+] were not significantly different (p > 0.05) from the RMLenamel measured at 0 
ppm Ag+. 
After an increase of [Ag+] in the solution to 0.1 ppm, changes in the RMLenamel 
measured at the three scan points were not consistent with each other. The 
RMLenamel measured at the scan point 1 and 2 were inhibited, whereas that of the 
scan point 3 was increased. After the following increase of [Ag+] in the solution to 
9.0 ppm and 3565.0 ppm, all the RMLenamel measured at every scan point were 
increased. 
    The mean PRMLenamel (%) shows that minor inhibitory efficacy on enamel 
demineralisation was observed for 0.1 ppm Ag+. However, this inhibitory efficacy 
disappeared with increasing [Ag+], as the enamel demineralisation was 
accelerated with increasing [Ag+] from 9.0 ppm to 3565.0 ppm Ag+. 
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Table 7.1 – The RMLenamel and PRMLenamel measured at each point for every [Ag+] in solution. PRMLenamel highlighted in red indicate that the RMLenamel were not 
significantly different from the RMLenamel measured at 0 ppm Ag+. 
Scan Point  0 ppm Ag+ 0.1 ppm Ag+ 9 ppm Ag+ 3565 ppm Ag+ 
1 RMLenamel+/-SE (X 10-4 g*cm-2*h-1) 2.5 + 0.0 2.2 + 0.1 2.5 + 0.1 2.7 + 0.0 
PRMLenamel (%) 0.0 12.0 0.0 -8.0 
2 RMLenamel+/-SE (X 10-4 g*cm-2*h-1) 1.1 + 0.0 1.0 + 0.1 1.1 + 0.1 1.2 + 0.0 
PRMLenamel (%) 0.0 9.1 0.0 -9.1 
3 RMLenamel+/-SE (X 10-4 g*cm-2*h-1) 1.7 + 0.0 1.8 + 0.1 2.1 + 0.1 2.4 + 0.1 
PRMLenamel (%) 0.0 -5.9 -23.5 -41.2 
Average Mean RMLenamel (X 10-4 g*cm-2*h-1) 1.8 + 0.4 1.7 + 0.4 1.9 + 0.4 2.1 + 0.5 
Mean PRMLenamel (%) 0.0 + 0.0 5.1 + 5.5 -7.8 + 7.8 -19.4 + 10.9 
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Fig. 7.4 shows a log-linear relationship (R2 = 0.99) between the mean 
PRMLenamel and the [Ag+] in the solution. This log-linear dependency indicates 
that enamel exhibited increasingly faster demineralisation at a higher [Ag+]. 
 
 
Figure 7.4 – The mean PRMLenamel plotted against increasing [Ag+] in the demineralisation 
solution. Error bars show the standard errors. 
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7.5 Discussion 
 
This in vitro study investigated the effects of increasing [Ag+] on the 
demineralisation of human enamel using SMR. Three concentrations (0.1 ppm, 
9.0 ppm and 3565.0 ppm) of Ag+ and a control (0 ppm) were selected in the 
present study, mirroring the concentrations used in the previous SMR study 
investigating the dose-response effects of Zn2+ on enamel demineralisation 
(Mohammed et al., 2015). This enabled the comparison of the dose-response 
effects of these two metal ions on the enamel demineralisation under the same 
condition. 
As human enamel has variations in compositions, which would, therefore, 
result in a difference in solubility (Robinson et al., 1995), demineralisation studies 
using different specimens in control and experimental groups require a large 
number of enamel samples to ensure the reproducibility. In this study, the rates 
of enamel demineralisation measured at each scan point for 0.1 ppm, 9.0 ppm 
and 3565.0 ppm of [Ag+] were compared with the rates of enamel initial 
demineralisation (without Ag+) measured at the same scan point with similar 
mineral mass on the same enamel sample. Therefore, numerous samples were 
not necessary as each scan point acted as its own control.  
In the present study, all the trends in mineral loss from demineralising enamel 
observed were linear with time (Fig. 7.3), which is consistent with previous SMR 
studies (Anderson et al., 1998; Anderson et al., 2004a; Mohammed et al., 2014a; 
Mohammed et al., 2015). Even though the mean RMLenamel values measured at 
three scan points for each [Ag+] were different, the change of mean PRMLenamel 
with increasing [Ag+] measured at each scan point showed a similar trend (Table 
7.1). The effects of 0.1 ppm Ag+ on demineralisation of enamel were not 
consistent between scan points, as the mean RMLenamel of scan points 1 and 2 
were decreased, whereas, the mean RMLenamel of the scan point 3 was increased 
after the addition of Ag+ (Table 7.1). This may be due to that the effect of Ag+ was 
not strong enough at this low [Ag+] to show a consistent effect on all the scan 
points of the enamel. Following the increase of [Ag+] to 9.0 ppm and then further 
to 3565.0 ppm, the mean RMLenamel at all scan points kept increasing (Table 7.1). 
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The increase in mean RMLenamel may be due to the substitution of Ca2+ by Ag+, 
forming Ag+ substituted enamel, which has a higher susceptibility to acid 
challenge than that of enamel (Singh et al., 2011). The increased susceptibility of 
the Ag+ substituted enamel to acid challenge may result from the difference 
between the charges of Ag+ and Ca2+, which made Ag+ unable to facilitate proper 
bonding with other ions, and thereby destabilised the HAP lattice. Therefore, the 
increase in mean RMLenamel following the increase of [Ag+] to 9.0 ppm and to 
3565.0 ppm indicates that the formation of Ag+ substituted enamel dominated the 
dose-response effects of Ag+ on enamel demineralisation at these [Ag+]. 
The change in the mean PRMLenamel (from 5.1+5.5 % to -7.8+7.8 %) following 
[Ag+] increased from 0.1 ppm to 9.0 ppm (an increase of 8.9 ppm Ag+), was 
comparable to that (from -7.8+7.8 % to -19.4+10.9 %) following [Ag+] increased 
from 9.0 ppm to 3565.0 ppm (an increase of 3556.0 ppm Ag+) (Table 7.1). This 
indicates that Ag+ exhibited a greater change in accelerating enamel 
demineralisation at lower [Ag+] compared to higher [Ag+], which led to a log-linear 
relationship observed between the mean PRMLenamel and the [Ag+] (Fig. 7.4). 
In a previous SMR study of the dose-response effects of Zn2+ on enamel 
demineralisation, a log-linear relationship was also found between the mean 
PRMLenamel and [Zn2+]. More noticeably, the inhibitory efficacy of Zn2+ increased 
with increasing [Zn2+] (Fig. 7.5) (Mohammed et al., 2015). The difference 
between the effects of Ag+ and Zn2+ on the enamel demineralisation may be due 
to the ability of the ion in substituting for the Ca2+ in HAP. So far, no substitution 
of Ca2+ in HAP with Zn2+ has been reported. It has been proposed that all 
attempts to produce Zn2+ substituted apatite resulted in a mixture of phase such 
as Zn3(PO4)2•4H2O (McConnell and Foreman, 1966; Mohammed et al., 2014b). 
 
87 
  
Figure 7.5 – Comparison between the log-linear dose-response effects of Ag+ (Blue line) and 
Zn2+ (Red line) (From Mohammed et al., 2015) on enamel demineralisation. Error bars show the 
standard errors. 
 
    The log-linear dependency of the inhibition of enamel demineralisation on [Zn2+] 
was suggested to be due to the occupation of the PO43- sites on enamel surfaces 
(Mohammed et al., 2015). As the number of the PO43- sites unoccupied with Zn2+ 
is decreased with increasing [Zn2+], the increase in the inhibitory efficacy is 
decreased with increasing [Zn2+], as more and more Zn2+ are competing for a 
smaller number of the unoccupied sites on the enamel surface. Whereas, the log-
linear dependency of acceleration of enamel demineralisation on [Ag+] may be 
due to the number of the Ca2+ sites on the enamel surfaces able to be substituted 
by Ag+, decreased with increasing [Ag+], which led to less change in the mean 
PRMLenamel exhibited at higher [Ag+] range. This is shown schematically in Fig. 
7.6. 
Therefore, Ag+ accelerates the enamel demineralisation. Thus, the cariostatic 
effects of AgNO3 topical treatment on carious enamel must be due to the 
antibacterial properties of Ag+ (Lansdown, 2002; Lansdown, 2006; Russell and 
Hugo, 1994; Thibodeau et al., 1978) (Section 3.2). Further, as the accelerating 
effect on enamel demineralisation of Ag+ increases with increasing concentration, 
the concentration of AgNO3 topically applied on the enamel should not be too 
high, in order to obtain an optimal therapeutic outcome. 
-35
-20
-5
10
25
40
55
70
85
100
0.01 0.1 1 10 100 1000 10000
M
e
an
 P
R
M
L e
n
am
e
l
(%
)
[Ag+] or [Zn2+] (ppm)
Mean PRML of Ag ion Mean PRML of Zn ionZn2+Ag+
0.
88 
 
 
Figure 7.6 – Schematic representation of the log-linear dependency of the acceleration of enamel 
demineralisation on [Ag+] showing a decreasing number of Ca2+ sites can be substituted by Ag+ 
with increasing [Ag+]. 
 
  
Increasing [Ag+] in the solution
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7.6 Conclusion 
 
There is a negative dose-response effect of Ag+ in solution on the 
demineralisation inhibition of human enamel. Further, there is a log-linear 
relationship between the inhibitory efficacy and the [Ag+]. 
  
Presented in 2016 IADR Vol 95 (#1053) and 2016 ORCA (#88, DOI: 10.1159/000445087) 
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Chapter 8 EFFECTS OF TOPICAL TREATMENTS WITH SILVER 
COMPOUNDS ON DEMINERALISATION OF HAP DISCS 
 
8.1 Introduction 
 
Silver nitrate (AgNO3), silver fluoride (AgF) and silver diammine fluoride (SDF, 
Ag[NH3]2F) have been used for the management of dental caries for many 
decades (Peng et al., 2012) (Chapter 3). Currently, Ag[NH3]2F is the most popular 
silver compound used in clinical practice (Horst et al., 2016). Different 
concentrations of Ag[NH3]2F are used in commercial products, with 3.16 M (Silver 
Capsule of Riva Star, SDI Ltd, Australia) the highest concentration available  
(Fung et al., 2013; SDI, 2016a).  
The inhibitory mechanisms of these silver compound topical treatments on 
dental mineral demineralisation remain obscure (Mei et al., 2017; Zhao et al., 
2017a). Therefore, real-time Ca2+ ISEs were used in this study to measure the 
reduction in the rate of Ca2+ release following topical treatments with 3.16 M 
AgNO3, 3.16 M AgF and 3.16 M Ag[NH3]2F, as an assessment of the caries 
inhibition efficacy (Huang et al., 2018). Furthermore, Ag+ and F- ISEs are also 
available (Section 5.2), which can be used to investigate the interactions of F- 
and Ag+ with dental mineral following treatments with silver compounds. NaF was 
not used to assess the inhibitory efficacy of the topical treatment with fluoride in 
the present study as the highest concentration of NaF agent is only about 0.95 
M. 
31P and 19F Magic Angle Spinning–Nuclear Magnetic Resonance (MAS–NMR) 
characterisation studies have been used in dental research to identify apatite 
species (Tsai and Chan, 2011), and to differentiate between FAP, 
fluorohydroxyapatite (FHA), CaF2 and HAP (Mohammed et al., 2013; White et al., 
1994; White et al., 1988). Therefore, they can be used to detect any phosphorous 
and fluorine reaction products formed after the interactions between silver 
compounds and dental mineral.  
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Photographs of the dental mineral samples (e.g., HAP discs) topically treated 
with silver compounds can also be used to monitor discolouration. As Ag3PO4 is 
yellow (Lewis, 1920), which is chemically reduced to black metallic silver after 
exposure to light and/or heat (Lou et al., 2011), colour changes of lesions 
following the silver compound topical treatments can indicate Ag3PO4 formation. 
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8.2 Aims  
 
The first aim was to understand the inhibitory mechanisms of AgNO3, AgF and 
Ag[NH3]2F topical treatments on the demineralisation of HAP discs. This was 
achieved by investigating the effects of topical treatments with AgNO3, AgF and 
Ag[NH3]2F on the demineralisation of HAP discs, using: Ca2+, Ag+ and F- ion 
selective electrodes (ISEs), digital camera, scanning electron microscopy (SEM), 
energy dispersive X-ray analysis (EDX). Further, 31P and 19F MAS-NMR were 
also used to identify any phosphorous and fluoride reaction products formed 
following the interactions between silver compounds and HAP powders.  
    The second aim was to compare the inhibitory efficacy and the effects of topical 
treatment with a commercial Ag[NH3]2F product with laboratory-prepared 
Ag[NH3]2F on demineralisation of HAP discs. This was achieved by investigating 
the effects of topical treatment with Silver Capsule of Riva Star, on the 
demineralisation inhibition of HAP discs, using the techniques mentioned above.  
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8.3 Materials and Methods 
 
ISE study, digital imaging, and SEM and EDX analyses were conducted using 
HAP discs topically treated with AgNO3, AgF and Ag[NH3]2F, which underwent 
demineralisation. 31P and 19F MAS-NMR analyses were conducted on HAP 
powders mixed with these silver compounds, with and without acid challenge. As 
the amounts of reaction products formed in these mixed powders were large, the 
changes in the proportions of the reaction products before and after acid 
challenge can be monitored. 
 
8.3.1 ISE Study 
 
 
Figure 8.1 – Nail-varnished porous HAP discs. 
 
Fifteen porous HAP discs (20% porosity, 12 mm in diameter, 2 mm in thickness; 
Plasma Biotal Ltd, UK) were varnished with red nail lacquer (KIKO, Italy) to leave 
only a 3 mm X 4 mm window on each sample exposed (Fig. 8.1). The window 
sizes were standardised to control the area exposed to acid challenge. The 
varnished discs were then allocated into five treatment groups (n = 3 each) 
(shown in Table 8.1). The demineralisation solution was made using 0.1 M 
CH3COOH buffered to pH 4.0, using KOH, as described in Section 6.3.2. 
 
4 mm 
3 mm 
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Table 8.1 – Compositions of treatment groups.  
Group 
names 
Compositions *Preparation 
DW Tx De-ionised water From Triplered Ltd (UK) 
AgNO3 Tx 3.16 M AgNO3 1.07 g AgNO3 + 2 mL DW 
AgF Tx 3.16 M AgF 0.80 g AgF + 2 mL DW 
Ag[NH3]2F Tx 3.16 M SDF 0.80 g AgF + 1 mL DW + 1 mL 30 wt% 
NH4OH 
Riva-SC Tx  Silver Capsule (3.16 M 
SDF)  
Riva Star of SDI Ltd (Australia) 
* = all chemicals shown in preparation are from Sigma-Aldrich, UK 
 
Calibrations of Ca2+, F- and Ag+ ISEs were conducted before the experiment, 
as described in Section 6.3.3, but at 37+0.3 0C (LLOD of Ca2+: 0.023 mM, LLOD 
of F-: 0.001 mM, LLOD of Ag+: 0.001 mM). Further, the activity coefficient of each 
ion was calculated with an ionic speciation program (Chemist, MicroMath, USA) 
(activity coefficient of Ca2+ ≈ 0.6, F- ≈ 1, Ag+ ≈ 1).  
In the ISE study, the top of the beaker was covered by parafilm and the beaker 
was surrounded by foil to minimise evaporation and avoid the exposure to light. 
The thermometer of the hotplate of the stirrer was used to heat up and maintain 
the solution at 37+0.3 0C, and the thermometer of the ISE was used to monitor 
the temperature. The stirring speed was set at the lowest to avoid too much 
agitation during the experiments. Ca2+, Ag+ and F- ISEs were used to 
simultaneously monitor the activities of Ca2+, F- and Ag+ as demineralisation 
progressed, at intervals of 1 min (Fig. 8.2a and b). 
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a  
b  
Figure 8.2 – a. Schematic representation of setup of the ISE study at 37+0.3 0C; b. Photo of the 
ISE setup in the study (F- ISE was behind Ca2+ ISE).  
 
HAP disc
Ca2+
ISE
Ag+
ISE
F-
ISE
37 0C
Magnetic stirrer/Hotplate
Foil
Parafilm
Thermometer of hotplate
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The protocol used in the ISE study is shown as a flowchart (Fig. 8.3). Firstly, 
each varnished HAP disc was immersed in 50 mL of demineralisation solution at 
37+0.3 0C for 4 h using a temperature stabilised stirrer (Stuart UC152D/KIT, UK). 
After 4 h demineralisation, the demineralised HAP discs were taken out, rinsed 
with DW, air-dried, and topically treated with the pre-assigned application agent 
for 1 min using a micro-brush (Centrix, USA), followed by air-drying. This protocol 
was as similar to the clinical procedures recommended by Crystal and Niederman 
(2016) as could be achieved in the present in vitro study. Each disc was then 
further demineralised for another 4 h, and the ion activities of Ca2+, Ag+ and F- 
were monitored at 1 min intervals using ISEs as before.  
Finally, the activity of Ca2+ (mM) was plotted as a function of time (h) for each 
group, and the percentage reduction in the rate of calcium loss of HAP (PRCLHAP) 
for each treatment was calculated, as described in Section 6.3.4. The activities 
of F- and Ag+ were similarly plotted as a function of time. 
 
 
Figure 8.3 – Protocol of the ISE study on HAP discs. 
 
8.3.2 Digital Photographs 
 
Digital photographs of the HAP discs in each treatment group were taken using 
a digital camera (Olympus TG-5, Japan) after the first 4 h demineralisation, after 
topical treatments, and after further 4 h demineralisation, in order to monitor the 
colour changes at each step. 
 
 
Varnished HAP discs (n = 3)
were put into pH 4.0
acetic acid for 4 h
demineralisation at 37 0C.
Demineralised HAP discs
were taken out, rinsed and
air-dried to be topically
treated with assigned agents
for 1 min, followed by air-dry.
Topically treated HAP discs
were re-immersed into the
acetic acid for further 4 h
demineralisation.
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8.3.3 SEM and EDX Analyses 
 
After the ISE study, each HAP disc was removed from the acid.  They were then 
carbon-coated in order to be imaged with SEM and elementally analysed with 
EDX. SEM (FEI Inspect-F, USA) was operated at a high voltage of 5.00 kV and 
5000 X magnification. Both SEM and EDX analyses were conducted in the middle 
area of the exposed window to avoid any interference from the nail varnish at the 
margin of the window. 
 
8.3.4 31P and 19F MAS-NMR Analyses 
 
HAP powders were treated with silver compounds and acid challenged using 
procedures similar to those used in the ISE study.  
1.0 g un-sintered HAP powders (CAPTAL ®  'R', Plasma Biotal Ltd, UK) were 
mixed with 2.5 mL of either DW (HAP + DW), 3.16 M AgNO3 (HAP + AgNO3), 
3.16 M AgF (HAP + AgF), 3.16 M Ag[NH3]2F (HAP + Ag[NH3]2F), or Silver 
Capsule of Riva Star (HAP + Riva-SC). Thereafter, the samples were collected 
after 1 min centrifugation (3000 rpm) (MICROSPIN 24S; Sorvall). Next, half of the 
collected samples were immersed in 5.0 mL demineralisation solution (pH 4.0) 
as used in the ISE study for 4 h, followed by 1 min centrifugation (3000 rpm) to 
prepare the acid challenged samples. All the collected samples were then put 
into a desiccator for 24 h for drying. 
     After desiccation, samples were analysed with 31P MAS-NMR and 19F MAS-
NMR (600 MHz Bruker, Coventry, UK). Solid-state 31P MAS-NMR analysis was 
carried out using a 14.1 Tesla spectrometer at a Larmor frequency of 242.94 
Mega-hertz (MHz) for a 16 min scan with a recycle delay of 1 min. Solid-state 19F 
MAS-NMR analysis was carried out using a 14.1 Tesla spectrometer at a Larmor 
frequency of 564.66 MHz for a 1 h scan with a recycle delay of 30 s. All scans 
were obtained under magic angle spinning conditions of 20 kHz.  
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8.4 Results 
 
8.4.1 Ca2+ ISE Study 
 
Fig. 8.4 shows a typical plot of Ca2+ release from a HAP disc of the DW treatment 
group. The Ca2+ release was linear with time, both before and after treatment. 
The rate of Ca2+ release was decreased following the DW treatment (Table 8.2). 
All three samples of the DW treatment group showed a similar linear Ca2+ release, 
both before and after treatment, and a similar reduction in the rate of Ca2+ release 
following the treatments. Errors of gradients were calculated using SigmaPlot 
10.0 (Systat Software, California, USA). 
  
 
Figure 8.4 - Typical Ca2+ release of DW treatment group. 
 
Table 8.2 - The RCLHAP before and after DW topical treatment of the Fig. 8.4. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
DW Tx  10.83 + 0.17 10.19 + 0.16 < 0.01 
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Fig. 8.5 shows a typical plot of Ca2+ release from a HAP disc of the AgNO3 
treatment group. The Ca2+ release was linear with time, both before and after 
treatment. The rate of Ca2+ release was decreased following the AgNO3 
treatment (Table 8.3). All three samples of the AgNO3 treatment group showed a 
similar linear Ca2+ release, both before and after treatment, and a similar 
reduction in the rate of Ca2+ release following the treatments.  
 
 
Figure 8.5 - Typical Ca2+ release of AgNO3 treatment group. 
 
Table 8.3 - The RCLHAP before and after AgNO3 topical treatment of the Fig. 8.5. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
AgNO3 Tx 7.26 + 0.51 5.95 + 0.45 < 0.01 
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Fig. 8.6 shows a typical plot of Ca2+ release from a HAP disc of the AgF 
treatment group. The Ca2+ release was linear with time, both before and after 
treatment. The rate of Ca2+ release was decreased following the AgF treatment 
(Table 8.4). All three samples of the AgF treatment group showed a similar linear 
Ca2+ release, both before and after treatment, and a similar reduction in the rate 
of Ca2+ release following the treatments. 
 
 
Figure 8.6 – Typical Ca2+ release of AgF treatment group. 
 
Table 8.4 - The RCLHAP before and after AgF topical treatment of the Fig. 8.6. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
AgF Tx 7.25 + 0.52 2.42 + 0.15 < 0.01 
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Fig. 8.7 shows a typical plot of Ca2+ release from a HAP disc of the Ag[NH3]2F 
treatment group. The Ca2+ release was linear with time, both before and after 
treatment. The rate of Ca2+ release was decreased following the Ag[NH3]2F 
treatment (Table 8.5). All three samples of the Ag[NH3]2F treatment group 
showed a similar linear Ca2+ release, both before and after treatment, and a 
similar reduction in the rate of Ca2+ release following the treatments.  
 
 
Figure 8.7 - Typical Ca2+ release of Ag[NH3]2F treatment group. 
 
Table 8.5 - The RCLHAP before and after Ag[NH3]2F topical treatment of the Fig. 8.7. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
Ag[NH3]2F Tx 7.56 + 0.50 2.17 + 0.31 < 0.01 
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Fig. 8.8 shows a typical plot of Ca2+ release from a HAP disc of the Riva-SC 
treatment group. The Ca2+ release was linear with time, both before and after 
treatment. The rate of Ca2+ release was decreased following the Riva-SC 
treatment (Table 8.6). All three samples of the Riva-SC treatment group showed 
a similar linear Ca2+ release, both before and after treatment, and a similar 
reduction in the rate of Ca2+ release following the treatments. 
 
 
Figure 8.8 – Typical Ca2+ release of Riva-SC treatment group. 
 
Table 8.6 - The RCLHAP before and after Riva-SC topical treatment of the Fig. 8.8. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
Riva-SC Tx 14.76 + 0.61 5.07 + 0.36 < 0.01 
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8.4.1.1. Summary of the Ca2+ Release from the HAP Discs of Each Treatment 
Group 
 
Table 8.7 shows the rates of calcium loss of HAP (RCLHAP) before and after 
treatments, and the percentages reduction in the rates of calcium loss of HAP 
(PRCLHAP) of every HAP disc in each treatment group. Every Ra (RCLHAP) 
measured was significantly different (p < 0.05) from the Rb (RCLHAP) of the same 
HAP disc sample. 
The mean RCLHAP before treatments were similar (≈ 0.010 mM/h), whereas, 
the mean RCLHAP following treatments were different. The mean RCLHAP 
following topical treatments with fluoride-containing silver compounds like AgF, 
Ag[NH3]2F and Riva-SC, were much lower than those following topical treatments 
with  AgNO3 and DW. 
 
Table 8.7 – The RCLHAP and PRCLHAP of every HAP disc in each treatment group. 
Tx Group HAP Disc Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) PRCLHAP (%) 
DW Tx 1 12.32 + 0.20 11.90 + 0.28 3.4 
2 10.83 + 0.17 10.19 + 0.16 5.9 
3 8.24 + 0.20 7.61 + 0.20 7.6 
Average 10.46 + 1.19 9.90 + 1.25 5.7 + 1.2 
AgNO3 Tx 1 11.58 + 0.20 10.46 + 0.50 9.7 
2 12.70 + 0.30 10.50 + 0.60 17.3 
3 7.26 + 0.51 5.95 + 0.45 18.0 
Average 10.51 + 1.66 8.97 + 1.51 15.0 + 2.7 
AgF Tx 1 9.19 + 0.52 2.85 + 0.77 69.0 
2 11.51 + 0.60 2.16 + 0.30 81.2 
3 7.25 + 0.52 2.42 + 0.15 66.6 
Average 9.32 + 0.23 2.48 + 0.20 72.3 + 4.5 
Ag[NH3]2F Tx 1 7.56 + 0.50 2.17 + 0.31 71.3 
2 7.26 + 0.50 1.62 + 0.70 77.7 
3 15.25 + 0.50 6.07 + 0.60 60.2 
Average 10.02 + 2.62 3.29 + 1.40 69.7 + 5.1 
Riva-SC Tx 1 10.04 + 0.50 4.04 + 0.30 61.2 
2 19.34 + 0.60 7.64 + 0.20 60.5 
3 14.76 + 0.61 5.07 + 0.36 65.7 
Average 14.83 + 2.58 5.58 + 1.11 62.4 + 1.6 
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Fig. 8.9 shows the mean PRCLHAP of each treatment group. The mean 
PRCLHAP of AgF, Ag[NH3]2F and Riva-SC treatment groups were much higher 
than that of AgNO3 treatment group, while the mean PRCLHAP of DW treatment 
group was the lowest. There were no significant differences between the mean 
PRCLHAP of AgF, Ag[NH3]2F and Riva-SC treatment groups. 
 
 
Figure 8.9 – The mean PRCLHAP of each treatment group. Error bars show the standard errors. 
Linking line between bars indicate significant differences at p < 0.05 between treatment groups. 
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8.4.2 Ag+ ISE study 
 
The Ag+ release profiles of each treatment group were plotted from the mean 
activities of Ag+ released from the three HAP discs of each treatment group (Fig. 
8.10). After re-immersion of HAP discs topically treated with AgNO3, AgF, 
Ag[NH3]2F and Riva-SC into acids, all the mean activities of Ag+ in the solution 
increased rapidly from zero and then subsequently decreased continually.  
    Even though the Ag+ release profiles are not linear, the approximate rates of 
the changes in the mean Ag+ activities can be extrapolated by the slopes of the 
trendlines of initial increase and later decrease in Ag+ activities.  
No Ag+ release was observed in the DW treatment group. 
 
 
Figure 8.10 – The mean Ag+ release from HAP discs under pH 4.0 demineralisation before and 
after treatments with DW, AgNO3, AgF, Ag[NH3]2F and Riva-SC. 
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    Table 8.8 shows the mean initial rates (RI) of increase in the Ag+ activities and 
the mean later rates (RL) of decrease in the Ag+ activities following topical 
treatments with silver compounds. However, there were no significant differences 
in RI and RL between each treatment group (Fig. 8.11). 
 
Table 8.8 – Mean RI and mean RL of the Ag+ release following each treatment. 
 
a  
b   
Figure 8.11 – (a) Mean RI and (b) mean RL of the Ag+ release of each treatment group. 
0.00 + 0.00
12.56 + 2.85
20.76 + 3.16 19.01 + 4.08
13.09 + 8.09
0
5
10
15
20
25
30
DW AgNO(3) AgF Ag[NH3]2F Riva-SC
M
e
an
 R
I
o
f 
A
g+
R
e
le
as
e
 (
X
 1
0
-2
m
M
/h
)
DW Tx                 AgNO3 Tx              AgF Tx             g[NH3]2F Tx         Riva-SC Tx
0.00 + 0.00
-0.12 + 0.01
-0.16 + 0.017
-0.24 + 0.08
-0.15 + 0.04
-0.35
-0.3
-0.25
-0.2
-0.15
-0.1
-0.05
0
DW AgNO(3) AgF Ag[NH3]2F Riva-SC
M
e
an
 R
L
o
f 
A
g+
R
e
le
as
e
 (
X
 1
0
-2
m
M
/h
)
DW Tx                 AgNO3 Tx              AgF Tx             Ag[NH3]2F Tx         Riva-SC Tx
Tx Group Mean RI+/-SE (X 10-2 mM/h) Mean RL+/-SE (X 10-2 mM/h) 
DW Tx 0.00 + 0.00 0.00 + 0.00 
AgNO3 Tx 12.56 + 2.85 -0.12 + 0.01 
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8.4.2.1 Mean [Ag+] during the post-treatment 4 h periods of Each Treatment 
Group 
 
The mean [Ag+] during the 4 h demineralisation period after re-immersion of the 
topically treated HAP samples into acid ([Ag+]4h) (Table 8.9) of each treatment 
group was calculated, in order to compare the effects of Ag+ in the acid on the 
demineralisation of the HAP discs.  
Fig. 8.12 shows the [Ag+]4h of each treatment group. There were no significant 
differences between the [Ag+]4h of AgNO3, AgF, Ag[NH3]2F and Riva-SC 
treatment groups. 
 
Table 8.9 – The mean [Ag+] during the 4 h demineralisation period after re-immersion of the 
topically treated HAP samples into acids ([Ag+]4h) of each treatment group. 
 
 
 
 
 
 
Figure 8.12 – The [Ag+]4h (ppm) of each treatment group. Error bars show the standard errors. 
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Riva-SC Tx 8.1 + 1.7 X 10-3 mM  0.87 + 0.18 ppm 
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8.4.3 F- ISE study 
 
The F- release profiles of each treatment group were plotted from the mean 
activities of F- released from the three HAP discs of each treatment group (Fig. 
8.13). After re-immersion of HAP discs topically treated with AgF, Ag[NH3]2F and 
Riva-SC into acids, there was a rapid increase in all the mean activities of F- from 
zero, which slowed with time.  
Even though the F- release profiles are not linear, the approximate rates of the 
changes in the mean F- activities can be extrapolated by the slopes of trendlines 
of initial increase and later increase in F- activities.  
No F- release was observed in DW and AgNO3 treatment groups. 
 
 
Figure 8.13 - The mean F- release from HAP discs under pH 4.0 demineralisation before and 
after treatments with DW, AgNO3, AgF, Ag[NH3]2F and Riva-SC. 
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Table 8.10 shows the mean RI and the mean RL of increase in the F- activities 
following silver compounds topical treatments. The mean RI of Ag[NH3]2F 
treatment group was significantly faster than the mean RI of AgF treatment group, 
but the mean RL of Ag[NH3]2F treatment group was significantly slower than the 
mean RL of AgF treatment group. The mean RI and RL of Riva-SC treatment 
group were not significantly different from other treatment groups (Fig. 8.14). 
 
 
Table 8.10 – Mean RI and mean RL of the F- release following each treatment. 
 
a   
b   
Figure 8.14 – (a) Mean RI and (b) mean RL of the F- release of each treatment group.
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8.4.3.1 Mean [F-] during the post-treatment 4 h periods of Each Treatment 
Group 
 
The mean [F-] during the 4 h demineralisation period after re-immersion of the 
topically treated HAP samples into acid ([F-]4h) (Table 8.11) of each treatment 
group was calculated, in order to compare the effects of F- in the acid on the 
demineralisation of the HAP discs.  
Fig. 8.15 shows the [F-]4h of each treatment group. The [F-]4h of Ag[NH3]2F and 
Riva-SC treatment groups were higher than the [F-]4h of AgF treatment group. 
There was no significant difference between the [F-]4h of Ag[NH3]2F and Riva-SC 
treatment groups. 
 
Table 8.11 – The mean [F-] during the 4 h demineralisation period after re-immersion of the 
topically treated HAP samples into acids ([F-]4h) of each treatment group. 
 
 
 
 
 
Figure 8.15 - The [F-]4h (ppm) of each treatment group. Error bars show the standard errors. 
Linking lines between bars indicate significant differences at p < 0.05 between treatment groups. 
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8.4.4 Digital Photographs 
 
Following topical treatments with AgNO3, AgF, Ag[NH3]2F and Riva-SC, yellow 
staining was observed on the HAP disc surfaces, which then turned to black 
staining after further 4 h demineralisation (Fig. 8.16). No staining was observed 
on the HAP discs topically treated with DW. 
 
 
Figure 8.16 – Digital photographs of HAP discs following different treatments in the ISE study. 
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8.4.5 SEM Images Analysis 
 
Fig. 8.17a ~ e shows typical SEM images of HAP disc surfaces topically treated 
with application agents after demineralisation. The HAP disc surfaces treated 
with AgF, Ag[NH3]2F or Riva-SC were less uneven than that treated with AgNO3, 
while the HAP disc surfaces treated with DW were the most uneven and porous. 
There were numerous cubic particles (~ 3 μm) deposited on HAP disc 
surfaces topically treated with silver compounds (Fig. 8.17b ~ e). Further, there 
were granular particles (~ 1 μm) deposited on HAP disc surfaces topically 
treated with AgF, Ag[NH3]2F or Riva-SC (Fig. 8.17c, d, and e).  
All particles deposited on the HAP disc surfaces were of similar sizes and were 
distributed evenly across the surfaces. Further, the HAP disc surfaces treated 
with AgF, Ag[NH3]2F or Riva-SC (Fig. 8.17c, d, and e) were more densely 
covered by the deposited particles than that treated with AgNO3 (Fig. 8.17b) due 
to the additional deposition of granular particles. 
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Figure 8.17  -   Typical SEM images (5.00 kV, 5000 X) of HAP discs in treatment groups of (a) DW, (b) AgNO3, (c) AgF, (d) Ag[NH3]2F and (e) Riva-
SC, after the ISE study.  
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8.4.6 EDX Analysis 
 
EDX analysis showed that elemental Ag (Fig. 8.18) was present on the HAP disc 
surfaces topically treated with AgNO3, AgF, Ag[NH3]2F and Riva-SC after 
demineralisation. The mean atomic percentage of Ag detected in AgF treatment 
group was higher than that of the Ag[NH3]2F treatment group, both of which were 
higher than 3.16 M AgNO3 treatment group. There were no significant differences 
between the mean atomic Ag % of Riva-SC and other treatment groups. 
No Ag was detected on the HAP surfaces topically treated with DW. 
 
 
Figure 8.18 – The mean atomic percentage of Ag of each treatment group. Error bars show the 
standard errors. Linking lines between bars indicate significant differences at p < 0.05 between 
treatment groups. 
  
0.00+0.00%
4.61+0.89%
7.65+0.26%
8.15+1.78%9.39+0.62%
0
2
4
6
8
10
12
DW Tx AgNO(3) Tx AgF Tx Ag[NH3]2F Tx Riva-SC
M
ea
n
 A
to
m
ic
 %
 o
f 
A
g
DW Tx                 AgNO3 Tx              AgF Tx             Ag[NH3]2          Riva-SC Tx
 
115 
Elemental F (Fig. 8.19) was present on the HAP surfaces topically treated with 
AgF, Ag[NH3]2F and Riva-SC after demineralisation. The mean percentage of F 
detected in the treatment group of AgF was slightly higher than those detected in 
the Ag[NH3]2F and Riva-SC treatment groups. However, there were no significant 
differences between the mean atomic F % of these treatment groups.  
No F was detected on the HAP surfaces topically treated with DW and AgNO3. 
 
 
Figure 8.19 – The mean atomic percentage of F of each treatment group. Error bars show the 
standard errors.  
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8.4.7 31P MAS-NMR Analysis 
 
The 31P MAS-NMR spectra (Fig. 8.20) showed that chemical shift peaks of HAP 
(2.9 ppm) and Ag3PO4 (28.8 ppm) were detected in HAP powders mixed with 
AgNO3, AgF, Ag[NH3]2F or Riva-SC. Furthermore, after acid challenge, the 
proportions of Ag3PO4 in all silver compound treatment groups increased, 
whereas the proportions of HAP decreased.  
 
 
Figure 8.20 - 31P MAS–NMR spectra of each treatment group before and after pH 4.0 acid 
challenge. 
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8.4.8 19F MAS-NMR Analysis 
 
The 19F MAS-NMR spectra (Fig. 8.21) showed that no fluoride compounds were 
detected in HAP powders mixed with DW or AgNO3. However, both CaF2 (-109.1 
ppm) and FHA (fluorohydroxyapatite) (-106.6 ppm) were detected in HAP 
powders mixed with AgF, Ag[NH3]2F or Riva-SC. As FHA has a relatively lower 
content of fluoride than FAP, its chemical shift (-106.6 ppm) is at the upfield side 
of the FAP (-103.6 ppm). 
 
 
Figure 8.21 – 19F MAS–NMR spectra of each treatment group before and after pH 4.0 acid 
challenge. (* = sidebands)  
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As the chemical shift peaks of CaF2 and FHA were too close and overlapped 
with each other, deconvolution was required using DmFit (France) (Section 5.6). 
Fig. 8.22 ~ Fig. 8.24 show that, after the acid challenge, the proportions of FHA 
in the HAP powders mixed with AgF, Ag[NH3]2F and Riva-SC increased, whereas 
the proportions of CaF2 decreased. 
 
a  
b  
Figure 8.22 - Deconvoluted 19F spectra of (a) HAP + AgF and (b) pH 4.0 HAP + AgF. 
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a  
b  
Figure 8.23 – Deconvoluted 19F spectra of (a) HAP + Ag[NH3]2F and (b) pH 4.0 HAP + Ag[NH3]2F. 
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a  
b  
Figure 8.24 – Deconvoluted 19F spectra of (a) HAP + Riva-SC and (b) pH 4.0 HAP + Riva-SC. 
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Chapter 9 DISCUSSION OF THE EFFECTS OF TOPICAL 
TREATMENTS WITH SILVER COMPOUNDS ON 
DEMINERALISATION OF HAP DISCS AND PROPOSED 
MODELS FOR MECHANISMS 
 
The linear Ca2+ release with time from demineralising HAP discs under acid 
challenge (Fig. 8.4 ~ Fig. 8.8) observed in the ISE study was consistent with 
previously reported results of mineral loss from HAP and enamel during 
demineralisation using real-time scanning microradiography (SMR) (Anderson et 
al., 1998; Anderson et al., 2004b; Hassanali et al., 2017). However, SMR could 
not be used in this study as it does not allow topical treatments of specimens 
during the experiment due to the time-consuming sample preparation procedure 
(Section 6.1). 
    After demineralisation, uneven HAP disc surfaces were observed (Fig. 
8.17a ~ e), which demonstrated the aggressive destruction from the acid attack. 
The surface roughness of HAP discs has been reported to increase after pH 4.0 
demineralisation using non-contact optical profilometry (Baysan and Anderson, 
2009). 
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9.1 Effects of Topical Treatment with De-ionised Water on 
Demineralisation of HAP Discs 
 
In the ISE study, following the topical treatment with de-ionised water (DW) on 
HAP discs, a small inhibitory efficacy (5.7+1.2 %) was observed (Fig. 8.9). This 
might be due to the removal of softened HAP surfaces during the topical 
applications using a micro-brush, which exposed the intact HAP layers beneath. 
Further, the physical forces of the topical treatment may smooth the HAP 
surfaces. Therefore, after re-immersion of the topically treated HAP discs back 
into acid, the demineralisation was initiated on an intact and smoothened HAP 
surface, which led to a slower Ca2+ release from the demineralising HAP discs. It 
has been suggested that eroded dental surfaces are more vulnerable to physical 
abrasion effects than sound dental surfaces (Shellis and Addy, 2014). Therefore, 
demineralisation of HAP discs can be slightly inhibited by the abrasion effects 
following using a micro-brush during the topical treatments.  
    In this study, the inhibitory efficacy of the topical treatments was based on the 
ratios between the slope values of “4 h” Ca2+ release trend-lines before and after 
the treatments. However, the ratios between the slope values of shorter time 
periods (e.g. 2 h or 3 h) for Ca2+ release trend-lines before and after the 
treatments may be different from the present result, leading to different inhibitory 
efficacy. Therefore, the time period chosen for the Ca2+ release can affect the 
interpretation of the results, which may lead to different conclusions. This is a 
limitation of the current study.        
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9.2 Effects of Topical Treatment with AgNO3 on 
Demineralisation of HAP Discs and Proposed Mechanistic 
Models 
 
9.2.1 Following Topical Treatment with AgNO3 
 
In the ISE study, immediately following topical treatment with AgNO3 on HAP 
discs, yellow staining was observed on the HAP disc surfaces (Fig. 8.16), which 
indicated the formation of yellow Ag3PO4 (Lewis, 1920). This was consistent with 
the formation of Ag3PO4 in the HAP powders mixed with AgNO3, detected with 
31P MAS-NMR (Fig. 8.20). It has been proposed that Ag+ can substitute for Ca2+ 
in the HAP lattice (Ling Feng et al., 1998; Singh et al., 2011) (Section 3.2). 
Therefore, some Ag+ substituted HAP could also be formed following the topical 
treatment with AgNO3. This is shown schematically in Fig. 9.1. 
 
 
Figure 9.1 – Schematic representation of an HAP disc topically treated with AgNO3. Ag3PO4 is 
formed on the HAP disc surface and some Ca2+ in the HAP disc is substituted by Ag+. 
 
9.2.2 After Re-immersion of HAP Discs Topically Treated with 
AgNO3 into Acid 
 
After re-immersing the HAP discs topically treated with AgNO3 back into acid, the 
ISE data showed that there was a small immediate reduction by 15.0+2.7 % in 
the rate of Ca2+ release (Fig. 8.5 and Fig. 8.9). 31P MAS-NMR spectra showed 
that in the HAP powders treated with AgNO3, after acid challenge, the proportion 
of Ag3PO4 increased and the proportion of HAP decreased (Fig. 8.20). This may 
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be due to the acidic demineralisation of HAP by the acid, providing more PO43- 
for further Ag3PO4 formation, which indicates that Ag3PO4 has higher acid-
resistance than HAP. Therefore, the inhibition of Ca2+ release from 
demineralising HAP discs following the topical treatment with AgNO3 may be 
associated with the formation of a “protective barrier” composed of Ag3PO4. This 
experimental result confirmed the theoretical inhibitory mechanism of AgNO3 on 
HAP demineralisation, proposed by Yamaga et al. (1972) (Section 3.2). Gradually, 
yellow Ag3PO4 on the treated HAP discs was reduced to black metallic silver due 
to the photosensitivity of Ag+, as described by Liu et al. (2012c). Even though foil 
was used in the present study to limit the exposure to light, it has been reported 
that Ag3PO4 will be reduced to metallic silver in both light and dark conditions 
(Lou et al., 2011). 
However, the mean PRCLHAP following topical treatment with AgNO3 (15.0+2.7 
%) is not much higher than that following topical treatment with DW (5.7+1.2 %) 
(Fig. 8.9), implying that the inhibitory efficacy of the topical treatment with AgNO3 
is low. The low inhibitory efficacy of the topical treatment may be due to the 
formation of Ag+ substituted HAP, which has been proposed to be more 
susceptible to acid challenge than HAP (Singh et al., 2011).  
The Ag+ released from the HAP discs topically treated with AgNO3 was 
detected with Ag+ ISEs after the re-immersion of the HAP discs back into acid 
(Fig. 8.10). The initial increase in the mean Ag+ activity could result from the 
release of Ag+ loosely attached to the HAP disc surfaces, whereas, the later 
decrease in the mean Ag+ activity could result from the chemical reduction of Ag+. 
These very small metallic silver particles will be dispersed in the solution due to 
the agitation of the magnetic stirrer.  
    Fig. 9.2a shows that, after re-immersing the HAP discs topically treated with 
AgNO3 back into acid, Ag+ loosely attached to the HAP disc surfaces is released 
into solution. Further, the Ag3PO4 protective barrier protects the HAP disc from 
demineralisation. Fig. 9.2b shows that some Ag+ in the solution and some 
Ag3PO4 on the HAP disc surface are gradually reduced to black metallic silver. 
Further, the metallic silver reduced from the Ag+ in the solution will be dispersed 
in the solution. 
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a  
b  
Figure 9.2 - Schematic representation of an HAP disc topically treated with AgNO3 following re-
immersion back into acid. a) Ag+ loosely attached to HAP disc surfaces is released into solution. 
b) Gradually, some Ag3PO4 on the HAP disc surface and some Ag+ in the solution are reduced to 
black metallic silver.  
 
9.2.3 After Removal of HAP Discs Topically Treated with AgNO3 
from Acid 
 
After removing the HAP discs topically treated with AgNO3 from acid, SEM 
images showed that the HAP disc surfaces were less uneven than the surfaces 
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topically treated with DW (Fig. 8.17a and b), which demonstrated the inhibitory 
efficacy of topical treatment with AgNO3. Deeper lesions observed on the HAP 
disc surfaces may be due to the loss of Ag+ substituted HAP, which has a higher 
susceptibility to acidic demineralisation.  
Cubic particles were observed on the HAP disc surfaces topically treated with 
AgNO3 (Fig. 8.17b). These cubic particles may be Ag3PO4 or metallic silver, as 
a previous study has reported that yellow cubic Ag3PO4 were found in the HAP 
powders mixed with AgNO3, which gradually reduced to black cubic metallic silver 
(Lou et al., 2011). In the present study, as only black staining was observed on 
the HAP disc surfaces topically treated with AgNO3 (Fig. 8.16), most of the 
Ag3PO4 has been reduced to metallic silver over the post-treatment 4 h 
demineralisation period.  
Fig. 8.5 shows that, during the post-treatment 4 h demineralisation period, the 
inhibited Ca2+ release from demineralising HAP disc following the topical 
treatment with AgNO3 was linear with time, even though Ag3PO4 in the protective 
barrier was gradually reduced to metallic silver. This indicates that the inhibitory 
efficacy of the topical treatment with AgNO3 was not subsequently affected by the 
chemical reduction of Ag3PO4 in the protective barrier to metallic silver. Therefore, 
the metallic silver particles reduced from Ag3PO4 particles continued to play the 
same protective role as the Ag3PO4 particles in the protective barrier during 
demineralisation. 
Fig. 9.3 shows that after removing the HAP discs topically treated with AgNO3 
from acid, deeper lesions developed in the Ag+ substituted HAP are observed, 
and therefore the demineralised HAP disc surface is very uneven. Further, all the 
Ag3PO4 on the HAP disc surfaces is reduced to metallic silver causing black 
staining. The HAP disc surface covered by the metallic silver is protected during 
the demineralisation. 
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Figure 9.3 – Schematic representation of an HAP topically treated with AgNO3 after 4 h 
demineralisation. Deeper lesions are developed in the Ag+ substituted HAP, therefore an uneven 
demineralised HAP disc surface is observed. Further, all the Ag3PO4 is reduced to metallic silver 
causing black staining. 
 
9.2.4 Analysis of the Inhibitory Efficacy of the Topical Treatment with 
AgNO3 on Demineralisation of HAP Discs  
 
As discussed in topical treatment with DW (Section 9.1), demineralisation of HAP 
discs can be inhibited merely by the abrasion effects from using a micro-brush 
during the topical treatment (PRCLHAP = 5.7+1.2 %). Therefore, the inhibitory 
efficacy (PRCLHAP = 15.0+2.7 %) observed following the topical treatment with 
AgNO3 on the demineralisation of HAP discs was partially be attributed to the 
abrasion effects of the micro-brush.  
 
 
Figure 9.4 – The effects of topical treatment influencing the inhibitory efficacy. 
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The rest of the inhibitory efficacy should be associated with the effects of 
topically applied AgNO3. The effects of topically applied AgNO3 include the 
effects of the reaction products deposited on the HAP disc surfaces and the 
effects of the ions released from the topically treated HAP discs (Fig. 9.4). As 
discussed previously (Section 9.2.2), Ag3PO4 particles were formed as a 
protective barrier on the HAP discs topically treated with AgNO3, which 
contributed to the inhibitory efficacy. Whereas, as the Ag+ in the solution released 
from the topically treated HAP discs accelerated the demineralisation due to the 
formation of Ag+ substituted HAP (Singh et al., 2011), the inhibitory efficacy was 
compromised. However, as the [Ag+]4h in the solution was only 0.61+0.10 ppm 
(Table 8.9), the accelerating effect of Ag+ should be small. According to the log-
linear dose-response of Ag+ on demineralisation of enamel reported in Chapter 7 
(Fig. 7.4), the effect of the Ag+ at 0.61 ppm is negligible. 
 
9.2.5 Conclusions 
 
In conclusion, Sections 9.2.1, 9.2.2, 9.2.3 and 9.2.4 show that the inhibitory 
efficacy of topical treatment with AgNO3 on demineralisation of HAP discs is 
associated with the formation of a protective barrier composed of Ag3PO4 
(gradually reduced to metallic silver), and the abrasion effects of topical treatment.  
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9.3 Effects of Topical Treatments with AgF and Ag[NH3]2F on 
Demineralisation of HAP Discs and Proposed Mechanistic 
Models 
 
9.3.1 Following Topical Treatments with AgF and Ag[NH3]2F 
 
In the ISE study, immediately following topical treatments with AgF and 
Ag[NH3]2F on HAP discs, yellow staining was observed on the HAP disc surfaces 
(Fig. 8.16), which indicated the formation of yellow Ag3PO4 (Lewis, 1920). This 
was consistent with the formation of Ag3PO4 in the HAP powders mixed with AgF 
and Ag[NH3]2F detected with 31P MAS-NMR (Fig. 8.20). Further, the formation of 
CaF2 and fluorohydroxyapatite (FHA) in the HAP powders mixed with AgF and 
Ag[NH3]2F was also detected with 19F MAS-NMR (Fig. 8.21). Therefore, the Ca2+ 
lost from HAP discs due to the formation of Ag+ substituted HAP (Ling Feng et 
al., 1998; Singh et al., 2011) will be preserved as CaF2, and unstable Ag+ 
substituted HAP will be replaced by more stable FHA (Robinson, 2009). Thus, 
HAP discs topically treated with AgF and Ag[NH3]2F should be better protected 
against demineralisation than those topically treated with AgNO3 due to the 
additional CaF2 deposits covering the HAP disc surfaces, and, the formation of 
acid-resistant FHA. This is shown schematically in Fig 9.5. 
 
 
Figure 9.5 – Schematic representation of an HAP disc topically treated with AgF or Ag[NH3]2F. 
Ag3PO4, CaF2 and FHA are formed on the HAP disc surface. 
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9.3.2 After Re-immersion of HAP Discs Topically Treated with AgF, 
and Ag[NH3]2F into Acid 
 
After re-immersing the HAP discs topically treated with AgF and Ag[NH3]2F back 
into acid, the ISE data showed that there was an immediate reduction in the rate 
of Ca2+ release (Fig. 8.6 and Fig. 8.7). The mean PRCLHAP of the AgF and 
Ag[NH3]2F treatment groups (72.3+4.5 % and 69.7+5.1 %) were much higher 
than that of the AgNO3 treatment group (15.0+2.7 %) (Fig. 8.9), showing that the 
inhibitory efficacy of F- was greater than that of Ag+.  
31P MAS-NMR spectra showed that in the HAP powders mixed with AgF, and 
Ag[NH3]2F, the proportions of Ag3PO4 increased, and the proportions of HAP 
decreased after acid challenge (Fig. 8.20). This indicates that the Ag3PO4 has 
higher acid-resistant than HAP (as discussed in Section 9.2.2). Furthermore, 19F 
MAS-NMR spectra showed that in the HAP powders mixed with AgF and 
Ag[NH3]2F, the proportions of CaF2 decreased and the proportions of FHA 
increased after acid challenge (Fig. 8.22 and Fig. 8.23). This may be due to the 
acidic demineralisation of CaF2, providing F- for further formation of FHA. Both 
CaF2 and FHA have been proposed to be able to inhibit the demineralisation of 
HAP (Rosin-Grget et al., 2013; ten Cate, 1997; White and Nancollas, 1990) 
(Section 2.4). Therefore, the inhibition of Ca2+ release from demineralising HAP 
discs following the topical treatments with AgF and Ag[NH3]2F could be 
associated with the formation of a protective barrier composed of Ag3PO4, CaF2 
and FHA. This experimental result confirmed the theoretical inhibitory mechanism 
of Ag[NH3]2F on HAP demineralisation, proposed by Yamaga et al. (1972) 
(Section 3.4.3). Gradually, yellow Ag3PO4 on the treated HAP discs was reduced 
to black metallic silver due to the photosensitivity of Ag+ (Liu et al., 2012c). 
The Ag+ released from the HAP discs topically treated with AgF and Ag[NH3]2F 
was detected with Ag+ ISEs after the re-immersion of the HAP discs back into 
acid (Fig. 8.10). As mentioned in AgNO3 treatment group (Section 9.2.2), the 
initial increase in the mean Ag+ activity could result from the release of Ag+ loosely 
attached to the HAP disc surfaces, whereas, the later decrease in the mean Ag+ 
activity could result from chemical reduction of Ag+. These very small metallic 
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silver particles will be dispersed in the solution due to the agitation of the magnetic 
stirrer. 
Fig. 8.11a and b shows that there were no significant differences in the initial 
increase rate of Ag+ activities and the later decrease rate of Ag+ activities between 
AgF and Ag[NH3]2F treatment groups. This indicates the hindrance of the 
chemical reduction of Ag+ by the formation of Ag[NH3]2+ following the Ag[NH3]2F 
topical treatment (Liu et al., 2012b) was not obvious. Similar Ag+ release profiles 
explain why there were no significant differences between the [Ag+]4h of AgF and 
Ag[NH3]2F treatment groups (Fig. 8.12). Therefore, the effects of Ag+ in the 
solution on both AgF and Ag[NH3]2F topically treated HAP discs should be similar. 
The F- released from the HAP discs topically treated with AgF and Ag[NH3]2F 
was detected with F- ISEs after the re-immersion of the HAP discs back into acid 
(Fig. 8.13). The initial increase in the mean F- activity could result from the release 
of F- loosely attached to the HAP disc surfaces (Arends and Christoffersen, 1990; 
Dijkman et al., 1982), whereas, the later increase in the mean F- activity could 
result from the slow dissolution of CaF2-like globules (Buzalaf et al., 2011; White 
and Nancollas, 1990; Rolla, 1988). It has been proposed that CaF2-like globule 
(CaF2 with the adsorption of HPO42-), which has lower solubility than pure CaF2, 
can act as a pH-driven F- reservoir, favouring the formation of FHA (ten Cate, 
2013; Vogel, 2011) (Section 2.4). 
Fig. 8.14a and b shows that the initial increase rate of F- activity following 
Ag[NH3]2F topical treatment was significantly faster than that following AgF 
topical treatment. However, the later increase rate of F- activity following 
Ag[NH3]2F topical treatments was significantly slower than that following AgF 
topical treatment. This may be due to that the proportion of CaF2 without the 
adsorption of HPO42-, which has higher solubility, formed following Ag[NH3]2F 
topical treatment was higher than that following AgF topical treatment, leading to 
faster initial F- release. Further, the proportion of CaF2 with the adsorption of 
HPO42- (CaF2-like globule) formed following Ag[NH3]2F topical treatment was 
lower than that following AgF topical treatment, leading slower later F- release. 
The much faster initial F- release following Ag[NH3]2F topical treatment resulted 
in significantly higher [F-]4h detected following Ag[NH3]2F topical treatment than 
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that following AgF topical treatment (Fig. 8.15). Therefore, the effects of F- in the 
solution on Ag[NH3]2F topically treated HAP discs should be higher than those on 
AgF topically treated HAP discs. Less CaF2-like globules formed following 
Ag[NH3]2F topical treatment may be due to the interference of the adsorption of 
HPO42- around CaF2 surfaces. The most likely interference factor could be the 
ammonium (NH4+) dissolved from the Ag[NH3]2F. However, further studies are 
required to confirm the extrapolation. 
Fig. 9.6a shows that, after re-immersing the HAP discs topically treated with 
AgF or Ag[NH3]2F back into acid, both Ag+ and F- loosely attached to HAP disc 
surface are released into solution. Further, the protective barrier composed of 
Ag3PO4, CaF2 and FHA protects the HAP disc from demineralisation. Fig. 9.6b 
shows that some Ag+ in the solution and some Ag3PO4 on the HAP disc surface 
are gradually reduced to metallic silver. Further, some CaF2 on the HAP disc 
surface is gradually dissolved, providing F- for further formation of FHA. 
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a  
b  
Figure 9.6 - Schematic representation of an HAP disc topically treated with AgF or Ag[NH3]2F 
following re-immersion back into acid. a) Both Ag+ and F- loosely attached to HAP disc surfaces 
are released into solution. b) Gradually, some Ag3PO4 on the HAP disc surface and some Ag+ in 
the solution are reduced to metallic silver, and some CaF2 on the HAP disc surface is dissolved, 
providing F- for further formation of FHA. 
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9.3.3 After Removal of HAP Discs Topically Treated with AgF, and 
Ag[NH3]2F from Acid 
 
After removing the HAP discs topically treated with AgF and Ag[NH3]2F from acid, 
SEM images showed that the HAP disc surfaces were less uneven than those 
topically treated with AgNO3 (Fig. 8.17b ~ d), which demonstrated that the 
inhibitory efficacy of F- was greater than that of Ag+.  
Cubic and granular particles were observed on the HAP disc surfaces topically 
treated with AgF and Ag[NH3]2F (Fig. 8.17c and 8.17d). As only black staining 
was observed on the HAP disc surfaces (Fig. 8.16), the cubic particles were 
mostly cubic metallic silver reduced from Ag3PO4 (as discussed in Section 9.2.3). 
On the other hand, the granular particles should be CaF2-like globules (Rolla and 
Saxegaard, 1990; Buzalaf et al., 2011) (Section 2.4). A previous study also 
reported that cubic metallic silver and CaF2-like globules were found in the HAP 
powders (2.5 mg) mixed with Ag[NH3]2F (0.5 mL) (Lou et al., 2011). However, 
they did not find Ag3PO4 following mixing with Ag[NH3]2F. This may be due to 
higher amounts of the HAP powder (1.0 g) and the Ag[NH3]2F (2.5 mL) used in 
this study, leading to more formation of Ag3PO4. Further, they identified CaF2-like 
globules which disappeared after water rinsing. However, as no rinsing procedure 
was conducted after the topical treatment in the present study, CaF2-like globules 
were observed on the HAP disc surfaces. 
The mean atomic percentage of Ag detected on the HAP disc surfaces topically 
treated with AgF was significantly higher than that of AgNO3 (Fig. 8.18). This 
indicates that the participation of F- increased the formation of silver compounds 
deposited on the surfaces. A previous study found that as the formation of CaF2 
requires slight dissolution of enamel, it results in the PO43- release from the 
dissociation of enamel mineral (mainly HAP) (Mohammed et al., 2013). Therefore, 
in the present study, as CaF2 was formed following topical treatments with AgF 
(Fig. 8.21), PO43- released from the dissociation of HAP discs led to more 
formation of Ag3PO4 on the surfaces. The mean atomic percentage of Ag 
detected on the HAP disc surfaces topically treated with Ag[NH3]2F was 
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significantly lower than that of AgF (Fig. 8.18), which may be due to that Ag3PO4 
can be dissolved in ammonium (Firsching, 1961) (Section 3.4.3).  
The mean atomic percentages of F detected on the HAP discs topically treated 
with AgF and Ag[NH3]2F were small (< 2 %) (Fig. 8.19). This indicates that most 
of the CaF2 was dissolved during the post-treatment 4 h demineralisation period. 
The mean atomic percentage of F detected on the HAP discs topically treated 
with AgF was slightly higher than that of Ag[NH3]2F treatment group (Fig. 8.19). 
The lower mean atomic percentages of F detected on the Ag[NH3]2F topically 
treated HAP discs should be due to the faster initial F- release (Fig. 8.14a), as 
discussed in Section 9.3.2.  
Fig. 8.6 and Fig. 8.7 show that, during the post-treatment 4 h demineralisation 
period, the inhibited Ca2+ release from demineralising HAP disc following the 
topical treatments with AgF and Ag[NH3]2F was linear with time, even though 
Ag3PO4 in the protective barrier was gradually reduced to metallic silver and the 
CaF2 in the protective barrier was gradually dissolved. This indicates that the 
inhibitory efficacy of topical treatments with these fluoride-containing silver 
compounds was not subsequently affected by the chemical reduction of Ag3PO4 
to metallic silver and the dissolution of CaF2. As mentioned in Section 9.2.3, the 
metallic silver particles reduced from Ag3PO4 particles continue to play the same 
protective role as the Ag3PO4 particles in the protective barrier. Therefore, the 
further FHA formation due to the supply of F- from CaF2 dissolution should 
compensate for the protective effect lost from the dissolution of CaF2 in the 
protective barrier. 
    Fig. 9.7 shows that after removing the HAP discs topically treated with AgF, or 
Ag[NH3]2F from acid, all the Ag3PO4 on the HAP disc is reduced to metallic silver 
causing black staining. Further, most of the CaF2 is dissolved, which favours 
further formation of FHA. The HAP disc surface covered by the metallic silver, 
CaF2 and FHA is protected during the demineralisation. 
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Figure 9.7 - Schematic representation of an HAP topically treated with AgF or Ag[NH3]2F after 4 
h demineralisation. All the Ag3PO4 is reduced to metallic silver causing black staining and most 
of the CaF2 is dissolved which favours further formation of FHA.  
 
9.3.4 Analysis of the Inhibitory Efficacy of the Topical Treatments 
with AgF and Ag[NH3]2F on Demineralisation of HAP Discs 
 
As discussed in Section 9.2.4, the inhibitory efficacy of the topical treatment on 
demineralisation of HAP discs can be influenced by the abrasion effects from 
using a micro-brush during the topical treatment and the effects of topical 
application agent (Fig. 9.4). Therefore, the abrasion effects of the topical 
treatment (PRCLHAP = 5.7+1.2 %) contributed to the inhibitory efficacy of topical 
treatments with AgF (PRCLHAP = 72.3+4.5 %) and Ag[NH3]2F (PRCLHAP = 
69.7+5.1 %).  
The effects of topical application agent include the effects of the reaction 
products deposited on the HAP disc surfaces and the effects of the ions released 
from the topically treated HAP discs (Fig. 9.4). Therefore, the protective barrier, 
composed of Ag3PO4, CaF2 and FHA, formed on the HAP disc surfaces topically 
treated with AgF and Ag[NH3]2F (Section 9.3.2) also contributed to the inhibitory 
efficacy.  
After re-immersing the treated HAP discs back into acids, both Ag+ and F- were 
released (Fig. 8.10 and Fig. 8.13). Ag+ in solution accelerates the 
demineralisation of HAP (Singh et al., 2011). According to the log-linear dose-
response of Ag+ on demineralisation of enamel (Fig. 7.4), the effects of the Ag+ 
at 1.00 ppm, [Ag+]4h of AgF, and 1.01 ppm, [Ag+]4h of Ag[NH3]2F (Table 8.9), will 
accelerate the demineralisation both by 1.2 % (PRMLenamel). On the other hand, 
F- in solution inhibits the demineralisation of HAP (White and Nancollas, 1990). 
Ag(s)
Demineralised HAP disc
CaF2
FHA FHA FHA FHA FHA FHA
Ag(s) Ag(s) Ag(s) Ag(s)
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According to the log-linear dose-response of F- on demineralisation of enamel 
(Fig. 6.7b) (Mohammed et al., 2014a), the effects of the F- at 0.18 ppm, [F-]4h of 
AgF, and 0.31 ppm, [F-]4h of Ag[NH3]2F (Table 8.11), will inhibit the 
demineralisation by 22.9 % and 28.9 % (PRMLenamel), respectively. 
Even though the inhibitory efficacy (PRMLenamel) resulting from the F- in solution 
following AgF topical treatment is lower than that following Ag[NH3]2F topical 
treatment, the PRCLHAP of topical treatments with AgF and Ag[NH3]2F were 
similar (Fig. 8.9). Therefore, the inhibitory efficacy from the protective barrier 
formed on the HAP disc surfaces topically treated with AgF was higher than that 
formed on the HAP disc surfaces topically treated with Ag[NH3]2F. This is 
consistent with higher amounts of silver and fluoride compounds detected on the 
AgF topically treated HAP discs (Fig. 8.18 and Fig. 8.19),  
 
9.3.5 Conclusions 
 
In conclusion, Sections 9.3.1, 9.3.2, 9.3.3 and 9.3.4 show that the inhibitory 
efficacy of topical treatments with AgF and Ag[NH3]2F on demineralisation of HAP 
discs is associated with the release of F- from the topically treated HAP discs, the 
formation of a protective barrier composed of Ag3PO4, CaF2 and FHA, and, the 
abrasion effects of topical treatments.  
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9.4 Difference Between the Effects of Topical Treatments with 
Riva-SC and 3.16 M Ag[NH3]2F on Demineralisation of HAP 
Discs 
 
The effects of topical treatment with Riva-SC (3.16 M Ag[NH3]2F, Silver Capsule 
of Riva Star SDI Ltd, Australia) on demineralisation of HAP discs were similar to 
those of laboratory-prepared (3.16 M) Ag[NH3]2F (Fig. 8.7 ~ Fig. 8.24). This 
suggests that they have the same inhibitory effects on the demineralisation of 
HAP discs, and therefore, the same mechanisms (Fig. 9.5 ~ Fig. 9.7).   
    However, the rates of F- release from the HAP discs topically treated with Riva-
SC, and the mean atomic percentages of Ag detected on the HAP disc surfaces 
topically treated with Riva-SC were not significantly different from other treatment 
groups like the laboratory-prepared (3.16 M) Ag[NH3]2F due to the high standard 
errors (Fig. 8.14 and Fig. 8.18). This may be due to that the composition of each 
Silver Capsule of Riva Star used in the study was not consistent. Therefore, a 
higher sample size is required to show the statistical differences. According to the 
SDS of the silver capsules of the Riva Star (SDI, 2016b), they contain 35 ~ 40 
wt% AgF and 15 ~ 20 wt% ammonia.  
. 
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9.5 Conclusions 
 
In conclusion, the demineralisation inhibitory mechanism of topical treatment with 
AgNO3 on HAP discs is associated with the formation of a protective barrier 
composed of Ag3PO4, and the abrasion effects of the topical treatment (see Fig. 
9.4). Whereas, the demineralisation inhibitory mechanism of topical treatment 
with AgF or Ag[NH3]2F on HAP discs is associated with F- released from the 
topically treated HAP discs, the formation of a protective barrier composed of 
Ag3PO4, CaF2 and FHA, and the abrasion effects of topical treatments.  
    The effects of topical treatment with Silver Capsule of Riva Star (3.16 M SDF, 
SDI Ltd, Australia) on demineralisation of HAP discs are similar to those of 
laboratory-prepared 3.16 M Ag[NH3]2F.  
Presented in 2017 IADR Vol 96 (#0066) and 2018 IADR Vol 97 (#0454) 
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Chapter 10 DOSE-RESPONSE EFFECTS OF TOPICAL 
TREATMENTS WITH DIFFERENT CONCENTRATIONS OF 
SILVER COMPOUNDS ON DEMINERALISATION OF HUMAN 
ENAMEL  
 
10.1 Introduction 
 
Even though numerous clinical trials have demonstrated the cariostatic efficacy 
of treatments with these silver compounds (Craig et al., 1987; Green, 1989; Miller, 
1905; Milgrom et al., 2018) (Chapter 3), the inhibitory mechanisms of topical 
treatments with AgNO3, AgF and Ag[NH3]2F on demineralisation of human 
enamel still remain obscure.  
    Today, Ag[NH3]2F is one of the most popular topically applied silver 
compounds used in clinical practice and has been reported to prevent and arrest 
dental caries in many clinical trials (Horst et al., 2016). Commercial Ag[NH3]2F 
products containing different concentrations are available on the market (Fung et 
al., 2013), with 38 wt% (2.36 M) the most commonly used and 50.9 wt% (3.16 M) 
the highest (Horst et al., 2016; SDI, 2016b). Several studies have shown that 
treatment with 38 wt% (2.36 M) Ag[NH3]2F is more effective than 12 wt% (0.75 M) 
Ag[NH3]2F in arresting dental caries (Fung et al., 2016; Fung et al., 2018; Yee et 
al., 2009). However, detailed dose-response effects of a range of topical 
treatments with silver compounds, including AgNO3, AgF and Ag[NH3]2F, on the 
demineralisation of human enamel have not been carried out.   
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10.2 Aims 
 
The inhibitory mechanisms of AgNO3, AgF and Ag[NH3]2F, on demineralisation 
of HAP discs have been discussed in Chapter 9. However, HAP discs and human 
enamel are different in composition and structure (Section 1.3). Therefore, the 
first aim of this chapter was to understand the inhibitory mechanisms of AgNO3, 
AgF and Ag[NH3]2F topical treatments on demineralisation of human enamel. 
This was achieved by investigating the effects of topical treatments with AgNO3, 
AgF and Ag[NH3]2F on demineralisation of human enamel, using; Ca2+, Ag+ and 
F- ion selective electrodes (ISEs), digital camera, scanning electron microscopy 
(SEM), energy dispersive X-ray analysis (EDX), 31P and 19F MAS-NMR, and 
Knoop micro-hardness tester.  
The second aim was to investigate the dose-response effects of topical 
treatments with silver compounds on the demineralisation of human enamel. This 
was achieved by investigating the effects of topical treatments with 0.75 M, 2.36 
M and 3.16 M of AgNO3, AgF and Ag[NH3]2F on demineralisation of human 
enamel, also using the techniques mentioned above.  
   The third aim was to compare the inhibitory efficacy and the effects of topical 
treatment with a commercial Ag[NH3]2F product with laboratory-prepared 
Ag[NH3]2F on the demineralisation of human enamel. This was achieved by 
investigating the effects of topical treatment with the Silver Capsule of Riva Star 
on demineralisation of human enamel using the techniques mentioned above. 
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10.3 Materials and Methods 
 
The protocol used in this study is shown as a flowchart in Fig. 10.1. Firstly, the 
effects of silver compounds on the demineralisation of human enamel (n = 6 each) 
were investigated using ISEs as described in Chapter 8. Next, enamel blocks 
from each treatment group underwent digital photographic imaging, SEM and 
EDX, MAS-NMR, and Knoop micro-hardness analyses. 
 
 
Figure 10.1 – Flowchart of the protocol of the study. 
  
SEM and EDX Analyses:
After ISE study, enamel blocks (n
= 2 each) were imaged with
SEM and elementally analysed
with EDX.
Digital Photographic Imaging:
Digital photographs of enamel surfaces of each
treatment group were taken using a camera
(Olympus TG-5, Japan) after the first 4 h
demineralisation, after topical treatments and
after further 4 h demineralisation to monitor
the colour changes.
ISE Study:
After 4 h demineralisation at pH 4.0, enamel
blocks (n = 6 each) were treated with assigned
agents before being re-immersed into acid for
further 4 h demineralisation. Ca2+, Ag+ and F-
activities were monitored with ISEs throughout
the study.
31P and 19F MAS-NMR:
After ISE study, enamel blocks (n
= 2 each) were powdered to be
characterised with 31P and 19F
MAS-NMR.
Knoop Micro-hardness Test:
After ISE study, enamel blocks (n
= 2 each) underwent Knoop
cross-section micro-hardness
profiling.
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10.3.1 ISE Study 
 
 
Figure 10.2 – Nail-varnished human enamel blocks. 
 
Sixty-six enamel blocks were sectioned from caries-free permanent molars 
(QMREC 2011/99) using a cutting machine (Struers Accutom-5, USA). Blocks 
were polished (300 LVAC, Kemet, UK) with carbide papers with roughness up to 
P4000 under copious water cooling to flatten and remove approximately 100 μ
m (thickness measured with calliper) of the enamel surface. The polishing 
procedure was required to avoid interference from high fluoride concentration in 
the outermost layer of enamel, which varies between individuals (Section 1.2.1), 
during demineralisation. Subsequently, blocks were varnished with red nail 
lacquer (KIKO, Italy) to leave only a 3 mm X 4 mm window on each block exposed 
(Fig 10.2). The window sizes were standardised to control the area exposed to 
acid challenge. Afterwards, blocks were allocated into eleven treatment groups 
(n = 6 each) (shown in Table 10.1). The demineralisation solution was made 
using 0.1 M CH3COOH buffered to pH 4.0, using KOH, as described in Section 
6.3.2. 
Calibrations of Ca2+, F- and Ag+ ISEs were conducted before each experiment, 
as described in Section 6.3.3, but at 37+0.3 0C (LLOD of Ca2+: 0.023 mM, LLOD 
of F-: 0.001 mM, LLOD of Ag+: 0.001 mM). Further, the activity coefficient of each 
ion was calculated with an ionic speciation program (Chemist, MicroMath, USA) 
(activity coefficient of Ca2+ ≈ 0.6, F- ≈ 1, Ag+ ≈ 1). 
 
 
4 mm 
3 mm 
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Table 10.1 – Compositions of treatment groups. 
Group names Compositions *Preparation 
DW Tx De-ionised water From Triplered Ltd (UK) 
0.75 M AgNO3 Tx 0.75 M AgNO3 0.26 g AgNO3 + 2 mL DW 
2.36 M AgNO3 Tx 2.36 M AgNO3 0.80 g AgNO3 + 2 mL DW 
3.16 M AgNO3 Tx 3.16 M AgNO3 1.07 g AgNO3 + 2 mL DW 
0.75 M AgF Tx 0.75 M AgF 0.20 g AgF + 2 mL DW 
2.36 M AgF Tx 2.36 M AgF 0.60 g AgF + 2 mL DW 
3.16 M AgF Tx 3.16 M AgF 0.80 g AgF + 2 mL DW 
0.75 M Ag[NH3]2F Tx 0.75 M SDF 0.20 g AgF + 1 mL DW + 1 mL 30 wt% NH4OH 
2.36 M Ag[NH3]2F Tx 2.36 M SDF 0.60 g AgF + 1 mL DW + 1 mL 30 wt% NH4OH 
3.16 M Ag[NH3]2F Tx 3.16 M SDF 0.80 g AgF + 1 mL DW + 1 mL 30 wt% NH4OH 
Riva-SC Tx Silver Capsule (3.16 M)  From Riva Star of SDI Ltd (Australia) 
* = all chemicals shown in preparation are from Sigma-Aldrich, UK 
 
The setup and the protocol of the ISE study was the same as described in 
Section 8.3.1. Firstly, each varnished enamel block was immersed in 50 mL of 
demineralisation solution at 37+0.3 0C for 4 h using a temperature stabilised 
stirrer (Stuart UC152D/KIT, UK), and Ca2+, Ag+ and F- ISEs were used to 
simultaneously monitor the activities of Ca2+, Ag+ and F- at intervals of 1 min as 
demineralisation progressed. Thereafter, each demineralised enamel block was 
taken out, rinsed, air-dried and topically treated for 1 min with assigned 
application agent using a micro-brush (Centrix, USA), followed by air-drying 
(Crystal and Niederman, 2016). Each enamel block was then demineralised 
again for a further 4 h, and all the ion activities were further monitored at 1 min 
intervals as before.  
Finally, the activity of Ca2+ (mM) was plotted as a function of time (h) for each 
group, and the percentage reduction in the rate of calcium loss from enamel 
(PRCLenamel) for each application was calculated, as described in Section 6.3.4. 
The activities of F- and Ag+ were similarly plotted as a function of time.  
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10.3.2 Digital Photographs 
 
Digital photographs of enamel surfaces in each treatment group were taken using 
a digital camera (Olympus TG-5, Japan) after the first 4 h demineralisation, after 
topical treatments and after further 4 h demineralisation, in order to monitor the 
colour changes at each step. 
 
10.3.3 SEM and EDX Analyses 
 
After the ISE study, experimented enamel blocks from each treatment group of 
ISE study (n = 2 each) were carbon-coated to be imaged with SEM and 
elementally analysed with EDX. SEM (FEI Inspect-F, USA) was operated at a 
high voltage of 5.00 kV and 5000 X magnification. Both SEM imaging and EDX 
analysis were conducted in the middle areas of the exposed windows to avoid 
the interference from the varnish. 
 
10.3.4 31P and 19F MAS-NMR Analyses 
 
The varnished areas of the experimented enamel blocks were removed using a 
micro-motor handpiece (SAESHIN, USA), in order to avoid any interference from 
varnish chemicals during the MAS-NMR analysis. After removal of the nail 
varnished areas, experimented enamel blocks from each treatment group of ISE 
study (n = 2 each) were ground with a grinding machine (Glen Creston Ltd, UK) 
for 30 s with a frequency of 30/s into powders (weight = 0.1 g). 
    The enamel powders were then analysed with 31P MAS-NMR and 19F MAS-
NMR (600 MHz Bruker, Coventry, UK). Solid-state 31P MAS-NMR analysis was 
carried out using a 14.1 Tesla spectrometer at a Larmor frequency of 242.94 
Mega-hertz (MHz) for a 4 h scan with a recycle delay of 1 min. Solid-state 19F 
MAS-NMR analysis was carried out using a 14.1 Tesla spectrometer at a Larmor 
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frequency of 564.66 MHz for a 20 h scan with a recycle delay of 30 s. All spectra 
were obtained under magic angle spinning conditions of 20 kHz. 
 
10.3.5 Knoop Micro-Hardness Analysis 
 
Experimented enamel blocks from each treatment group of ISE study (n = 2 each) 
were varnished with blue nail lacquer (KIKO, Italy) to highlight and protect the 
window areas (Fig. 10.3a) during embedding of the block into acrylic resin 
(Kemdent, UK). Next, half of each enamel blocks were removed by polishing with 
carbide papers with roughness up to P4000 under copious water cooling in order 
to expose the middle area of each enamel cross-sections (Fig. 10.3b).  
 
 
Figure 10.3 – (a) Demineralised lesion of enamel block varnished with blue nail lacquer. (b) 
Resin-embedded block for micro-hardness test.   
 
Before carrying out Knoop hardness indentation, microscopic photographs (40 
X) were taken by attaching a digital camera (Olympus TG-5, Japan) to the 
eyepiece of the Knoop hardness tester to compare the appearances of enamel 
lesion treated with different topical application agents.  
Next, the embedded enamel blocks then underwent Knoop cross-sectional 
micro-hardness profiling (CSMH) using a Knoop micro-hardness tester (MicroMet 
4, UK). Each indentation was conducted with a load of 50 gf for 15 s, as 
suggested by Craig and Peyton (1958). The micro-hardness of the enamel was 
determined at 10 adjacent sites at increments of 40 µm from the centre of the 
a b 
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blue nail varnished lesion surface toward dentine (Fig. 10.4). Three sets of 
indentations were carried out on each block at the same depth 100 µm apart (as 
shown in Fig. 10.4). The median values of the three sets of indentations 
conducted at the same depth level on each block were then recorded, as 
described by Chu and Lo (2008). Finally, the averaged values from the two 
enamel blocks in each treatment group were collected. 
 
 
Figure 10.4 – Schematic representation of Knoop CSMH. 
  
Resin
Dentine
Enamel 
Red nail varnish Blue nail varnish
(treatment surface)
Knoop indentations
100 μm
40 μm
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10.4 Results 
 
10.4.1 Ca2+ ISE Study 
 
Fig. 10.5 shows a typical plot of Ca2+ release from an enamel block of the DW 
treatment group. The Ca2+ release was linear with time both before and after 
treatment. The rate of Ca2+ release was increased following the DW treatment 
(Table 10.2). All six enamel blocks of the DW treatment group showed a similar 
linear Ca2+ release, both before and after treatments, and a similar increase in 
the rate of Ca2+ release following treatments. Errors of gradients were calculated 
using SigmaPlot 10.0 (Systat Software, California, USA). 
 
 
Figure 10.5 - Typical Ca2+ release of DW treatment group. 
 
Table 10.2 –The RCLenamel before and after DW topical treatment of the Fig. 10.5. 
Treatment Rb+/-SE (X 10-3 mM/h)  Ra+/-SE (X 10-3 mM/h) p value 
DW Tx  35.97 + 0.10 41.87 + 0.10 < 0.01 
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Fig. 10.6 shows a typical plot of Ca2+ release from an enamel block of the 0.75 
M AgNO3 treatment group. The Ca2+ release was linear with time both before and 
after treatment. The rate of Ca2+ release was decreased following the 0.75 M 
AgNO3 treatment (Table 10.3). All six enamel blocks of the 0.75 M AgNO3 
treatment group showed a similar linear Ca2+ release, both before and after 
treatments, and a similar reduction in the rate of Ca2+ release following treatments. 
Fig. 10.7 and Fig. 10.8 show typical plots of Ca2+ release from the enamel 
blocks of the 2.36 M and 3.16 M AgNO3 treatment groups. The Ca2+ release was 
also linear with time both before and after treatments. However, the reduction in 
the rates of Ca2+ release decreased with increasing concentration of AgNO3 
(Table 10.3). 
 
Table 10.3 - The RCLenamel before and after AgNO3 topical treatments of the Fig. 10.6 ~ 10.8. 
Treatment Rb+/-SE (X 10-3 mM/h)  Ra+/-SE (X 10-3 mM/h) p value 
0.75 M AgNO3 Tx 21.64 + 0.10 16.97 + 0.09 < 0.01 
2.36 M AgNO3 Tx 34.33 + 0.10 34.57 + 0.30 < 0.01 
3.16 M AgNO3 Tx 33.24 + 0.10 33.54 + 0.20 < 0.01 
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Figure 10.6 - Typical Ca2+ release of 0.75 M AgNO3 treatment group. 
 
 
Figure 10.7 - Typical Ca2+ release of 2.36 M AgNO3 treatment group. 
 
 
Figure 10.8 - Typical Ca2+ release of 3.16 M AgNO3 treatment group. 
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Fig. 10.9 shows a typical plot of Ca2+ release from an enamel block of the 0.75 
M AgF treatment group. The Ca2+ release was linear with time both before and 
after treatment. The rate of Ca2+ release was decreased following the 0.75 M AgF 
treatment (Table 10.4). All six enamel blocks of the 0.75 M AgF treatment group 
showed a similar linear Ca2+ release, both before and after treatments, and a 
similar reduction in the rate of Ca2+ release following treatments.  
Fig. 10.10 and Fig. 10.11 show typical plots of Ca2+ release from the enamel 
blocks of the 2.36 M and 3.16 M AgF treatment groups, The Ca2+ release was 
also linear with time both before and after treatments. Further, the reduction in 
the rates of Ca2+ increased with increasing concentration of AgF (Table 10.4). 
 
Table 10.4 - The RCLenamel before and after AgF topical treatments of the Fig. 10.9 ~ 10.11. 
Treatment Rb+/-SE (X 10-3 mM/h)  Ra+/-SE (X 10-3 mM/h) p value 
0.75 M AgF Tx 29.69 + 0.08 13.34 + 0.05 < 0.01 
2.36 M AgF Tx 33.89 + 0.10 12.01 + 0.10 < 0.01 
3.16 M AgF Tx 24.97 + 0.07 5.34 + 0.04 < 0.01 
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Figure 10.9 - Typical Ca2+ release of 0.75 M AgF treatment group. 
 
 
Figure 10.10 - Typical Ca2+ release of 2.36 M AgF treatment group. 
 
 
Figure 10.11 - Typical Ca2+ release of 3.16 M AgF treatment group. 
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Fig. 10.12 shows a typical plot of Ca2+ release from an enamel block of the 
0.75 M Ag[NH3]2F treatment group. The Ca2+ release was linear with time both 
before and after treatment. The rate of Ca2+ release was decreased following the 
0.75 M Ag[NH3]2F treatment (Table 10.5). All six enamel blocks of the 0.75 M 
Ag[NH3]2F treatment group showed a similar linear Ca2+ release, both before and 
after treatments, and a similar reduction in the rate of Ca2+ release following 
treatments.  
Fig. 10.13 and Fig. 10.14 show typical plots of Ca2+ release from the enamel 
blocks of the 2.36 M and 3.16 M Ag[NH3]2F treatment groups. The Ca2+ release 
was also linear with time both before and after treatments. Further, the reduction 
in the rates of Ca2+ increased with increasing concentration of Ag[NH3]2F (Table 
10.5). 
 
Table 10.5 - The RCLenamel before and after Ag[NH3]2F topical treatments of the Fig. 10.12 ~ 10.14. 
Treatment Rb+/-SE (X 10-3 
mM/h)  
Ra+/-SE (X 10-3 
mM/h) 
p 
value 
0.75 M Ag[NH3]2F 
Tx 
36.02 + 0.10 23.94 + 0.10 < 0.01 
2.36 M Ag[NH3]2F 
Tx 
31.29 + 0.10 15.48 + 0.10 < 0.01 
3.16 M Ag[NH3]2F 
Tx 
46.44 + 0.10 18.01 + 0.20 < 0.01 
 
  
 
154 
 
Figure 10.12 - Typical Ca2+ release of 0.75 M Ag[NH3]2F treatment group. 
 
 
Figure 10.13 - Typical Ca2+ release of 2.36 M Ag[NH3]2F treatment group. 
 
 
Figure 10.14 - Typical Ca2+ release of 3.16 M Ag[NH3]2F treatment group. 
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Fig. 10.15 shows a typical plot of Ca2+ release from the enamel block of the 
Riva-SC treatment group. The Ca2+ release was linear with time both before and 
after treatment. The rate of Ca2+ release was decreased following the Riva-SC 
treatment (Table 10.6). All six enamel blocks of the Riva-SC treatment group 
showed a similar linear Ca2+ release, both before and after treatments, and a 
similar reduction in the rate of Ca2+ release following treatments.  
 
 
Figure 10.15 – Typical Ca2+ release of Riva-SC treatment group. 
 
Table 10.6 - The RCLenamel before and after Riva-SC topical treatment of the Fig. 10.15. 
Treatment Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) p value 
Riva-SC Tx 26.74 + 0.10 11.28 + 0.10 < 0.01 
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10.4.1.1 Summary of the Ca2+ Release from the Enamel Blocks of Each 
Treatment Group 
 
Table 10.7 shows the rates of calcium loss of enamel (RCLenamel) before and after 
treatments, and the percentages reduction in the rates of calcium loss of enamel 
(PRCLenamel) of every enamel in all treatment groups. Every Ra (RCLenamel) 
measured was significantly different (p < 0.05) from the Rb (RCLenamel) of the 
same enamel block. 
The mean RCLenamel before treatments of all treatment groups were similar (≈ 
0.030 mM/h), whereas, the mean RCLenamel following treatments were different. 
The mean RCLenamel following topical treatments with fluoride-containing silver 
compounds like AgF, Ag[NH3]2F and Riva-SC, were much lower than those 
following topical treatments with AgNO3 and DW. Further, the PRCLenamel of AgF 
and Ag[NH3]2F treatment groups increased with increasing concentrations, 
whereas, the PRCLenamel of AgNO3 treatment group decreased with increasing 
concentration. 
Only in the DW treatment group, the mean RCLenamel following treatments (Ra) 
was faster than the mean RCLenamel before treatments (Rb). 
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Table 10.7 - The RCLenamel and PRCLenamel of every Enamel in each treatment group. 
Tx Group Enamel Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) PRCLenamel (%) 
DW Tx 1 21.65 + 0.20 22.16 + 0.10 -2.4 
2 35.97 + 0.10 41.87 + 0.10 -16.4 
3 34.43 + 0.20 38.80 + 0.20 -12.7 
4 46.69 + 0.20 51.09 + 0.10 -9.4 
5 29.10 + 0.20 30.69 + 0.10 -5.5 
6 20.13 + 0.10 23.49 + 0.10 -16.7 
Average 31.33 + 4.05 34.68 + 4.60 -10.5 + 2.4 
0.75 M 
AgNO3 Tx 
1 33.18 + 0.20 22.32 + 0.10 32.7 
2 33.91 + 0.02 27.78 + 0.20 18.1 
3 21.64 + 0.10 16.97 + 0.09 21.6 
4 46.20 + 0.20 41.95 + 0.10 9.2 
5 11.92 + 0.20 8.92 + 0.10 25.2 
6 14.12 + 0.10 10.60 + 0.10 24.9 
Average 26.83 + 5.41 21.42 + 5.02 21.9 + 3.2 
2.36 M 
AgNO3 Tx 
1 40.99 + 0.40 31.20 + 0.50 23.9 
2 21.51 + 0.20 22.79 + 0.20 -6.0 
3 19.13 + 0.10 14.93 + 0.10 22.0 
4 34.33 + 0.10 34.57 + 0.30 -0.7 
5 28.00 + 0.10 30.43 + 0.10 -8.7 
6 31.58 + 0.10 32.56 + 0.30 -3.1 
Average 29.26 + 3.33 27.74 + 3.04 4.6 + 5.9 
3.16 M 
AgNO3 Tx 
1 25.92 + 0.10 28.83 + 0.30 -11.2 
2 28.39 + 0.10 31.12 + 0.30 -9.6 
3 43.16 + 0.20 32.64 + 0.20 24.4 
4 39.34 + 0.20 40.99 + 0.30 -4.2 
5 38.20 + 0.10 37.62 + 0.20 1.5 
6 33.24 + 0.10 33.54 + 0.20 -0.9 
Average 34.71 + 2.74 34.12 + 1.82 0.0 + 5.3 
0.75 M 
AgF Tx 
1 29.69 + 0.08 13.34 + 0.05 55.1 
2 50.55 + 0.10 39.52 + 0.10 21.8 
3 21.34 + 0.01 8.43 + 0.10 60.5 
4 19.57 + 0.01 9.41 + 0.10 51.9 
5 42.16 + 0.10 21.95 + 0.10 47.9 
6 20.33 + 0.10 11.71 + 0.20 42.4 
Average 30.61 + 5.31 17.39 + 4.84 46.6 + 5.6 
2.36 M 
AgF Tx 
1 33.89 + 0.10 12.01 + 0.10 64.6 
2 34.10 + 0.10 19.23 + 0.10 43.7 
3 24.19 + 0.10 8.60 + 0.10 64.4 
4 25.20 + 0.20 4.72 + 0.10 81.3 
5 15.01 + 0.10 7.53 + 0.10 49.8 
6 35.77 + 0.10 13.04 + 0.10 63.5 
Average 28.03 + 3.28 10.86 + 2.08 61.2 + 5.4 
3.16 M 
AgF Tx 
1 44.57 + 0.20 11.04 + 0.20 75.2 
2 25.14 + 0.10 5.82 + 0.21 76.8 
3 52.56 + 0.11 24.84 + 0.10 52.7 
4 24.97 + 0.07 5.34 + 0.04 78.6 
5 33.86 + 0.10 10.82 + 0.12 68.0 
6 41.03 + 0.10 23.87 + 0.20 41.8 
Average 37.02 + 4.51 13.62 + 3.54 65.6 + 6.1 
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Table 10.7 continued. 
Tx Group Enamel Rb+/-SE (X 10-3 mM/h) Ra+/-SE (X 10-3 mM/h) PRCLenamel (%) 
0.75 M 
Ag[NH3]2F Tx 
1 36.02 + 0.10 23.94 + 0.10 33.5 
2 55.34 + 0.21 32.87 + 0.30 40.6 
3 38.17 + 0.30 23.85 + 0.60 37.5 
4 21.52 + 0.20 11.25 + 0.10 47.7 
5 23.24 + 0.30 13.29 + 0.30 42.8 
6 29.00 + 0.30 12.28 + 0.20 57.7 
Average 33.88 + 5.07 19.58 + 3.54 43.3 + 3.5 
2.36 M 
Ag[NH3]2F Tx 
1 47.68 + 0.10 25.53 + 0.30 46.5 
2 29.82 + 0.10 8.73 + 0.20 70.7 
3 20.93 + 0.10 5.29 + 0.10 74.7 
4 18.64 + 0.10 7.53 + 0.10 59.6 
5 31.29 + 0.10 15.48 + 0.10 50.5 
6 32.78 + 0.10 12.04 + 0.40 63.3 
Average 30.19 + 4.22 12.43 + 3.00 60.9 + 4.5 
3.16 M 
Ag[NH3]2F Tx 
1 20.82 + 0.10 9.31 + 0.20 55.3 
2 42.52 + 0.20 15.20 + 0.20 64.3 
3 17.54 + 0.10   4.10 + 0.20 76.6 
4 26.80 + 0.20 7.29 + 0.10 72.8 
5 46.44 + 0.10 18.01 + 0.20 61.2 
6 32.82 + 0.10 12.69 + 0.10 61.3 
Average 31.16 + 4.75 11.10 + 2.11 65.3 + 3.3 
Riva-SC Tx 1 17.08 + 0.10 5.40 + 0.10 68.4 
2 45.50 + 0.20 18.25 + 0.20 59.9 
3 35.26 + 0.20 20.74 + 0.20 41.2 
4 26.74 + 0.10 11.28 + 0.10 57.8 
5 23.81 + 0.10 7.03 + 0.20 70.5 
6 41.89 + 0.20 13.31 + 0.10 68.2 
Average 31.71 + 4.50 12.67 + 2.47 61.0 + 4.5 
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Fig. 10.16 shows the mean PRCLenamel of 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F, Riva-SC and DW treatment groups. The mean PRCLenamel of 3.16 M 
AgF, 3.16 M Ag[NH3]2F and Riva-SC treatment groups were much higher than 
those of 3.16 M AgNO3 treatment group, while the mean PRCLenamel of DW 
treatment group was negative. There were no significant differences between the 
mean PRCLenamel of AgF, Ag[NH3]2F and Riva-SC treatment groups. 
 
 
Figure 10.16 - The mean PRCLenamel of 3.16 M AgNO3, 3.16 M AgF, 3.16 M Ag[NH3]2F, Riva-SC 
and DW treatment groups. Error bars show the standard errors. Linking lines between treatment 
groups indicate significant differences at p < 0.05 between them. 
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    Fig. 10.17 shows the mean PRCLenamel of 0.75 M, 2.36 M and 3.16 M AgNO3 
treatment groups. The mean PRCLenamel of AgNO3 treatment groups decreased 
with increasing concentration of AgNO3. However, there was no significant 
difference between the mean PRCLenamel of 2.36 M and 3.16 M AgNO3 treatment 
groups. 
    Fig. 10.18 shows that there was a log-linear dose-response relationship 
between the mean PRCLenamel of topical treatment with AgNO3 and the 
concentration of topically applied AgNO3.  
 
 
Figure 10.17 – The mean PRCLenamel of 0.75 M, 2.36 M and 3.16 M AgNO3 treatment groups.  
 
 
Figure 10.18 - A log-linear dose-response relationship between the mean PRCLenamel of AgNO3 
and [AgNO3]. 
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Fig. 10.19 shows the mean PRCLenamel of 0.75 M, 2.36 M and 3.16 M AgF 
treatment groups. The mean PRCLenamel of AgF treatment groups increased with 
increasing concentration of AgF. However, there was no significant difference 
between the mean PRCLenamel of 2.36 M and 3.16 M AgF treatment groups. 
    Fig. 10.20 shows that there was a log-linear dose-response relationship 
between the mean PRCLenamel of topical treatment with AgF and the 
concentration of topically applied AgF.  
 
 
Figure 10.19 - The mean PRCLenamel of 0.75 M, 2.36 M and 3.16 M AgF treatment groups. 
 
 
Figure 10.20 - A log-linear dose-response relationship between the mean PRCLenamel of AgF and 
[AgF]. 
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Fig. 10.21 shows the mean PRCLenamel of 0.75 M, 2.36 M and 3.16 M 
Ag[NH3]2F treatment groups. The mean PRCLenamel of Ag[NH3]2F treatment 
groups increased with increasing concentration of Ag[NH3]2F. However, there 
was no significant difference between the mean PRCLenamel of 2.36 M and 3.16 
M Ag[NH3]2F treatment groups. 
    Fig. 10.22 shows that there was a log-linear dose-response relationship 
between the mean PRCLenamel of topical treatment with Ag[NH3]2F and the 
concentration of topically applied Ag[NH3]2F.  
 
 
Figure 10.21 - The mean PRCLenamel of 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F treatment 
groups. 
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Figure 10.22 - A log-linear dose-response relationship between the mean PRCLenamel of 
Ag[NH3]2F and [Ag[NH3]2F]. 
10.4.2 Ag+ ISE Study 
 
Fig. 10.23 shows the Ag+ release profiles of 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F, Riva-SC and DW treatment groups, which were based on the mean 
activities of Ag+ released from the six enamel blocks of each treatment group. 
After re-immersion of enamel blocks topically treated with silver compounds into 
acids, all the mean activities of Ag+ in the solution increased rapidly from zero, 
and then subsequently decreased continually.   
    Even though the Ag+ release profiles are not linear, the approximate rates of 
the changes in the mean Ag+ activities can be extrapolated by the slopes of 
trendlines of initial increase and later decrease in Ag+ activities. The standard 
error of each trendline was shown later in Table 10.8. 
    No Ag+ release was detected in DW treatment group. 
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Figure 10.23 - The mean Ag+ release from enamel under pH 4.0 demineralisation before and 
after topical treatments with DW, and 3.16 M silver compounds. 
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Fig. 10.24 ~ Fig. 10.26 show the Ag+ release profiles of 0.75 M, 2.36 M and 
3.16 M AgNO3, AgF and Ag[NH3]2F treatment groups, which were based on the 
mean activities of Ag+ released from the six enamel blocks of each treatment 
group.  
After re-immersion of enamel blocks topically treated with AgNO3, AgF and 
Ag[NH3]2F into acids, all the mean activities of Ag+ in the solution increased 
rapidly from zero, and then subsequently decreased continually.  
Even though the Ag+ release profiles are not linear, the approximate rates of 
the changes in the mean Ag+ activities can be extrapolated by the slopes of 
trendlines of initial increase and later decrease in Ag+ activities. The standard 
error of each trendline was shown later in Table 10.8. 
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Figure 10.24 - The Ag+ release profiles of 0.75 M, 2.36 M and 3.16 M AgNO3 treatment groups. 
 
 
Figure 10.25 - The Ag+ release profiles of 0.75 M, 2.36 M and 3.16 M AgF treatment groups. 
 
 
Figure 10.26 - The Ag+ release profiles of 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F treatment groups. 
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Table 10.8 shows the mean initial rates (RI) of increase in the Ag+ activities 
and the mean later rates (RL) of decrease in the Ag+ activities of all treatment 
groups.  
 
Table 10.8 – Mean RI and mean RL of the Ag+ release following each treatment. 
 
 
  
Tx Group Mean RI+/-SE (X 10-2 mM/h) Mean RL+/-SE (X 10-2 mM/h) 
DW Tx 0.00 + 0.00 0.00 + 0.00 
0.75 M AgNO3 Tx 7.53 + 0.66 -0.03 + 0.02 
2.36 M AgNO3 Tx 9.56 + 0.88 -0.16 + 0.06 
3.16 M AgNO3 Tx 17.71 + 5.09 -0.24 + 0.02 
0.75 M AgF Tx 13.05 + 4.37 -0.16 + 0.04 
2.36 M AgF Tx 20.55 + 5.09 -0.30 + 0.06 
3.16 M AgF Tx 10.90 + 2.76 -0.27 + 0.07 
0.75 M Ag[NH3]2F Tx 13.61 + 3.36 -0.18 + 0.05 
2.36 M Ag[NH3]2F Tx 26.08 + 7.02 -0.14 + 0.03 
3.16 M Ag[NH3]2F Tx 13.11 + 1.38 -0.24 + 0.02 
Riva-SC Tx 25.54 + 4.72 -0.32 + 0.05 
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Fig. 10.27a and b shows the mean RI and the mean RL of Ag+ release of 3.16 
M AgNO3, 3.16 M AgF, 3.16 M Ag[NH3]2F, Riva-SC and DW treatment groups. 
There was a significant difference between the RI of 3.16 M AgF and Riva-SC 
treatment groups. However, there were no significant differences between the RL 
of each treatment group.  
 
a  
b  
Figure 10.27 - (a) Mean RI and (b) mean RL of the Ag+ release of DW and 3.16 M treatment 
groups. 
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Fig. 10.28 ~ Fig. 10.30 show the mean RI and the mean RL of Ag+ release of 
0.75 M, 2.36 M and 3.16 M AgNO3, AgF and Ag[NH3]2F treatment groups. In 
AgNO3 treatment groups, both the mean RI and the mean RL of Ag+ release 
increased with concentration. However, in AgF and Ag[NH3]2F treatment groups, 
no relationships between either the mean RI or the mean RL of the Ag+ release, 
and the concentrations were found. 
 
a  b  
Figure 10.28 - (a) Mean RI and (b) mean RL of the Ag+ release of AgNO3 treatment groups. 
 
a  b  
Figure 10.29 - (a) Mean RI and (b) mean RL of the Ag+ release of AgF treatment groups. 
 
a  b  
Figure 10.30 - (a) Mean RI and (b) mean RL of the Ag+ release of Ag[NH3]2F treatment groups. 
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10.4.2.1 Mean [Ag+] during the post-treatment 4 h periods of Each Treatment 
Group 
 
The mean [Ag+] during the 4 h demineralisation period after re-immersion of the 
topically treated enamel blocks into acid ([Ag+]4h) (Table 10.9) of each treatment 
group was calculated, in order to compare the effects of Ag+ in the acid on the 
demineralisation of the enamel. 
 
Table 10.9 – The mean [Ag+] during the 4 h demineralisation period after re-immersion of the 
topically treated enamel blocks into acids ([Ag+]4h) of each treatment group. 
Tx groups [Ag+]4h 
DW 0.0 + 0.0 X 10-3 mM 0.00 + 0.00 ppm 
0.75 M AgNO3 5.4 + 0.2 X 10-3 mM  0.58 + 0.02 ppm 
2.36 M AgNO3 6.3 + 0.4 X 10-3 mM 0.68 + 0.04 ppm 
3.16 M AgNO3 8.8 + 1.7 X 10-3 mM 0.95 + 0.18 ppm 
0.75 M AgF 8.3 + 2.1 X 10-3 mM 0.89 + 0.22 ppm 
2.36 M AgF 10.7 + 2.3 X 10-3 mM  1.16 + 0.25 ppm 
3.16 M AgF 8.3 + 2.5 X 10-3 mM 0.89 + 0.27 ppm 
0.75 M Ag[NH3]2F 7.5 + 1.0 X 10-3 mM  0.81 + 0.11 ppm 
2.36 M Ag[NH3]2F 10.5 + 2.6 X 10-3 mM 1.14 + 0.28 ppm 
3.16 M Ag[NH3]2F 7.2 + 0.3 X 10-3 mM 0.78 + 0.06 ppm 
Riva-SC 10.1 + 1.5 X 10-3 mM 1.09 + 0.16 ppm 
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     Fig. 10.31 shows the [Ag+]4h (ppm) of 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F, Riva-SC and DW treatment groups. The [Ag+]4h of the Riva-SC 
treatment group was the highest. However, the only significant difference was 
between the [Ag+]4h of Ag[NH3]2F and Riva-SC treatment groups. 
 
 
Figure 10.31 – The [Ag+]4h (ppm) of 3.16 M AgNO3, 3.16 M AgF, 3.16 M Ag[NH3]2F, Riva-SC and 
DW treatment groups. Error bars show the standard errors. Linking lines between bars indicate 
significant differences at p < 0.05 between treatment groups. 
 
    Fig. 10.32 shows the [Ag+]4h (ppm) of 0.75 M, 2.36 M and 3.16 M AgNO3 
treatment groups. The [Ag+]4h of the AgNO3 treatment groups increased with 
increasing concentration of AgNO3. However, there was no significant difference 
between the [Ag+]4h of the 2.36 M and 3.16 M treatment groups. 
   Fig. 10.33 shows the [Ag+]4h (ppm) of 0.75 M, 2.36 M and 3.16 M AgF treatment 
groups. There were no significant differences between the [Ag+]4h of 0.75 M, 2.36 
M and 3.16 M AgF treatment groups. 
Fig. 10.34 shows the [Ag+]4h (ppm) of 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F 
treatment groups. There were no significant differences between the [Ag+]4h of 
0.75 M, 2.36 M and 3.16 M Ag[NH3]2F treatment groups. 
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Figure 10.32 - The [Ag+]4h (ppm) of 0.75 M, 2.36 M and 3.16 M AgNO3 treatment groups.  
 
 
Figure 10.33 - The [Ag+]4h (ppm) of 0.75 M, 2.36 M and 3.16 M AgF treatment groups.  
 
 
Figure 10.34 - The [Ag+]4h (ppm) of 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F treatment groups. 
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10.4.3 F- ISE Study 
 
Fig. 10.35 shows the F- release profiles of 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F, Riva-SC and DW treatment groups, which were based on the mean 
activities of F- released from the six enamel blocks each treatment group. After 
re-immersion of enamel blocks topically treated with fluoride-containing silver 
compounds back into acids, there was a rapid increase in all the mean activities 
of F- from zero, which slowed with time.  
    Even though the F- release profiles are not linear, the approximate rates of the 
changes in the mean F- activities can be extrapolated by the slopes of trendlines 
of initial and later increase in F- activities. The standard error of each trendline 
was shown later in Table 10.10. 
    No F- release was detected in DW and AgNO3 treatment groups. 
 
 
Figure 10.35 - The mean F- release from enamel under pH 4.0 demineralisation before and after 
topical treatment with DW, and 3.16 M silver compounds. 
 
  
y = 2.508E-01x - 1.000E+00
R² = 7.805E-01
y = 4.935E-03x + 6.114E-03
R² = 9.913E-01
y = 7.277E-01x - 2.911E+00
R² = 6.221E-01
y = 8.849E-04x + 3.845E-02
R² = 9.668E-01
y = 7.793E-01x - 3.124E+00
R² = 8.521E-01
y = 8.225E-04x + 3.736E-02
R² = 9.537E-01
0.001
0.011
0.021
0.031
0.041
0.051
0.061
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0
M
e
an
 F
-
A
ct
iv
it
y 
(m
M
)
Time (h)
DW Tx AgNO(3) Tx AgF Tx Ag[NH3]2F Tx Riva-SC Tx
Before Tx After Tx
AgNO3 Ag[NH3]2F Riva-SC TxDW AgF Tx Tx
 
174 
Fig. 10.36 and Fig. 10.37 show the F- release profiles of 0.75 M, 2.36 M and 
3.16 M AgF and Ag[NH3]2F treatment groups, which were based on the mean 
activities of F- released from the six enamel blocks of each treatment group. After 
re-immersion of enamel blocks topically treated with AgF and Ag[NH3]2F back 
into acids, there was a rapid increase in all the mean activities of F- from zero, 
which slowed with time.  
    Even though the F- release profiles are not linear, the approximate rates of the 
changes in the mean F- activities can be extrapolated by the slopes of trendlines 
of initial and later increase in F- activities. The standard error of each trendline is 
shown later in Table 10.10. 
 
 
Figure 10.36 - The F- release profiles of 0.75 M, 2.36 M and 3.16 M AgF treatment groups. 
 
 
 
Figure 10.37 - The F- release profiles of 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F treatment groups.  
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Table 10.10 shows the mean initial rates (RI) of increase in the F- activities and 
the mean later rates (RL) of increase in the F- activities of all treatment groups. 
 
Table 10.10 – Mean RI and mean RL of the F- release following each treatment. 
 
  
Tx Group Mean RI+/-SE (X 10-2 mM/h) Mean RL+/-SE (X 10-2 mM/h) 
DW Tx 0.00 + 0.00 0.00 + 0.00 
0.75 M AgNO3 Tx 0.00 + 0.00 0.00 + 0.00 
2.36 M AgNO3 Tx 0.00 + 0.00 0.00 + 0.00 
3.16 M AgNO3 Tx 0.00 + 0.00 0.00 + 0.00 
0.75 M AgF Tx 4.17 + 2.29 0.29 + 0.04 
2.36 M AgF Tx 7.50 + 1.31 0.39 + 0.05 
3.16 M AgF Tx 25.08 + 5.92 0.49 + 0.06 
0.75 M Ag[NH3]2F Tx 21.24 + 5.49 0.12 + 0.04 
2.36 M Ag[NH3]2F Tx 31.17 + 3.37 0.08 + 0.01 
3.16 M Ag[NH3]2F Tx 72.77 + 4.94 0.09 + 0.02 
Riva-SC Tx 77.93 + 3.70 0.08 + 0.03 
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Fig. 10.38a and b shows the mean RI and the mean RL of F- release of 3.16 M 
AgNO3, 3.16 M AgF, 3.16 M Ag[NH3]2F, Riva-SC and DW treatment groups. The 
mean RI of 3.16 M Ag[NH3]2F and Riva-SC treatment groups were significantly 
higher than that of 3.16 M AgF treatment group. However, the mean RL of 3.16 
M Ag[NH3]2F and Riva-SC treatment groups were significantly lower than that of 
3.16 M AgF treatment group.  
 
a  
b   
Figure 10.38 - (a) Mean RI and (b) mean RL of the F- release of DW and 3.16 M treatment groups. 
Fig. 10.39 and Fig. 10.40 show the mean RI and the mean RL of F- release of 
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treatment groups, both the mean RI and the mean RL of F- release increased with 
concentration. In Ag[NH3]2F treatment groups, the mean RI of F- release 
increased with concentration. However, there was no relationship between the 
mean RL of F- release and the concentration of topically applied Ag[NH3]2F was 
found. 
 
a  b  
Figure 10.39 - (a) Mean RI and (b) mean RL of the F- release of 0.75 M, 2.36 M and 3.16 M AgF 
treatment groups. 
 
a  b  
Figure 10.40 - (a) Mean RI and (b) mean RL of the F- release of 0.75 M, 2.36 M and 3.16 M 
Ag[NH3]2F treatment groups. 
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10.4.3.1 Mean [F-] during the post-treatment 4 h periods of Each Treatment 
Group 
 
The mean [F-] during the 4 h demineralisation period after re-immersion of the 
topically treated enamel blocks into acid ([F-]4h) (Table 10.11) of each treatment 
group was calculated, in order to compare the effects of F- in the acid on the 
demineralisation of the enamel.  
 
Table 10.11 – The mean [F-] during the 4 h demineralisation period after re-immersion of the 
topically treated enamel blocks into acids ([F-]4h) of each treatment group. 
Tx groups [F-]4h 
DW 0.0 + 0.0 X 10-3 mM 0.00 + 0.00 ppm 
0.75 M AgNO3 0.0 + 0.0 X 10-3 mM 0.00 + 0.00 ppm 
2.36 M AgNO3 0.0 + 0.0 X 10-3 mM 0.00 + 0.00 ppm 
3.16 M AgNO3 0.0 + 0.0 X 10-3 mM 0.00 + 0.00 ppm 
0.75 M AgF 6.2 + 0.6 X 10-3 mM 0.12 + 0.01 ppm 
2.36 M AgF 8.8 + 0.8 X 10-3 mM 0.17 + 0.01 ppm 
3.16 M AgF 17.8 + 1.8 X 10-3 mM 0.34 + 0.03 ppm 
0.75 M Ag[NH3]2F 13.5 + 1.7 X 10-3 mM 0.26 + 0.03 ppm 
2.36 M Ag[NH3]2F 16.5 + 2.5 X 10-3 mM 0.31 + 0.05 ppm 
3.16 M Ag[NH3]2F 21.9 + 1.2 X 10-3 mM 0.42 + 0.02 ppm 
Riva-SC 21.1 + 1.0 X 10-3 mM 0.40 + 0.02 ppm 
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Fig. 10.41 shows the [F-]4h (ppm) of 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F, Riva-SC and DW treatment groups. The [F-]4h of the 3.16 M Ag[NH3]2F 
and Riva-SC treatment groups were higher than that of the 3.16 M AgF treatment 
group. However, there was no significant difference between the [F-]4h of 
Ag[NH3]2F and Riva-SC treatment groups, and there was no significant difference 
between the [F-]4h of AgF and Riva-SC treatment groups 
 
 
Figure 10.41 - The [F-]4h (ppm) of 3.16 M AgNO3, 3.16 M AgF, 3.16 M Ag[NH3]2F, Riva-SC and 
DW treatment groups. Error bars show the standard errors. Linking lines between bars indicate 
significant differences at p < 0.05 between treatment groups. 
 
    Fig. 10.42 shows the [F-]4h (ppm) of 0.75 M, 2.36 M and 3.16 M AgF treatment 
groups. The [F-]4h in the solution increased with increasing concentration of AgF. 
    Fig. 10.43 shows the [F-]4h (ppm) of 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F 
treatment groups. The [F-]4h in the solution increased with increasing 
concentration of Ag[NH3]2F. 
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Figure 10.42 - The [F-]4h (ppm) of 0.75 M, 2.36 M and 3.16 M AgF treatment groups. 
 
 
Figure 10.43 - The [F-]4h (ppm) of 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F treatment groups. 
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10.4.4 Digital Photographs 
 
Fig. 10.44 and Fig. 10.45 show that following topical treatments with AgNO3, AgF, 
and Ag[NH3]2F, yellow staining was observed, which then turned to black after 
further 4 h demineralisation. Further, the yellow and black staining increased with 
increasing concentrations of AgNO3, AgF, and Ag[NH3]2F.  
No staining was observed on the enamel surfaces topically treated with DW. 
 
 
Figure 10.44 - The colours of enamel treated with DW and Riva-SC following different treatments 
of the ISE study. 
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Figure 10.45 - The colours of enamel treated with different concentrations of AgNO3, AgF and 
Ag[NH3]2F following different treatments of the ISE study. 
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10.4.5 SEM Images Analysis 
 
Fig. 10.46a is a typical SEM image of enamel topically treated with DW after 
demineralisation, showing hollow enamel cores, breakages and irregular craters 
on the enamel surfaces.  
Fig. 10.46b ~ Fig. 10.46d are typical SEM images of enamel topically treated 
with AgNO3 after demineralisation, showing craters and breakages on the enamel 
surfaces. Demineralised pores were observed on the enamel surfaces topically 
treated with 3.16 M and 2.36 M AgNO3. However, only uneven demineralised 
surfaces were observed on the surfaces topically treated with 0.75 M AgNO3, 
(Fig. 10.46b). Further, the demineralised pores observed on the 3.16 M AgNO3 
treated enamel surfaces were deeper than those observed on the 2.36 M AgNO3 
treated enamel surfaces. Numerous cubic particles (~ 1.5 μm) (Fig. 10.46b ~ 
Fig. 10.46d) were deposited on all enamel surfaces treated with AgNO3. Further, 
the number of particles increased with increasing concentration of AgNO3. 
 Fig. 10.46e ~ Fig. 10.46j are typical SEM images of enamel topically treated 
with AgF and Ag[NH3]2F after demineralisation, showing that mainly ripple-like 
features observed on all enamel surfaces. On enamel surfaces treated with 0.75 
M AgF and 0.75 M Ag[NH3]2F, focal pores (Worawongvasu, 2015) and narrow 
breakages were also found  (Fig. 10.46e and Fig. 10.46h). Numerous cubic 
particles (~ 1.5 μm) and granular particles (~ 1 μm) were observed on enamel 
surfaces treated with AgF and Ag[NH3]2F (Fig. 10.46e ~ Fig. 10.46j). Further, the 
number of these particles increased with increasing concentrations of AgF and 
Ag[NH3]2F.  
Fig. 10.46k is a typical SEM image of enamel topically treated with Riva-SC 
after demineralisation, showing similar demineralised surfaces to those topically 
treated with AgF and Ag[NH3]2F. Further, numerous cubic particles (~ 1.5 μm) 
and granular particles (~ 1 μm) were also observed on the surfaces topically 
treated Riva-SC. Narrow breakages were occasionally observed. 
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Figure 10.46 - Typical SEM images of enamel blocks of (a) DW Tx, (b) 0.75 M AgNO3 Tx, (c) 
2.36 M AgNO3 Tx and (d) 3.16 M AgNO3 Tx, (e) 0.75 M AgF Tx, (f) 2.36 M AgF Tx and (g) 3.16 
M AgF Tx, (h) 0.75 M Ag[NH3]2F Tx, (i) 2.36 M Ag[NH3]2F Tx and (j) 3.16 M Ag[NH3]2F Tx, and (k) 
Riva-SC Tx. 
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10.4.6 EDX Analysis 
 
Fig. 10.47 shows the mean atomic percentages of Ag detected on the enamel 
surfaces topically treated with 3.16 M AgNO3, 3.16 M AgF, 3.16 M Ag[NH3]2F, 
Riva-SC and DW after demineralisation. Elemental Ag was present on the 
enamel surfaces topically treated with 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F and Riva-SC. The mean atomic percentage of Ag detected in 3.16 M 
AgF treatment group was higher than that in 3.16 M Ag[NH3]2F treatment group, 
both of which were higher than 3.16 M AgNO3 treatment group. There were no 
significant differences between the mean atomic Ag % of Riva-SC and other 
treatment groups. 
 
 
Figure 10.47 – The mean atomic percentages of Ag of 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F, Riva-SC and DW treatment groups. Linking lines between bars indicate significant 
differences at p < 0.05 between treatment groups. 
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Fig. 10.48 shows the mean atomic percentages of Ag detected on the enamel 
surfaces topically treated with 0.75 M, 2.36 M and 3.16 M AgNO3. All the mean 
Ag atomic percentages were low, and there were no significant differences 
between the mean atomic percentages of Ag of each treatment group. 
    Fig. 10.49 shows the mean atomic percentages of Ag detected on the enamel 
surfaces topically treated with 0.75 M, 2.36 M and 3.16 M AgF. The mean Ag 
atomic percentage increased with increasing concentration of AgF. However, 
there was no significant difference between the mean Ag atomic percentages of 
2.36 M AgF and 3.16 M AgF treatment groups. 
Fig. 10.50 shows the mean atomic percentages of Ag detected on the enamel 
surfaces topically treated with 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F. The mean 
Ag atomic percentage increased with increasing concentration of Ag[NH3]2F. 
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Figure 10.48 - The mean atomic percentages of Ag of AgNO3 treatment groups. 
 
 
Figure 10.49 - The mean atomic percentages of Ag of AgF treatment groups. 
 
 
Figure 10.50 - The mean atomic percentages of Ag of Ag[NH3]2F treatment groups. 
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    Fig. 10.51 shows the mean atomic percentages of F detected on the enamel 
surfaces topically treated with 3.16 M AgNO3, 3.16 M AgF, 3.16 M Ag[NH3]2F, 
Riva-SC and DW after demineralisation. Elemental F was present on the enamel 
surfaces topically treated with 3.16 M AgF, 3.16 M Ag[NH3]2F and Riva-SC. The 
mean atomic percentages of F detected in 3.16 M AgF and Riva-SC treatment 
groups were higher than that in 3.16 M Ag[NH3]2F treatment group. There was 
no significant difference between the mean atomic F % of Riva-SC and 3.16 M 
AgF treatment groups. 
 
 
Figure 10.51 - The mean atomic percentages of F of 3.16 M AgNO3, 3.16 M AgF, 3.16 M 
Ag[NH3]2F, Riva-SC and DW treatment groups. Error bars show the standard errors. Linking lines 
between bars indicate significant differences at p < 0.05 between treatment groups. 
 
Fig. 10.52 shows the mean atomic percentages of F detected on the enamel 
surfaces topically treated with 0.75 M, 2.36 M and 3.16 M AgF. The mean F 
atomic percentage increased with increasing concentration of AgF. There was no 
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between the mean F atomic percentages of 2.36 M AgF and 0.75 M AgF 
treatment groups. 
Fig. 10.53 shows the mean atomic percentages of F detected on the enamel 
surfaces topically treated with 0.75 M, 2.36 M and 3.16 M Ag[NH3]2F. The mean 
F atomic percentage increased with increasing concentration of Ag[NH3]2F. No F 
was detected on the enamel surfaces topically treated with 0.75 M Ag[NH3]2F. 
 
 
Figure 10.52 - The mean atomic percentages of F of AgF treatment groups. 
 
 
Figure 10.53 - The mean atomic percentages of F of Ag[NH3]2F treatment groups. 
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10.4.7 31P MAS-NMR Analysis 
 
The 31P MAS-NMR spectra (Fig. 10.54) showed that only the chemical shift peaks 
of carbonate hydroxyapatite (CHAP) (3.3 ppm) were detected in powdered 
enamel treated with topical application agents. CHAP is the major components 
of enamel mineral (Section 1.2) 
 
 
Figure 10.54 – 31P MAS-NMR spectra of each treatment group before and after pH 4.0 acid 
challenge. 
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10.4.8 19F MAS-NMR Analysis 
 
The 19F MAS-NMR spectra (Fig. 10.55) showed that no fluoride compounds were 
detected in powdered enamel treated with DW or different concentrations of 
AgNO3. However, both CaF2 (-109.1 ppm) and fluorohydroxyapatite (FHA) (-
104.1 ppm) were detected in powdered enamel treated with different 
concentrations of AgF and Ag[NH3]2F, and Riva-SC. The proportions of CaF2 
detected in AgF treatment groups were higher than those detected in Ag[NH3]2F 
treatment groups. Further, the proportions of CaF2 increased with increasing 
concentrations of AgF and Ag[NH3]2F topically applied. However, even after long 
MAS-NMR scans (20 h), only very small amounts of CaF2 and FHA were detected, 
which could not be deconvoluted (Section 5.6). 
 
 
Figure 10.55 – 19F MAS-NMR spectra of each treatment group before and after pH 4.0 acid 
challenge. 
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10.4.9 Microscopic photographs of Human Enamel Sections 
 
Typical microscopic photographs, taken using a digital camera attached to the 
eyepiece of the Knoop hardness tester suggested two types of lesions. The first 
type was a deep erosive-like lesion overlaying a more translucent zone of a 
carious lesion, observed in the enamel blocks topically treated with DW or AgNO3 
(Fig. 10.56a ~ Fig. 10.56d), as described by Larsen (1990). The second type 
was a shallow erosive-like lesion with or without the presence of a more 
translucent zone of carious lesion underneath, observed in the enamel blocks 
topically treated with AgF, Ag[NH3]2F or Riva-SC (Fig. 10.56e ~ Fig. 10.56k). 
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Figure 10.56 - Typical images (40X) of lesions sections of (a) DW Tx, (b) 0.75 M AgNO3 Tx, (c) 
2.36 M AgNO3 Tx  and (d) 3.16 M AgNO3 Tx, (e) 0.75 M AgF Tx, (f) 2.36 M AgF Tx  and (g) 3.16 
M AgF Tx, (h) 0.75 M Ag[NH3]2F Tx, (i) 2.36 M Ag[NH3]2F Tx and (j) 3.16 M Ag[NH3]2F Tx, and 
(k) Riva-SC Tx.
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10.4.10 Knoop CSMH profiles of Human Enamel Sections 
 
The Knoop CSMH profiles (Fig. 10.57a ~ Fig. 10.57d) showed that the KHN 
values recorded at the depth level of 40 μm were low only in DW and AgNO3 
treatment groups. Whereas, the KHN values recorded at all depth levels along 
the thickness of enamel sections in AgF, Ag[NH3]2F and Riva-SC treatment 
groups were high and similar to each other (Fig. 10.57e ~ Fig. 10.57k).  
 
 
Figure 10.57 – Knoop CSMH of (a) DW Tx, (b ~ d) AgNO3 Tx, (e ~ g) AgF Tx  and (h ~ j) Ag[NH3]2F 
Tx  in different concentrations, and (k) Riva-SC Tx. 
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Chapter 11 DISCUSSION OF THE EFFECTS OF TOPICAL 
TREATMENTS WITH SILVER COMPOUNDS ON 
DEMINERALISATION OF HUMAN ENAMEL AND PROPOSED 
MODELS FOR MECHANISMS 
 
This discussion chapter will be focused on the effects of topical treatments with 
DW and 3.16 M silver compounds on the demineralisation of human enamel. The 
dose-response effects of topical treatments with silver compounds on the 
demineralisation of human enamel will be discussed later in Chapter 12. 
The release of Ca2+ from the demineralising enamel blocks was approximately 
linear with time (Fig. 10.5 ~ Fig. 10.15). This is similar to previous ISE studies on 
HAP discs (Huang et al., 2018), and SMR results previously reported of enamel 
mineral loss from enamel during demineralisation (Anderson et al., 1998; 
Hassanali et al., 2017; Wang et al., 2005).  
    After demineralisation, the uneven enamel surfaces were observed (Fig. 
10.46a ~ Fig. 10.46k), which demonstrated the aggressive destruction from the 
acid attack. Hollow enamel cores, breakages and focal pores were found on the 
demineralised surfaces, which are typical demineralised enamel lesions reported 
in previous studies (Wang et al., 2006; Worawongvasu, 2015). 
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11.1 Effects of Topical Treatment with De-ionised Water on 
Demineralisation of Human Enamel 
 
In the ISE study, following the topical treatment with de-ionised water (DW) on 
human enamel, the demineralisation of human enamel increased (PRCLenamel = 
-10.5+2.4 %) (Fig. 10.16). The increase in demineralisation rate of enamel may 
be due to the removal of softened human enamel surfaces during the topical 
application using a micro-brush, which exposed more soluble enamel layers 
underneath. Deeper layers of enamel are more soluble due to a higher content 
of destabilising agents such as CO32- and Mg2+ (Robinson et al., 2000) (Section 
1.2.1). Therefore, demineralisation of human enamel is accelerated by the 
abrasion effects from using a micro-brush during the topical treatments. 
After the ISE study, uneven enamel surfaces with hollow enamel cores were 
observed with SEM (Fig. 10.46a), which demonstrated a typical “honeycomb” 
erosion lesion, as described by Wang et al. (2006) (Section 2.3.2). Deep erosion 
lesions covering a more translucent zone of carious lesions were observed in the 
human enamel samples topically treated with DW (Fig. 10.56a). Larsen has 
proposed that when demineralised enamel lesions are produced artificially in 
aqueous solutions undersaturated with respect to both HAP and fluorapatite 
(FAP), the outer enamel surface is initially removed by erosion, followed by a 
uniform development of a carious lesion beneath the erosive lesion, so-called 
“double lesion” (Larsen, 1990).  
As KHN numbers are associated with the mineral content in the tested enamels 
(Davidson et al., 1974), a double lesion resulting from demineralisation might be 
the reason for the low Knoop hardness values recorded at the depth levels of 40 
µm (around 100 KHN) in enamel sections topically treated with DW (Fig. 10.57a), 
compared to those  recorded at deeper levels (around 260 KHN).  
  
 
197 
11.2 Effects of Topical Treatment with AgNO3 on 
Demineralisation of Human Enamel and Proposed Mechanistic 
Models 
 
11.2.1 Following Topical Treatment with AgNO3 
 
In the ISE study, immediately following topical treatment with 3.16 M AgNO3 on 
human enamel, yellow staining was observed on the human enamel surfaces 
(Fig. 10.45), which indicated the formation of yellow Ag3PO4 (Lewis, 1920). This 
was consistent with the formation of a Ag3PO4 protective barrier on HAP discs 
topically treated with AgNO3 reported in Chapter 9. In Chapter 7, Ag+ was 
proposed to substitute for the Ca2+ in human enamel. Therefore, some Ag+ 
substituted enamel mineral could also be formed following the topical treatment 
with 3.16 M AgNO3. This is shown schematically in Fig. 11.1. 
 
 
Figure 11.1 – Schematic representation of an enamel block topically treated with 3.16 M AgNO3. 
Ag3PO4 is formed on the enamel surface and some Ca2+ in the enamel mineral is substituted by 
Ag+. 
 
11.2.2 After Re-immersion of Human Enamel Topically Treated with 
AgNO3 into Acid 
 
After re-immersing the human enamel topically treated with 3.16 M AgNO3 back 
into acid, the ISE data showed that there was little change in the rate of Ca2+ 
release (PRCLenamel = 0.0+5.3 %) (Fig. 10.16). This indicated that if 3.16 M 
AgNO3 is used in the clinical practice, no inhibitory efficacy of the treatment can 
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be expected and the cariostatic efficacy of the treatment will only rely on its 
antibacterial properties (Lansdown, 2002). Even though a Ag3PO4 protective 
barrier was formed on the enamel surfaces following AgNO3 treatment (Yamaga 
et al., 1972) (Section 3.2), the inhibitory efficacy against demineralisation was low. 
The low inhibitory efficacy of the 3.16 M AgNO3 topical treatment should be due 
to the accelerating effects from the micro-brush abrasion during the topical 
treatment (PRCLenamel = -10.5+2.4 %) (Section 11.1). Further, the formation of 
Ag+ substituted enamel also compromised the inhibitory efficacy (Chapter 7). 
Gradually, the yellow Ag3PO4 particles on the treated enamel surfaces were 
reduced to black metallic silver due to the photosensitivity of Ag+, as described 
by Liu et al. (2012c).  
The Ag+ released from the enamel sample topically treated with 3.16 M AgNO3 
was detected with Ag ISEs after the re-immersion of the enamel block back into 
acid (Fig. 10.23). The initial increase in the mean Ag+ activity could result from 
the release of Ag+ loosely attached to the enamel surfaces, whereas, the later 
decrease in the mean Ag+ activity could result from chemical reduction of Ag+. 
The small metallic silver particles reduced from Ag+ in the solution will be 
dispersed due to the agitation of the magnetic stirrer.  
Fig. 11.2a shows that, after re-immersing the human enamel topically treated 
with 3.16 M AgNO3 back into acid, Ag+ loosely attached to the enamel surfaces 
is released into solution. Further, the Ag3PO4 protective barrier protects the 
enamel from demineralisation. Fig. 11.2b shows that some Ag+ in the solution 
and some Ag3PO4 on the enamel surface are gradually reduced to black metallic 
silver. Further, the metallic silver reduced from the Ag+ in the solution will be 
dispersed in the solution.  
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a  
b  
Figure 11.2 – Schematic representation of an enamel block topically treated with 3.16 M AgNO3 
following re-immersion back into acid. After immersion of a) Ag+ loosely attached to enamel 
surfaces is released into solution. b) Gradually, some Ag3PO4 on the enamel surface and some 
Ag+ in the solution are reduced to black metallic silver. 
 
11.2.3 After Removal of Human Enamel Topically Treated with 
AgNO3 from Acid 
 
After removing the enamel block topically treated with 3.16 M AgNO3 from acid, 
SEM images showed that the enamel surfaces were less uneven than the 
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surfaces topically treated with DW (Fig. 10.46a and Fig. 10.46d), which 
demonstrated the inhibitory efficacy of topical treatment with 3.16 M AgNO3. 
Deeper lesions observed on the enamel surfaces may be due to the loss of Ag+ 
substituted enamel, which has higher susceptibility than enamel. 
Cubic particles were observed on the enamel surfaces topically treated with 
3.16 M AgNO3 (Fig. 10.46d). Lou et al. (2011) previously found that cubic Ag3PO4 
in the HAP powders mixed with AgNO3 was gradually reduced to cubic metallic 
silver. Therefore, in the present study, these cubic particles deposited on the 
enamel surfaces may be Ag3PO4 or metallic silver. However, as only black 
staining was observed on the enamel surfaces topically treated with 3.16 M 
AgNO3 (Fig. 10.45), and no Ag3PO4 was detected with 31P MAS-NMR in the 
powdered enamel treated with 3.16 M AgNO3 (Fig. 10.54), most of the Ag3PO4 
should be reduced to metallic silver over the post-treatment 4 h demineralisation 
period. 
 Fig. 10.8 shows that, during the post-treatment 4 h demineralisation period, 
the Ca2+ release from demineralising human enamel following the 3.16 M AgNO3 
topical treatment was linear with time, even though Ag3PO4 in the protective 
barrier was gradually reduced to metallic silver. This indicates that the efficacy of 
topical treatment with 3.16 M AgNO3 was not subsequently affected by the 
chemical reduction of Ag3PO4 in the protective barrier to metallic silver. Therefore, 
the black metallic silver particles reduced from Ag3PO4 particles continued to play 
the same role as Ag3PO4 particles in the protective barrier during 
demineralisation. It has been proposed that topical AgNO3 can lead to formation 
of a black protective barrier on the treated tooth surface to inhibit demineralisation 
(Miller, 1905). Further, it has been reported that the black staining of teeth 
restored with amalgam can lead to the inhibition of dental caries progression 
(Stebbins, 1891). 
The microscopic photographs taken through the eyepiece of the Knoop micro-
hardness tester showed “double lesions” in enamel sections topically treated with 
3.16 M of AgNO3 (Fig. 10.56d), which were similar to those reported enamel 
sections topically treated with DW (Fig. 10.56a). Further, lower Knoop hardness 
values were recorded at the depth levels of 40 µm (around 120 KHN) in enamel 
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sections topically treated with 3.16 M AgNO3, compared to those recorded at 
deeper levels (around 280 KHN) (Fig. 10.57d), which was also similar to the 
results of DW topical treatment group (Fig. 10.57a). This indicates that the 
inhibitory efficacy of the AgNO3 treatment was low. A previous study has also 
reported that there was no difference between the lesion depths of enamels 
treated with AgNO3 and DW after demineralisation (Liu et al., 2012b).  
    Fig. 11.3 shows that, after removing the enamel block topically treated with 
3.16 M AgNO3 from acid, deeper lesions are developed in the Ag+ substituted 
enamel, therefore uneven demineralised enamel surface is observed. Further, all 
the Ag3PO4 on the enamel surface is reduced to metallic silver causing black 
staining. These metallic silver particles continue to protect the enamel as Ag3PO4 
during the demineralisation. 
 
 
Figure 11.3 – Schematic representation of an enamel block topically treated with AgNO3 after 4 
h demineralisation. Deeper lesions are developed in the substituted enamel, therefore uneven 
demineralised enamel surface is observed. Further, all the Ag3PO4 is reduced to black metallic 
silver causing black staining. 
 
 
 
11.2.4 Analysis of the Inhibitory Efficacy of the Topical Treatment 
with AgNO3 on Demineralisation of Human Enamel  
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As discussed in Section 9.2.4, inhibitory efficacy of topical treatment can be 
influenced by the abrasion effects from using a micro-brush during the topical 
treatment and the effects of topically applied agent (Fig. 9.4). Therefore, as the 
abrasion effects from using a micro-brush during the topical treatments 
(PRCLenamel = -10.5+2.4 %) accelerated the demineralisation of human enamel, 
the inhibitory efficacy (PRCLenamel = 0.0+5.3 %) observed following the topical 
treatment with 3.16 M AgNO3 should totally rely on the effects of topically applied 
AgNO3.  
The effects of topically applied AgNO3 include the effects of the reaction 
products deposited on the enamel surfaces and the effects of the ions released 
from the topically treated enamel blocks (Fig. 9.4). Ag3PO4 particles were formed 
as a protective barrier on the enamel topically treated with 3.16 M AgNO3 (Section 
11.2.2), which contributed to the inhibitory efficacy. However, as the Ag+ in the 
solution released from the treated enamel accelerated the demineralisation of 
enamel (see Chapter 7), the inhibitory efficacy was compromised. The [Ag+]4h in 
the solution following 3.16 M topical treatment was 0.95+0.18 ppm (Table 10.9). 
According to the log-linear dose-response of Ag+ on demineralisation of enamel 
reported previously (Fig. 7.4), the effect of the Ag+ at 0.95 ppm will accelerate 
the enamel demineralisation by 1.1 % (PRMLenamel). 
 
11.2.5 Conclusions 
 
In conclusion, Sections 11.2.1, 11.2.2 11.2.3 and 11.2.4 show that the inhibitory 
efficacy of topical treatment with AgNO3 on demineralisation of enamel is 
associated with the formation of a protective barrier composed of Ag3PO4. This 
is similar to the inhibitory mechanism of topical treatment with AgNO3 on 
demineralisation of HAP discs (Chapter 9).  
11.3 Effects of Topical Treatments with AgF and Ag[NH3]2F on 
Demineralisation of Human Enamel and Proposed Mechanistic 
Models 
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11.3.1 Following Topical Treatments with AgF and Ag[NH3]2F 
 
In the ISE study, immediately following topical treatment with 3.16 M AgF and 
3.16 M Ag[NH3]2F on human enamel, yellow staining was observed on the human 
enamel surfaces (Fig.10.45), which indicated the formation of yellow Ag3PO4. 
Further, CaF2 and fluorohydroxyapatite (FHA) in the powdered enamel treated 
with 3.16 M AgF and 3.16 M Ag[NH3]2F were also detected with 19F MAS-NMR 
(Fig. 10.55). These powdered enamel samples were collected after the ISE study. 
As the [F-]4h of 3.16 M AgF and 3.16 M Ag[NH3]2F treatment groups during the 
post-treatment 4 h demineralisation periods of the ISE study were too low (< 1 
ppm) (Table 10.11) to facilitate the formation of CaF2 (Rosin-Grget et al., 2013) 
(Section 2.4), these CaF2 and FHA should be formed during topical treatments. 
It has been reported that, under pH 4.0 acid challenge, CaF2 (with minor FHA) 
could be predominantly formed on human enamel only when the concentration 
of F- in the solution was above 135 ppm (Mohammed et al., 2013). Previous study 
has found Ag3PO4 and CaF2 in enamel powder mixed with Ag[NH3]2F (Suzuki et 
al., 1974). However, no FHA was found due to the limitation of characterisation 
ability of X-ray diffraction analysis (XRD). 
Therefore, the CaF2 and FHA participate in the formation of the protective 
barrier following 3.16 M AgF and 3.16 M Ag[NH3]2F topical treatments. As Ca2+ 
lost from enamel due to the formation of Ag+ substituted enamel can be preserved 
as CaF2, and unstable Ag+ substituted enamel can be replaced by more stable 
FHA (Robinson, 2009), enamel blocks topically treated with 3.16 M AgF, and 3.16 
M Ag[NH3]2F should be better protected against demineralisation than those 
topically treated with 3.16 M AgNO3. This is shown schematically in Fig. 11.4. 
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Figure 11.4 – Schematic representation of an enamel block topically treated with AgF or 
Ag[NH3]2F. Ag3PO4, CaF2 and FHA are formed on the enamel surface.  
 
11.3.2 After Re-immersion of Human Enamel Topically Treated with 
AgF and Ag[NH3]2F into Acid 
 
After re-immersing the human enamel topically treated with 3.16 M AgF and 3.16 
M Ag[NH3]2F back into acid, the ISE data showed that there was an immediate 
reduction in the rate of Ca2+ release (Fig. 10.11 and Fig 10.14). The mean 
PRCLenamel of the 3.16 M AgF and 3.16 M Ag[NH3]2F (65.6+6.1 % and 65.3+3.3 
%) were much higher than that of the 3.16 M AgNO3 treatment group (0.0+5.3 %) 
(Fig. 10.16), showing that the inhibitory efficacy of F- was greater than that of Ag+. 
Previous studies also found that Ag[NH3]2F treated demineralised enamel block 
released less Ca2+ into demineralisation solution leading to less mineral loss (Wu 
and Yang, 2002, Rosas et al., 2014). The pronounced inhibitory efficacy of topical 
treatments with these fluoride-containing silver compounds should be associated 
with the additional deposition of CaF2 and the formation of acid-resistant FHA 
(Arends and Christoffersen, 1990; ten Cate, 1997) (Section 2.4). Therefore, the 
inhibitory efficacy of topical treatment with 3.16 M AgF and 3.16 M Ag[NH3]2F are 
associated with the formation of a protective barrier composed of Ag3PO4, CaF2 
and FHA. Gradually, yellow Ag3PO4 on the treated enamel surfaces was reduced 
to black metallic silver due to the photosensitivity of Ag+, as described by Liu et 
al. (2012c). 
    The Ag+ released from the human enamel topically treated with 3.16 M AgF, 
and 3.16 M Ag[NH3]2F were detected with Ag+ ISEs after the re-immersion of the 
enamel back into acid (Fig. 10.23). As mentioned in 3.16 M AgNO3 treatment 
group (Section 11.2.2), the initial increase in the mean Ag+ activity could result 
CaF2CaF2 CaF2 CaF2Ag3PO4 Ag3PO4 Ag3PO4 Ag3PO4 Ag3PO4
Enamel
CaF2
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from the release of Ag+ loosely attached to the enamel surfaces, whereas, the 
later decrease in the mean Ag+ activity could result from chemical reduction of 
Ag+. These metallic silver particles will be dispersed in the solution due to the 
agitation of the magnetic stirrer.  
Fig. 10.27a and b shows that the increase rate of Ag+ activities and the later 
decrease rate of Ag+ activities following 3.16 M AgF and 3.16 M Ag[NH3]2F topical 
treatments were similar. This indicates that the ability of ammonia in hindering 
the chemical reduction of Ag+ was not obvious following the Ag[NH3]2F topical 
treatment (Liu et al., 2012b) (Section 3.4). Similar Ag+ release profiles explain 
why there were no significant differences between the [Ag+]4h of 3.16 M AgF and 
3.16 M Ag[NH3]2F treatment groups (Fig. 10.31). Therefore, the effects of Ag+ in 
the solution on both 3.16 M AgF and 3.16 M Ag[NH3]2F topically treated enamel 
blocks should be similar. 
The F- released from the human enamel topically treated with 3.16 M AgF, and 
3.16 M Ag[NH3]2F were detected with F- ISEs after the re-immersion of the 
enamel back into acid (Fig. 10.35). The initial increase in the mean F- activity 
could result from the release of F- loosely attached to the enamel surfaces 
(Arends and Christoffersen, 1990; Dijkman et al., 1982), whereas, the later 
increase in the mean F- activity could result from the slow dissolution of CaF2-like 
globules (CaF2 with the adsorption of HPO42-), favouring the formation of FHA 
(ten Cate, 2013; Vogel, 2011) (Section 2.4). The rates of initial F- release from 
human enamel (Fig. 10.35) are faster than the rates of initial F- release from HAP 
discs observed in chapter 8 (Fig. 8.13). This may be due to the porosity of human 
enamel (about 1 ~ 2 %) being lower than that of HAP discs (about 20 %), so the 
diffusion of F- from the human enamel is faster due to reduced adsorption ability 
of F- to the human enamel. 
Fig. 10.38a and b shows that the initial increase rate of F- activity following 
3.16 M Ag[NH3]2F topical treatment was faster than that following 3.16 M AgF 
topical treatment. However, the later increase rate of F- activity following 3.16 M 
Ag[NH3]2F topical treatment was slower than that following 3.16 M AgF topical 
treatment. This may be due to that the proportion of CaF2 without the adsorption 
of HPO42-, which has higher solubility, formed following 3.16 M Ag[NH3]2F topical 
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treatment was higher than that following 3.16 M AgF topical treatment, leading to 
faster initial F- release. Further, the proportion of CaF2 with the adsorption of 
HPO42- (CaF2-like globule) formed following 3.16 M Ag[NH3]2F topical treatment 
was lower than that following 3.16 M AgF topical treatment, leading slower later 
F- release. The much faster initial F- release following 3.16 M Ag[NH3]2F topical 
treatment resulted in significant higher [F-]4h than that detected following 3.16 M 
AgF topical treatment (Fig. 10.41). Therefore, the effects of F- in the solution on 
3.16 M Ag[NH3]2F topically treated enamel blocks should be higher than those on 
3.16 M AgF topically treated enamel blocks. Less CaF2-like globules formed 
following 3.16 M Ag[NH3]2F topical treatment may be due to the interference of 
the adsorption of HPO42- around CaF2 surfaces. The most likely interference 
factor could be the ammonium (NH4+) dissolved from the Ag[NH3]2F. However, 
further studies are required to confirm the postulation. 
Fig. 11.5a shows that, after re-immersing the human enamel topically treated 
with 3.16 M AgF or 3.16 M Ag[NH3]2F back into acid, both Ag+ and F- loosely 
attached to enamel surface are released into solution. Further, the protective 
barrier composed of Ag3PO4, CaF2 and FHA protects the enamel from 
demineralisation. Fig. 11.5b shows that some Ag+ in the solution and some 
Ag3PO4 on the enamel surface are gradually reduced to metallic silver. Further, 
some CaF2 on the enamel surface is gradually dissolved, providing F- for further 
formation of FHA. 
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a  
b  
Figure 11.5 – Schematic representation of an enamel block topically treated with AgF or 
Ag[NH3]2F following re-immersion back into acid. a) Both Ag+ and F- loosely attached to enamel 
surface are released into solution. b) Gradually, some Ag3PO4 on the enamel surface and some 
Ag+ in the solution are reduced to metallic silver, and some CaF2 on the enamel surface is 
dissolved, providing F- for further formation of FHA. 
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11.3.3 After Removal of Human Enamel Topically Treated with AgF 
and Ag[NH3]2F from Acid 
 
After removing the human enamel topically treated with 3.16 AgF and 3.16 M 
Ag[NH3]2F from acid, SEM images showed that the enamel surfaces were less 
uneven than those topically treated with 3.16 M AgNO3 (Fig. 10.46d, Fig. 10.46g 
and Fig. 10.46j), which demonstrated that the inhibitory efficacy of F- was greater 
than that of Ag+.  
Cubic and granular particles were observed on the enamel surfaces (Fig. 
10.46g and Fig. 10.46j). These cubic particles should mostly be black cubic 
metallic silver rather than yellow cubic Ag3PO4 (Lou et al., 2011), as only black 
staining was observed on the enamel surfaces (Fig. 10.45), and no Ag3PO4 was 
detected with 31P MAS-NMR in the powdered enamel treated with 3.16 M AgF 
and 3.16 M Ag[NH3]2F (Fig. 10.54). This indicates that most of the Ag3PO4 was 
chemically reduced to metallic silver during the post-treatment 4 h 
demineralisation period. Black staining of the AgF or Ag[NH3]2F treated dental 
lesions has been reported by multiple clinical and in vitro studies (Peng et al., 
2012, Chu et al., 2014, Zhao et al., 2017). On the other hand, the granular 
particles should be CaF2-like globules (Buzalaf et al., 2011; Rolla and Saxegaard, 
1990) (Section 2.4). These CaF2-like globules sometimes clustered as an 
agglomeration on the treated enamel surfaces (Navarro et al., 2001), as could be 
seen on the enamel surfaces treated with 3.16 M Ag[NH3]2F (Fig. 10.46j). 
The mean atomic percentage of Ag detected on the enamel surfaces topically 
treated with 3.16 M AgF was significantly higher than that of 3.16 M AgNO3 (Fig. 
10.47). This indicates that following 3.16 M AgF topical treatment, which 
facilitated the CaF2 formation (Fig. 10.55), more Ag3PO4 was formed due to the 
further PO43- release from the dissociation of enamel  (Mohammed et al., 2013). 
These Ag3PO4 particles were then reduced to metallic silver to be detected with 
EDX. The mean atomic percentage of Ag detected on the enamel surfaces 
topically treated with 3.16 M Ag[NH3]2F was significantly lower than that of 3.16 
M AgF (Fig. 10.47). It may be due to that Ag3PO4 can be dissolved in ammonium 
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(Firsching, 1961) (Section 3.4.2). Therefore less metallic silver could be reduced 
from Ag3PO4 following 3.16 M Ag[NH3]2F treatment. 
The mean atomic percentage of F detected on the enamel surfaces topically 
treated with 3.16 M AgF was significantly higher than that of 3.16 M Ag[NH3]2F 
treatment group (Fig. 10.51), which was consistent with higher proportions of 
CaF2 detected in powdered enamel treated with 3.16 M AgF than those treated 
with 3.16 M Ag[NH3]2F (Fig. 10.55). The lower mean atomic percentage of F 
detected on the 3.16 M Ag[NH3]2F topically treated enamel surfaces should be 
due to the faster initial F- release (Fig. 10.38a), as discussed in Section 11.3.2. 
    Fig. 10.11 and Fig. 10.14 show that, during the post-treatment 4 h 
demineralisation period, the inhibited Ca2+ release from demineralising human 
enamel following the topical treatments with 3.16 M AgF and 3.16 M Ag[NH3]2F 
was linear with time, even though Ag3PO4 in the protective barrier was chemically 
reduced and CaF2 in the protective barrier was dissolved. This indicates that the 
inhibitory efficacy of topical treatments with these fluoride-containing silver 
compounds was not subsequently affected by the chemical reduction of Ag3PO4 
to metallic silver and the dissolution of CaF2. As mentioned in Section 11.2.3, the 
metallic silver particles reduced from Ag3PO4 particles continue to play the same 
role as the Ag3PO4 particles in the protective barrier. Therefore, further FHA 
formation due to the supply of F- from CaF2 dissolution should compensate for 
the protective effect lost from the dissolution of CaF2 particles in the protective 
barrier. 
    Using the microscopy of the Knoop micro-hardness tester, the lesions observed 
in enamel sections topically treated with 3.16 M and AgF, 3.16 M Ag[NH3]2F were 
all shallower (Fig. 10.56g and j) than those observed in 3.16 M AgNO3 treatment 
group (Fig. 10.56d). This should be due to the participation of F-. Larsen has 
proposed that in a solution with a higher concentration of F-, the artificial 
demineralised erosive lesion is shallower (Larsen, 1990). It has been reported 
that F- of Ag[NH3]2F can penetrate intact human enamel up to a depth of 20 μm 
(Suzuki et al., 1974). In the present study, the penetration depth of F- should be 
higher as Ag[NH3]2F was applied on demineralised enamel surfaces. The Knoop 
CSMH profiles of enamel sections topically treated with 3.16 M AgF, and 3.16 M 
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Ag[NH3]2F (Fig. 10.57g and j) all had similar KHN values (around 280 KHN) along 
the entire depth from lesion surfaces, which is due to the pronounced protective 
effect of these fluoride-containing silver compound topical treatments. A previous 
study also found that Ag[NH3]2F treated enamel block immersed in lactic acid for 
two days had less lesion depth and increased micro-hardness compared to the 
negative control group (Li et al., 1984). Further, it has been proposed that carious 
enamel treated with Ag[NH3]2F had increased micro-hardness up to a depth of 
about 150 μm, compared to lesions treated with de-ionised water  (Zhao et al., 
2017). 
Fig. 11.6 shows that, after removing the human enamel topically treated with 
3.16 AgF or 3.16 M Ag[NH3]2F from acid, all the Ag3PO4 on the enamel is reduced 
to metallic silver causing black staining. Further, most of the CaF2 is dissolved, 
which favours further formation of FHA. The enamel surface covered by the 
metallic silver, CaF2 and FHA is protected during the demineralisation. 
 
 
Figure 11.6 – Schematic representation of an enamel block topically treated with AgF or 
Ag[NH3]2F after 4 h demineralisation. All the Ag3PO4 is reduced to metallic silver causing black 
staining and most of the CaF2 is dissolved which favours further formation of FHA. 
 
11.3.4 Analysis of the Inhibitory Efficacy of the Topical Treatments 
with AgF, Ag[NH3]2F and Riva-SC on Demineralisation of Human 
Enamel 
 
As discussed in Section 9.2.4, the inhibitory efficacy of the topical treatment on 
demineralisation can be influenced by the abrasion effects from using a micro-
brush during the topical treatment and the effects of topical application agent (Fig. 
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9.4). However, as the abrasion effect of topical treatment accelerates the 
demineralisation of human enamel by 10.5+2.4 %, the inhibitory efficacy of topical 
treatments with 3.16 AgF (PRCLenamel = 65.6+6.1 %) and 3.16 M Ag[NH3]2F 
(PRCLenamel = 65.3+3.3 %) should all be attributed to the effects of topical 
application agents.  
The effects of topical application agents include the effects of the reaction 
products deposited on the enamel surfaces and the effects of the ions released 
from the topically treated enamel (Fig. 9.4). Ag3PO4, CaF2 and FHA were formed 
as a protective barrier on the enamel topically treated with 3.16 M AgF and 3.16 
M Ag[NH3]2F (Section 11.3.1), which contributed to the inhibitory efficacy. 
After re-immersing the enamel topically treated with these fluoride-containing 
silver compounds back into acids, both Ag+ and F- were released. The [Ag+]4h of 
3.16 M AgF and 3.16 M Ag[NH3]2F treatment groups were ≈ 0.89+0.27 ppm and
≈ 0.78+0.06 ppm (Table 10.9). Therefore, according to the log-linear dose-
response of Ag+ on demineralisation of enamel (Fig. 7.4), the effects of the Ag+ 
at 0.89 ppm and 0.78 ppm will accelerate the enamel demineralisation by 0.90 % 
and 0.59 % (PRMLenamel), respectively. On the other hand, the [F-]4h of 3.16 M 
AgF and 3.16 M Ag[NH3]2F treatment groups were ≈ 0.34+0.03 ppm and ≈ 
0.42+0.02 ppm (Table 10.11). Therefore, according to the log-linear dose-
response of F- on demineralisation of enamel (Fig. 6.7b), the effects of the F- at 
0.34 ppm and 0.42 ppm will inhibit the demineralisation by 29.91 % and 32.18 % 
(PRMLenamel), respectively.  
Even though the inhibitory efficacy (PRMLenamel) resulting from the F- in solution 
following 3.16 M AgF topical treatment is lower than that following 3.16 M 
Ag[NH3]2F topical treatment, the PRCLenamel of topical treatments with 3.16 M AgF 
and 3.16 M Ag[NH3]2F were similar (Fig. 10.16). Therefore, the inhibitory efficacy 
from the protective barrier formed on the human enamel surfaces topically treated 
with 3.16 M AgF was higher than that formed on the human enamel surfaces 
topically treated with 3.16 M Ag[NH3]2F, This is consistent with higher amounts of 
silver and fluoride compounds detected on the 3.16 M AgF topically treated 
enamel surfaces (Fig. 10.47 and Fig. 10.51),  
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11.3.5 Conclusions 
 
In conclusion, Sections 11.3.1, 11.3.2 11.3.3 and 11.3.4 show that the inhibitory 
efficacy of topical treatments with 3.16 M AgF and 3.16 M Ag[NH3]2F on 
demineralisation of human enamel is associated with the release of F- from the 
topically treated enamel surfaces and the formation of a protective barrier 
composed of Ag3PO4, CaF2 and FHA. This is similar to the inhibitory mechanisms 
of topical treatment with AgF and Ag[NH3]2F on demineralisation of HAP discs 
(Chapter 9). 
  
 
213 
11.4 Difference Between the Effects of Topical Treatments with 
Riva-SC and 3.16 M Ag[NH3]2F on Demineralisation of Human 
enamel 
 
The effects of topical treatment with Riva-SC (3.16 M Ag[NH3]2F, Silver Capsule 
of Riva Star SDI Ltd, Australia) on demineralisation of human enamel were similar 
to those of laboratory-prepared 3.16 M Ag[NH3]2F (Fig. 10.14 ~ Fig. 10.57). This 
suggests that they have the same inhibitory mechanism on the demineralisation 
of human enamel (Fig. 11.4 ~ Fig. 11.6). However, the mean atomic percentage 
of Ag detected on the enamel surfaces topically treated with Riva-SC was not 
significantly different from other treatment groups (Fig. 10.47). This may be due 
to that the composition of each Silver Capsules of Riva Star used in the study 
was not consistent. Therefore, a higher sample size is required to show the 
statistical differences. Further, the mean atomic percentage of F of Riva-SC 
treatment group was higher than that of 3.16 M Ag[NH3]2F treatment group (Fig. 
10.51). This may be due to that the ammonia contents in some Silver Capsules 
of Riva Star were lower than that in the laboratory-prepared 3.16 M Ag[NH3]2F 
(as discussed in Section 11.3.2). 
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11.5 Conclusions 
 
In conclusion, the inhibitory mechanism of topical treatment with AgNO3 on 
human enamel is associated with the formation of a Ag3PO4 protective barrier. 
Whereas, the inhibitory mechanism of topical treatment with AgF or Ag[NH3]2F is 
associated with the F- released from the topically treated enamel and the 
formation of a protective barrier, composed of Ag3PO4, CaF2 and FHA. The 
inhibitory mechanisms of topical treatments with silver compounds on 
demineralisation of human enamel are similar to those of HAP discs. 
The effects of topical treatment with Silver Capsule of Riva Star (3.16 M SDF, 
SDI Ltd, Australia) on demineralisation of human enamel are similar to those of 
topical treatment with laboratory-prepared 3.16 M Ag[NH3]2F. 
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Chapter 12 DISCUSSION OF DOSE-RESPONSE EFFECTS OF 
TOPICAL TREATMENTS WITH SILVER COMPOUNDS ON 
DEMINERALISATION OF HUMAN ENAMEL AND PROPOSED 
MODELS FOR MECHANISMS 
 
The effects of topical treatments with 2.36 M, 0.75 M and 3.16 M of these silver 
compounds on enamel demineralisation were investigated (Chapter 10), in order 
to understand the dose-response mechanisms of topical treatments with AgNO3, 
AgF and Ag[NH3]2F on demineralisation of human enamel. These concentrations 
are the same as those used in the commercial silver compounds such as Caristop 
12% (0.75 M Ag[NH3]2F, Biodinamica Química E Farmacéutica Ltda), Saforide 
(2.36 M Ag[NH3]2F, Toyo Seiyaku Kasei Co. Ltd) and Riva Star (3.16 M Ag[NH3]2F, 
SDI Ltd, Australia) (Fung et al., 2013, SDI, 2016a). Therefore, the dose-response 
results reported in this study were clinically relevant to the topical treatment 
outcomes using these concentrations of silver compounds. 
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12.1 Dose-response Effects of Topical Treatment with AgNO3 
on Demineralisation of Human Enamel and Proposed 
Mechanistic Models 
 
The Ca2+ ISE data (Fig. 10.17) showed that the mean PRCLenamel of topical 
treatment with AgNO3 decreased with increasing concentration. The SEM images 
also demonstrated similar dose-response (Fig. 10.46b ~ d). Craters and 
breakages observed on the surfaces topically treated with 3.16 M AgNO3 (Fig. 
10.46d) were larger and deeper than those observed on the enamel surfaces 
topically treated with 2.36 M AgNO3 (Fig. 10.46c). Further, on the enamel 
surfaces topically treated with 0.75 M AgNO3, only uneven surfaces were 
observed (Fig. 10.46b). No dose-response was observed in the enamel sections 
and the Knoop CSMH profiles (Fig. 10.56b ~ d and Fig. 10.57b ~ d), as the 
change in the inhibitory efficacy was too small. A previous study reported that 5 
min immersion of human enamel blocks in 2.36 M AgNO3 led to negligible 
inhibition efficacy in demineralisation at pH 4.4 (Liu et al., 2012b), which is 
different from the PRCLenamel (= 4.6+5.9 %) of the 2.36 M AgNO3 topical treatment 
observed in the present study. This may be due to the inhibitory efficacy of the 
agent in their study being based on the reduction in the lesion depth measured 
with Micro-CT, whereas, the inhibitory efficacy in the present study was based on 
the subtle change in the rates of Ca2+ release. This may explain the lower 
inhibitory efficacy of the topical 2.36 M AgNO3 treatment observed in the present 
study. 
Cubic metallic silver particles (reduced from Ag3PO4) found on the enamel 
surfaces topically treated with higher concentrations of AgNO3 were larger and 
more packed together (Fig. 10.46b ~ d), leading to the darker black staining 
observed on the enamel surfaces (Fig. 10.45), which indicates that the 
components in the protective barrier accumulated with increasing concentration 
of topically applied AgNO3. The increased protective barrier would lead to 
increased inhibitory efficacy, which contradicts the dose-response of (PRCLenamel) 
observed in the Ca2+ ISE data (Fig. 10.17). 
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The conflict can be explained by the loss of the protective barrier formed on 
the lost enamel structures due to the formation of craters and breakages. As more 
enamel structures were lost following the topical treatment with higher 
concentrations of topically applied AgNO3 (Fig. 10.46b ~ d), leading to the loss 
of protective barrier, the inhibitory efficacy of the treatment decreased (Fig. 
10.17). This is consistent with the decreased mean percentage of Ag detected on 
enamel surfaces topically treated with 3.16 M AgNO3 (0.96+0.12 %), compared 
to that detected on those topically treated with 2.36 M AgNO3 (1.09+0.28 %) (Fig. 
10.47). The structure loss should be due to the formation of Ag+ substituted 
enamel, whose susceptibility increased with increasing incorporation of Ag+ 
(Chapter 7). The proposed dose-response mechanism of AgNO3 topical 
treatment on human enamel is shown schematically in Fig. 12.1.  
 
 
Figure 12.1 – Schematic representation of proposed dose-response inhibitory mechanism of 
topical treatment with AgNO3 on human enamel demineralisation. Following topical treatment with 
AgNO3, both formation of Ag3PO4 and Ag+ substituted enamel increases with increasing 
concentration. After acid challenge, Ag3PO4 is reduced to metallic silver. The enamel surface with 
more Ag+ substituted enamel is more destructed. Further, some metallic silver is lost due to the 
loss of enamel structure. 
 
Increasing [AgNO3] Tx
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After Acid 
Challenge
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12.1.1 The Dose-response Effects of Ag+ on the Dose-response 
Inhibitory Efficacy of the Topical Treatment with AgNO3 on Enamel 
Demineralisation 
 
In the ISE study, the accelerating enamel demineralisation effects of Ag+ due to 
the formation of Ag+ substituted enamel (Chapter 7) can be expected during 
AgNO3 topical treatment on enamel, and, after re-immersion back into acid.  
There was a log-linear relationship (R2 = 1.00) between the mean PRCLenamel 
and the concentration of AgNO3 (Fig. 10.18), which is similar to the dose-
response PRMLenamel of Ag+ in solution reported in the SMR study (Fig. 7.4). This 
indicates that the dose-response effects of the topical treatment with AgNO3 are 
associated with the accelerating enamel demineralisation effect of Ag+ in the 
topically applied AgNO3. 
After re-immersing the enamel topically treated with AgNO3 back into acid, the 
[Ag+]4h increased with increasing concentration of AgNO3 (Fig. 10.32). Further, 
Fig. 12.2 shows that a log-linear relationship was found between the mean 
PRCLenamel of AgNO3 topical treatment and the [Ag+]4h (R2 =0.74) (Green line), 
which is similar to the dose-response PRMLenamel of Ag+ in solution reported in 
the SMR study (Grey line). This indicates that the dose-response inhibitory of the 
AgNO3 topical treatment is also associated with the accelerating enamel 
demineralisation effect of Ag+ in the demineralisation solution. 
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Figure 12.2 - Comparison of the log-linear relationship between the mean PRCLenamel of AgNO3 
topical treatment and the [Ag+]4h (Green line), and the log-linear relationship between the mean 
PRMLenamel of Ag+ and the [Ag+] in solution (Grey line). Error bars show the standard errors. 
 
However, the R2 value of the dose-response PRCLenamel of [Ag+]4h (R2 =0.75) 
is lower than the R2 value of the dose-response PRCLenamel of topically applied 
[AgNO3] (R2 = 1.00). Further, the slope value (= -39.67 %/ppm) of the dose-
response PRCLenamel of [Ag+]4h reported in the present ISE study (Green line) was 
much steeper than the slope value (= -2.32 %/ppm) of the dose-response 
PRMLenamel of Ag+ in solution reported in the SMR study (Grey line), (Fig. 12.2). 
Therefore, the dose-response inhibitory efficacy of topical treatment with AgNO3 
was mainly due to the high [Ag+] in the topical application agent (all [AgNO3] > 
80000 ppm Ag+) rather than the low [Ag+] in the demineralisation solution (all 
[Ag+]4h < 1 ppm Ag+).  
    There are differences between the inhibitory efficacy (PRCLenamel) of AgNO3 
topical treatments observed in the present ISE study (Green line), and the 
theoretical inhibitory efficacy (PRMLenamel) of [Ag+]4h obtained from the dose-
response PRMLenamel of Ag+ in solution reported in the SMR study (Grey line) (Fig. 
12.3). The difference is due to the topical applied AgNO3, which facilitates the 
formation of a protective barrier on the topically treated enamel. Further, the 
difference decreased with increasing concentration, which is due to the loss of 
enamel structure, leading to the loss of the protective barrier. 
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Figure 12.3 – The difference between the inhibitory efficacy (PRCLenamel) of AgNO3  (Green dots) 
observed in ISE study and the theoretical inhibitory efficacy (PRMLenamel) of [Ag+]4h (Grey dots) 
obtained from dose-response PRMLenamel of Ag+ reported in the SMR study. 
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12.2 Dose-response Effects of Topical Treatments with AgF and 
Ag[NH3]2F on Demineralisation of Human Enamel and Proposed 
Mechanistic Models 
 
The Ca2+ ISE data (Fig. 10.19 and Fig. 10.21) showed that the mean PRCLenamel 
of AgF and Ag[NH3]2F topical treatments increased with increasing 
concentrations. The SEM images also demonstrated similar dose-response (Fig. 
10.46e ~ j). Only ripple-like demineralised lesions were observed on the enamel 
surfaces topically treated with 2.36 M and 3.16 M of AgF and Ag[NH3]2F (Fig. 
10.46f, g, i and j), whereas, demineralised holes were observed on the surfaces 
topically treated with 0.75 M AgF and 0.75 M Ag[NH3]2F (Fig. 10.46e and h). No 
dose-response was observed in the enamel sections and the Knoop CSMH 
profiles (Fig. 10.56e ~ j and Fig. 10.57e ~ j), as the change in the inhibitory 
efficacy was too small. 
The amount of cubic metallic silver particles (reduced from Ag3PO4) found on 
the enamel surfaces topically treated with AgF and Ag[NH3]2F increased with 
increasing concentrations of AgF and Ag[NH3]2F (Fig. 10.46e ~ j), leading to 
increased black staining observed on the enamel surfaces topically treated with 
higher concentrations of AgF and Ag[NH3]2F (Fig. 10.45). Further, the mean 
atomic percentages of Ag detected on the enamel surfaces also increased with 
increasing concentrations of AgF and Ag[NH3]2F (Fig. 10.49 and Fig. 10.50). All 
these findings indicate that the amount of metallic silver accumulated in the 
protective barrier with increasing concentration of topically applied AgF and 
Ag[NH3]2F.  
It is also noted that the amount of granular CaF2 particles found on the enamel 
surfaces topically treated with AgF and Ag[NH3]2F increased with increasing 
concentrations of AgF and Ag[NH3]2F (Fig. 10.46e ~ j). Further, the mean atomic 
percentages of F detected on the enamel surfaces increased with increasing 
concentrations of AgF and Ag[NH3]2F (Fig. 10.52 and Fig. 10.53). Also, the 
proportion of CaF2 detected with 19F MAS-NMR in the powdered enamel samples 
topically treated with AgF and Ag[NH3]2F increased with increasing 
concentrations (Fig. 10.55). All these findings indicate that the amount of CaF2 
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also accumulated in the protective barrier with increasing concentration of 
topically applied AgF and Ag[NH3]2F.  
As CaF2 can act as a reservoir of F- for the formation of FHA (ten Cate, 1997) 
(Section 2.4), the amount of FHA should also accumulate in the protective barrier 
with increasing concentration of topically applied AgF and Ag[NH3]2F. Even 
though, from the current 19F MAS-NMR spectra (Fig. 10.55), it was difficult to tell 
whether the proportion of FHA in the powdered enamel samples increased with 
increasing concentrations of AgF and Ag[NH3]2F due to the small amounts of FHA 
formed following the topical treatments, previous 19F MAS-NMR study has shown 
that the incorporation of fluoride into enamel mineral, forming FHA, increased 
with increasing [F-] in the solution (Mohammed et al., 2013). In the present study, 
FHA was detected with 19F MAS-NMR in the powdered enamel treated with 0.75 
M Ag[NH3]2F (Fig. 10.55), but no F was detected with EDX on the enamel 
surfaces topically with 0.75 M Ag[NH3]2F (Fig. 10.53). This might be due to the 
detected limit of EDX, which has been proposed to be around 0.1 wt% (Goldstein 
et al., 2003). 
The inhibitory efficacy of topical treatments with AgF and Ag[NH3]2F, and, the 
amounts of metallic silver (reduced from Ag3PO4), CaF2 and FHA increased with 
increasing concentration. Therefore, the increased inhibitory efficacy of topical 
treatments with AgF and Ag[NH3]2F is associated with the accumulation of the 
components in the protective barrier. The proposed dose-response mechanism 
of AgF or Ag[NH3]2F topical treatment on human enamel is shown schematically 
in Fig. 12.4. 
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Figure 12.4 – Schematic representation of proposed dose-response inhibitory mechanism of 
topical treatment with AgF or Ag[NH3]2F on human enamel demineralisation. Following topical 
treatment with AgF or Ag[NH3]2F, the formation of Ag3PO4, CaF2 and FHA increases with 
increasing concentration. After acid challenge, Ag3PO4 is reduced to metallic silver and CaF2 is 
dissolved for further formation of FHA. 
 
12.2.1 The Dose-response Effects of Ag+ on the Dose-response 
Inhibitory Efficacy of the Topical Treatment with AgF and Ag[NH3]2F 
on Enamel Demineralisation 
 
In the ISE study, the accelerating enamel demineralisation effects of Ag+ due to 
the formation of Ag+ substituted enamel (Chapter 7) can be expected during AgF 
and Ag[NH3]2F topical treatments on enamel, and, after re-immersion back into 
acid.  
However, the direction of the log-linear relationships between the mean 
PRCLenamel and the concentrations of AgF and Ag[NH3]2F (Fig. 10.20 and Fig. 
10.22) is different from the dose-response PRMLenamel of Ag+ in solution reported 
in the SMR study (Fig. 7.4). Further, after re-immersing the enamel topically 
treated with AgF and Ag[NH3]2F back into acid, there were no significant 
differences between the [Ag+]4h following different concentrations AgF and 
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Ag[NH3]2F topical treatments (Fig. 10.33 and Fig. 10.34). Fig. 12.5 and Fig. 12.6 
show that there were no log-linear relationships between the mean PRCLenamel of 
either AgF or Ag[NH3]2F topical treatment, and their [Ag+]4h (R2 = 0.09 and 0.06) 
(Red and Blue lines), which is different from the log-linear dose-response 
relationship between the mean PRMLenamel of Ag+ and the [Ag+] reported in SMR 
study (Grey line). Therefore, the dose-response effects of Ag+ did not have much 
influence on the dose-response inhibitory efficacy (PRCLenamel) of the AgF and 
Ag[NH3]2F topical treatments. 
The difference between the dose-response PRCLenamel of AgF and Ag[NH3]2F 
topical treatments and that of AgNO3 topical treatment may be due to the 
involvement of F-. As discussed in Sections 11.3.1, following topical treatments 
with AgF and Ag[NH3]2F, Ca2+ lost from enamel due to the formation of Ag+ 
substituted enamel can be preserved as CaF2, and unstable Ag+ substituted 
enamel will be replaced by more stable FHA (Robinson, 2009). 
 
 
Figure 12.5 - Comparison of the log-linear relationship between the mean PRCLenamel of AgF 
topical treatment and the [Ag+]4h (Red line) and the log-linear relationship between the mean 
PRMLenamel of Ag+ and the [Ag+] in solution (Grey line). Error bars show the standard errors. 
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Figure 12.6 - Comparison of the log-linear relationship between the mean PRCLenamel of 
Ag[NH3]2F topical treatment and the [Ag+]4h (Blue line) and the log-linear relationship between the 
mean PRMLenamel of Ag+ and the [Ag+] in solution (Grey line). Error bars show the standard errors. 
 
12.2.2 The Dose-response Effects of F- on the Dose-response 
Inhibitory Efficacy of the Topical Treatments with AgF and 
Ag[NH3]2F on Enamel Demineralisation 
 
In the ISE study, the inhibiting enamel demineralisation effect of F- due to the 
formation of FHA and CaF2 (Mohammed et al., 2014a) can be expected during 
topical treatments with AgF and Ag[NH3]2F on enamel, and, after re-immersion 
into acid. 
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After re-immersing the enamel topically treated with AgF and Ag[NH3]2F back 
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y = 13.47 ln(x) + 57.95 
R² = 0.06 
y = (2.32)ln(x) - 1.17 
R² = 0.99 -35
-15
5
25
45
65
-35
-15
5
25
45
65
0.01 0.1 1 10 100 1000 10000
M
e
an
 P
R
M
L
e
n
am
e
l o
f A
g
+
in
 So
lu
tio
n
 (%
)M
ea
n
 P
R
C
L e
n
am
e
l
o
f 
To
p
ic
al
 A
g[
N
H
3]
2F
 T
x 
(%
)
Concentration of Ag+ in Solution (ppm)
Mean PRCL of topical Ag[NH3]2F Tx Mean PRML of Ag ion in solutionAg+[Ag+]4h Ag[NH3]2F Tx
-15
(ISE) (SMR)
0.
-15
SE = 53.85
SE = 0.26
 
226 
AgF and Ag[NH3]2F, and their [F-]4h (Red and Blue lines), which is similar to the 
dose-response PRMLenamel of F- in solution reported in the SMR study (Purple 
line). This indicates that the dose-response effects of the topical treatments with 
AgF and Ag[NH3]2F are also associated with the inhibiting enamel 
demineralisation effect of F- in the demineralisation solutions. 
However, the R2 values of the dose-response PRCLenamel of [F-]4h (R2 =0.78 
and 0.78) are lower than the R2 values of the dose-response PRCLenamel of 
topically applied [AgF] and [Ag[NH3]2F] (R2 = 1.00). Further, the slope values (= 
16.57 %/ppm and 42.25 %/ppm) of the dose-response PRCLenamel of [F-]4h 
reported in the present ISE study (Red and Blue lines) were steeper than the 
slope value (= 11.10 %/ppm) of the dose-response PRMLenamel of F- in solution 
reported in the SMR study (Purple line) (Fig. 12.7 and Fig. 12.8). Therefore, the 
dose-response inhibitory efficacy of topical treatments with AgF and Ag[NH3]2F 
was mainly due to the high [F-] in the topical application agents (all [AgF] and 
[Ag[NH3]2F] > 14250 ppm F-) rather than the low [F-] in the demineralisation 
solutions (all [F-]4h < 1 ppm F-). 
 
 
Figure 12.7 - Comparison of the log-linear relationship between the mean PRCLenamel of AgF 
topical treatment and the [F-]4h (Red line) and the log-linear relationship between the mean 
PRMLenamel of F- and the [F-] in solution (Purple line). Error bars show the standard errors. 
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Figure 12.8 - Comparison of the log-linear relationship between the mean PRCLenamel of 
Ag[NH3]2F topical treatment and the [F-]4h (Blue line) and the log-linear relationship between the 
mean PRMLenamel of F- and the [F-] in solution (Purple line). Error bars show the standard errors. 
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Figure 12.9 - The difference between the inhibitory efficacy (PRCLenamel) of AgF (Red dots) 
observed in ISE study and the theoretical inhibitory efficacy (PRMLenamel) of [F-]4h (Purple dots) 
obtained from dose-response PRMLenamel of F- reported in the SMR study. 
 
 
Figure 12.10 - The difference between the inhibitory efficacy (PRCLenamel) of Ag[NH3]2F (Blue 
dots) observed in ISE study and the theoretical inhibitory efficacy (PRMLenamel) of [F-]4h (Purple 
dots) obtained from dose-response PRMLenamel of F- reported in the SMR study. 
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12.3 Conclusions 
 
In conclusion, the dose-response inhibitory mechanism of topical treatment with 
AgNO3 on human enamel demineralisation is associated with the substitution of 
Ca2+ in enamel mineral by Ag+. Whereas, the dose-response inhibitory 
mechanisms of topical treatments with AgF and Ag[NH3]2F on human enamel 
demineralisation are associated with the increased release of F- from the topically 
treated enamel surfaces, and the accumulation of the components in the 
protective barrier.  
    For AgNO3, the dose-response effects of Ag+ influence the dose-response 
inhibitory efficacy. Whereas, for AgF and Ag[NH3]2F, only dose-response effects 
of F- play a major role in the dose-response inhibitory efficacy. 
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Chapter 13 DISCUSSION 
 
13.1 Comparison of Effects of Topical Treatments with Silver 
Compounds on Demineralisation of HAP Discs and Human 
Enamel 
 
This study demonstrated the effects of topical treatments with silver nitrate 
(AgNO3), silver fluoride (AgF), silver diammine fluoride (SDF; Ag[NH3]2F) and 
Silver Capsule of Riva Star (3.16 M SDF, SDI Ltd, Australia) (Riva-SC) on the 
inhibition of demineralisation of hydroxyapatite (HAP) discs (Chapter 8) and 
human enamel (Chapter 10). Even though HAP discs have been accepted as a 
good model for human enamel in many demineralisation studies (Anderson et al., 
2004a; do Amaral et al., 2016; Jones et al., 2013; Kosoric et al., 2010), it is 
compositionally and structurally different from human enamel (Section 1.3).  
    This section aims to compare the effects of topical treatments with silver 
compounds (3.16 M) on the demineralisation of HAP discs and human enamel. 
 
13.1.1 Before Topical Treatments with Silver Compounds 
 
In the ISE study (Chapter 8 and 10), before topical treatment with each silver 
compound, the release of Ca2+ from both HAP discs and human enamel in the 
demineralisation solution was linear with time (Fig. 8.4 ~ Fig. 8.8 and Fig. 10.5 
~ Fig. 10.15). However, the rates of Ca2+ release from demineralising human 
enamel (≈ 0.030 mM/h) (Table 10.7) were faster than those from demineralising 
HAP discs (≈ 0.010 mM/h) (Table 8.7). This should be due to the presence of 
carbonate in human enamel, acting as a destabilising agent (Mukundan et al., 
1999) (Section 1.3). 
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13.1.2 Following Topical Treatments with Silver Compounds 
 
Immediately following topical treatments with all silver compounds (AgNO3, AgF, 
Ag[NH3]2F and Riva-SC) on both HAP discs and human enamel, yellow staining 
was observed (Fig. 8.16, Fig. 10.44 and Fig. 10.45), suggesting the formation of 
yellow Ag3PO4 (Lewis, 1920). Further, in the treatment groups of fluoride-
containing silver compounds (AgF, Ag[NH3]2F and Riva-SC), CaF2 and FHA were 
detected in the powder samples of both HAP and human enamel (Fig. 8.21 and 
Fig. 10.55). This suggests that the reaction products formed following topical 
treatments with silver compounds on both HAP discs and human enamel are the 
same. 
 
13.1.3 After Re-immersion of Topically Treated HAP Discs and 
Human Enamel into Acids 
 
 
Figure 13.1 – Mean PRCLenamel and mean PRCLHAP of all treatment groups. 
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HAP layers (Section 9.1), whereas, the rate of Ca2+ release from demineralising 
human enamel was increased (Fig. 10.5) due to the removal of softened enamel 
surfaces and the exposure of more soluble deeper enamel layers (Section 11.1). 
Therefore, the abrasion effects of using a micro-brush during topical treatments 
on HAP discs and human enamel are different. This should be the reason why 
PRCLenamel of silver compound treatment group were all slightly lower than the 
PRCLHAP (Fig. 13.1). 
    The [Ag+]4h of both HAP disc and human enamel treatment groups were similar 
(Fig. 13.2). However, the [F-]4h of human enamel treatment groups were all 
slightly higher than those of HAP disc treatment groups (Fig. 13.3). This should 
result from the minor additional amounts of fluoride in the human enamel, which 
is an unavoidable interference even though the superficial layers of enamel 
abundant in fluoride were removed before the study.  
 
 
Figure 13.2 – [Ag+]4h of enamel and HAP disc treatment groups. 
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Figure 13.3 - [F-]4h of enamel and HAP disc treatment groups. 
 
13.1.4 After Removal of HAP Discs and Human Enamel Topically 
Treated with Silver Compounds from Acids 
 
After removing the HAP discs and human enamel topically treated with DW, the 
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on the surfaces topically treated with fluoride-containing silver compounds (AgF, 
Ag[NH3]2F and Riva-SC) (Fig. 8.17b ~ e and Fig. 10.46d, g, j, k). 
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compounds were the same; AgF Tx > Riva-SC Tx > Ag[NH3]2F Tx > AgNO3 Tx. 
However, the mean atomic percentages of Ag detected on the HAP disc surfaces 
were all higher than those detected on the similarly treated enamel (Fig. 13.4). 
This could be due to that the metallic silver particles deposited on the HAP discs 
(~ 3 μm) were larger than those (~ 1.5 μm) on the enamel, and can be more 
easily detected by EDX (Section 8.4.5 and Section 10.4.5). The larger size of 
metallic silver particles on the HAP discs may be due to that the evenly 
demineralised HAP disc surfaces made the exposure of Ag3PO4 deposits to light 
and heat easier than the irregular demineralised enamel surfaces. 
 
 
Figure 13.4 - Mean percentages of Ag detected on HAP disc and human enamel surfaces. 
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deeper layers of human enamel by the abrasion effects of topical treatments. As 
the formation of CaF2 requires slight dissolution of the enamel surfaces in order 
to provide the necessary Ca2+ (Buzalaf et al., 2011) (Section 2.4), more soluble 
enamel mineral favours more CaF2 formation. 
    Therefore, as there was much more CaF2 in the protective barriers formed on 
the enamel surfaces topically treated with fluoride-containing silver compounds 
(AgF, Ag[NH3]2F and Riva-SC) than those formed on the HAP discs, the inhibitory 
efficacy from the enamel protective barriers should be much higher than those 
from the HAP disc protective barrier. This explains why even though the abrasion 
effects accelerated the Ca2+ release from enamel by 10.61+2.39 %, the 
PRCLenamel of these fluoride-containing silver compound treatment groups were 
still similar to the PRCLHAP (Fig. 13.1). 
 
 
Figure 13.5 – Mean percentages of F detected on HAP disc and human enamel surfaces. 
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13.2 Clinical Implications of the Dose-response Effects of 
Topical Treatments with Silver Compounds on 
Demineralisation of Human Enamel 
 
In the present study, the protocol of topical treatments on human enamel followed 
the one mostly recommended to be used in the clinical practice (Crystal et al., 
2017). Further, the concentrations of the silver compounds, including 0.75 M, 
2.36 M and 3.16 M, were the concentrations used in the commercial products 
(Fung et al., 2013; SDI, 2016a) (Section 3.4.2). 
 
 
Figure 13.6 – Dose-response effects of topical treatments with AgNO3 (Green line), AgF (Red 
line) and Ag[NH3]2F (Blue line) on demineralisation of human enamel. 
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(Lansdown, 2006; Thibodeau et al., 1978). On the other hand, as the inhibitory 
efficacy of topical treatments with 0.75 M and 2.36 M AgNO3 was 21.9+3.2 % and 
4.6+5.9 % observed (Fig. 10.17), both inhibitory efficacy and antibacterial 
properties can contribute to the cariostatic effect following topical treatments with 
these concentrations of AgNO3. However, the PRCLenamel of 2.36 M AgNO3 
topical treatment was not significantly higher than that of 3.16 M AgNO3. 
Therefore, the inhibitory efficacy of 2.36 M AgNO3 topical treatments may also be 
negligible. An in vitro study found that 5 min immersion of human enamel in 2.36 
M AgNO3 did not inhibit the demineralisation of enamel at pH 4.4 (Liu et al., 
2012b). 
The inhibitory efficacy of AgNO3 topical treatment increases with decreasing 
concentration (Fig. 13.6). Further, as most of the cariogenic bacteria can be 
inhibited by 20 ppm Ag+, the applicatio4n of 0.75 M AgNO3 (81000 ppm Ag+) is 
unnecessary. Therefore, AgNO3 with concentrations lower than 0.75 M can be 
applied in the topical treatment on enamel caries to exert antibacterial properties 
and optimal inhibitory efficacy at the same time. 
 
13.2.2 Topical Treatments with Different Concentrations of AgF or 
Ag[NH3]2F on Demineralisation of Human Enamel 
 
The PRCLenamel of topical treatments with fluoride-containing silver compounds 
(AgF and Ag[NH3]2F) were much higher than that of AgNO3 (Fig. 10.16). 
Therefore, fluoride-containing silver compounds used in the clinical practice can 
exert both pronounced inhibitory efficacy of enamel demineralisation and 
antibacterial properties.  
Ag[NH3]2F is one of the most popular fluoride-containing silver compounds 
used in the clinical practice (Horst et al., 2016), which has a wide concentration 
range of commercial products available  (Fung et al., 2013; SDI, 2016a). The 
Ag[NH3]2F product with the lowest concentration (Saforide 3.8%, Tokyo Seiyaku 
Kasei Co. Ltd, 4484 ppm F-) contains fluoride concentration similar to that of 
fluoride dentifrice (100 ~ 1500 ppm F-) (Mohammed et al., 2014a), whereas, the 
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Ag[NH3]2F product with the highest concentration (Riva Star, SDI Ltd, 60000 ppm 
F-) contains fluoride concentration much higher than that of fluoride varnish (~ 
22000 ppm F-) (Hazelrigg et al., 2003). As the inhibitory efficacy of the topical 
treatment with Ag[NH3]2F increases with increasing concentration (Fig. 13.6), 
concentrations of Ag[NH3]2F higher than 3.16 M (60000 ppm F-) can be used to 
optimise the inhibitory efficacy of the topical treatment.  
However, the safety concerns about the extremely high F- concentration in the 
silver compounds have been expressed (Gotjamanos, 1997; Gotjamanos and 
Afonso, 1997; Gotjamanos and Orton, 1998). Even though a previous study has 
proposed that the concentrations of Ag[NH3]2F products used in clinical practice 
is hundreds times less than the lethal dose of Ag[NH3]2F by oral administration 
(520 mg/kg) (Horst et al., 2016), some patients have reported tooth pain, gum 
pain, gum swelling and gum bleaching after being treated with Ag[NH3]2F 
(Duangthip et al., 2018). Therefore, high concentration fluoride-containing silver 
compounds should be used with caution. 
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Chapter 14 CONCLUSIONS, FUTURE WORK AND CLINICAL 
RELEVANCE 
 
14.1 Conclusions 
 
The conclusions from this study are as follows: 
 
1. Real-time Ca2+ ISEs can be used in in vitro study for quantifying the 
demineralisation inhibitory efficacy of inhibitors by real-time monitoring 
demineralisation kinetics before and after the treatment.  
2. There is a dose-response effect of Ag+ on the demineralisation of human 
enamel. The accelerating effect of Ag+ on demineralisation increased with 
increasing concentration. Further, a log-linear relationship was found between 
the inhibitory efficacy and the concentration of Ag+ in the solution. 
3. Topical treatments with silver compounds, including AgNO3, AgF and 
Ag[NH3]2F, inhibited the demineralisation of hydroxyapatite (HAP) discs and 
human enamel. The inhibitory mechanism of topical treatment with AgNO3 is 
associated with; 1) the formation of a protective barrier composed of Ag3PO4. 
Whereas, the inhibitory mechanism of topical treatment with AgF or Ag[NH3]2F is 
associated with; 1) the release of F- from the topically treated dental mineral 
surfaces, 2) the formation of a protective barrier composed of Ag3PO4, CaF2 and 
FHA. Further, the abrasion effects of the topical treatments inhibited the 
demineralisation of HAP discs but accelerated the demineralisation of human 
enamel. 
4. The inhibitory efficacy of topical treatment with AgNO3 on human enamel 
demineralisation decreased with increasing concentration due to; 1) substitution 
of Ca2+ in enamel mineral by Ag+, which destabilises the treated enamel surfaces. 
Whereas, the inhibitory efficacy of topical treatment with AgF or Ag[NH3]2F 
increased with increasing concentration due to; 1) the increased release of F- 
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from the topically treated enamel surfaces, 2) the accumulation of the 
components in the protective barrier on the treated enamel surfaces. Further, a 
log-linear relationship between the dose-response inhibitory efficacy of topical 
treatment with AgNO3, AgF or Ag[NH3]2F on demineralisation of human enamel 
and the topically applied concentration of AgNO3, AgF or Ag[NH3]2F was found. 
5. The effects of topical treatments with Silver Capsule of Riva Star (SDI Ltd, 
Australia) on the demineralisation of HAP discs and human enamel are similar to 
those of topical treatments with laboratory-prepared 3.16 M Ag[NH3]2F. 
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14.2 Future Work 
 
The current in vitro study was carried out under conditions without any effects of 
the physiological factors in the oral environment. This allowed the strict chemical 
control of individual variables of multi-factorial diseases like dental caries and 
dental erosion. However, physiological factors in the in vivo situation, including 
dietary habits, personal oral hygiene conditions, the functions of salivary glands, 
and a pellicle coating, also influence caries and erosion progression (Hunter, 
1988; Kidd, 2005). Therefore, in order to fully understand the effects of topical 
treatments with silver compounds, further studies are required to investigate the 
additional effects of these physiological factors. Furthermore, the effects of a 
dynamic pH cycling process need to be considered in order to simulate in situ 
conditions. 
    Hydroxyapatite (HAP) discs were used as enamel analogues in this study in 
order to avoid inhomogeneities from human enamel. Bovine enamel could be 
another choice to be used in the future study (Laurance-Young et al., 2011), 
which has more uniform composition than human enamel but more physiological 
features than HAP discs (Mellberg, 1992). Further, only one protocol of topical 
treatment with silver compound was used in the present study. Even though the 
protocol has been proposed to be the optimum for cariostatic effectiveness 
(Crystal et al., 2017), other delivery protocols should be investigated. For 
example, University of California San Francisco (UCSF) proposed that the 
application time of Ag[NH3]2F should be more than 1 min, followed by rinsing of 
the treated lesion (Horst et al., 2016). Even though concerns have been 
expressed about losing effectiveness by the rinsing procedure (Horst, 2018), the 
discrepancy between the inhibitory efficacies exerted by these two protocols 
could be compared using the real-time ISE methodology. Further, by modifying 
the protocol used in the study, a novel protocol, which exerts higher inhibitory 
efficacy might be found.  
    An inhibitory efficacy up to 65 % of topical treatment with AgF or Ag[NH3]2F 
was found with increasing concentrations (up to 3.16 M) in the present study, but 
higher concentrations could be used in the future dose-response study to 
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measure optimal inhibitory efficacy. Further, the inhibitory efficacy obtained was 
based on 4 h demineralisation only, and so longer periods could be used to 
investigate the inhibitory efficacy over longer time periods. For example, as the 
secretion of saliva is lowest during 8 h sleep, which increases caries risk (Dawes, 
2008), an 8 h demineralisation period can be used. 
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14.3 Clinical Relevance 
 
In clinical practice, topical treatment with Ag[NH3]2F is a better choice over AgNO3 
and AgF used for the management of dental caries. Ag[NH3]2F topical treatment 
has higher inhibitory efficacy on enamel demineralisation than AgNO3 and is able 
to stabilise the Ag+. Biannual application of 38 wt% (2.36 M) Ag[NH3]2F is the 
most effective protocol for treating dental caries (Duangthip et al., 2017; Fung et 
al., 2016; Fung et al., 2018) (Section 3.4.2). However, as this study has reported, 
the inhibitory efficacy of Ag[NH3]2F increases with increasing concentration, so 
there is a potential that annual applications of Ag[NH3]2F with concentrations 
higher than 2.36 M will be sufficient to exert similar cariostatic effects on human 
enamel.  
However, the black staining remains an aesthetic problem. SSKI has been 
introduced, which can be applied to remove the black staining of the lesions 
topically treated with Ag[NH3]2F (Ngo et al., 2002) (Section 3.4). Future clinical 
trials are required to investigate whether the black staining of the treated lesions 
can be effectively and permanently removed by using SSKI without 
compromising the inhibitory efficacy of the Ag[NH3]2F topical treatment. 
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Appendix A: Tables of SDF studies 
Clinical effects of SDF applications on coronal caries in primary and permanent teeth  
Studies (year/Sites) Caries 
effect 
studied  
Subjects/Dentitions Durations Groups compared 
(*application times) 
Main findings 
McDonald and Sheiham 
(1994/UK)(McDonald and 
Sheiham, 1994) 
Arrest  52 children (2-9 years 
old)/primary  
18 
months 
Gp 1: SnF2 
Gp 2: SDF/SnF2 
Gp 3: Minimal 
preparation + 
SDF/SnF2 + composite 
resin 
Gp 4: Minimal 
preparation + 
composite resin 
Gp 5: no treatment 
Caries in progress (%): 
Gp 1: 46.5 % 
Gp 2: 26.6 % 
Gp 3: 5.2 % 
Gp 4: 11.1 % 
Gp 5: 53.0 % 
Caries can be treated in a non-traumatic 
way. 
Gotjamanos T. 
(1996/Australia)(Gotjamanos, 
1996) 
Arrest 55 carious primary teeth 
(from 6-13-year-
olds)/primary 
3-56 
months 
55 carious dentins 
treated with 50.9% 
SDF and GIC 
SDF treatment for deep caries does not 
affect pulp vitality.   
Lo et al. (2001/China)(Lo et al., 
2001) 
Arrest and 
prevention 
375 children (3-5 years 
old)/primary 
18 
months 
Gp 1: annual 38% SDF 
+ carious tissue 
removal 
Gp 2: annual 38% SDF  
Gp 3: 3 monthly NaF 
(5%) + carious tissue 
removal 
Gp 4: 3-monthly NaF 
(5%) 
Gp 5: no treatment 
Mean no. of new carious surfaces/arrest 
carious surfaces: 
Gp 1: 0.4/2.8  
Gp 2: 0.4/3.0 
Gp 3: 0.8/1.7 
Gp 4: 0.6/1.5 
Gp 5: 1.2/1.0 
1. 38% SDF is more effective than 5% NaF 
in preventing and arresting caires. 
2. Carious tissue removal is unnecessary for 
SDF treatment. 
Chu et al. (2002/China)(Chu et 
al., 2002) 
Arrest  375 children (3-5 years 
old)/primary 
30 
months 
Gp 1: annual 38% SDF  
+ carious tissue 
removal 
Gp 2: annual 38% SDF  
Gp 3: 3-monthly 5% 
NaF + carious tissue 
removal 
Mean no. of arrest carious surfaces: 
Gp 1: 2.5 
Gp 2: 2.8 
Gp 3: 1.5 
Gp 4: 1.5 
Gp 5: 1.3 
SDF is effective in caries arrest in primary 
teeth. 
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Gp 4: 3-monthly NaF 
(5%) 
Gp 5: no treatment 
Llodra et al. (2005/Cuba)(Llodra 
et al., 2005) 
Arrest and 
prevention 
425 children(> 6 years 
old)/primary and 
permanent 1st molars 
36 
months  
Gp 1: biannual 38% 
SDF  
Gp 2: no treatment 
(*3 min) 
 
Mean no. of new carious surfaces 
(primary/permanent 1st molars): 
Gp 1: 0.29/ 0.37 
Gp 2: 1.43/1.06 
SDF is effective for caries reduction in 
primary teeth and first permanent molars. 
Braga et al. (2009/Brazil)(Braga 
et al., 2009) 
Arrest 22 children/permanent 
1st molars 
30 
months 
Gp 1: cross-tooth-
brushing technique 
(CTT) 
Gp 2: 3 time weekly 
10% SDF 
Gp 3: GIC sealant 
(*3 min) 
 
All treatments are effective in control 
occlusal incipient caries. 
Yee et al. (2009/Nepal)(Yee et al., 
2009) 
Arrest  976 children (3-9 years 
old)/primary 
24 
months 
Gp 1: 38% SDF/tannic 
acid 
Gp 2: 38% SDF  
Gp 3: 12% SDF  
Gp 4: no treatment 
(*2 min) 
Mean no. of arrest carious surfaces: 
Gp 1: 2.2 
Gp 2: 2.1 
Gp 3: 1.5 
Gp 4: 1.0 
38% SDF is more effective than 12% SDF in 
caries arrest. 
Zhi et al. (2012/China)(Zhi et al., 
2012) 
Arrest 212 children(3-4 years 
old)/primary 
24 
months 
Gp 1: annual 38% SDF 
Gp 2: biannual 38% 
SDF 
Gp 3: annual GIC  
Caries arrest rates: 
Gp 1: 79% 
Gp 2: 91% 
Gp 3: 82% 
Increasing application frequency to biannual 
can enhance the caries arrest rate. 
Dos Santos et al. 
(2012/Brazil)(Dos Santos et al., 
2012) 
Arrest  91 children/Primary 12 
months 
Gp 1: 30% SDF  
Gp 2: GIC 
(*3 min) 
SDF was more effective than GIC (RR = 
38.6%) for caries arrest. 
Liu et al. (2012/China)(Liu et al., 
2012a) 
Prevention 501 children (mean age 
9.1years)/permanent 1st 
molars 
24 
months 
Gp 1: Resin sealant 
Gp 2: biannual 5% NaF 
Gp 3: annual 38% SDF 
Gp 4: placebo control 
Proportions  of  pit/fissure  sites   
with  dentin  caries : 
Gp 1: 1.6% 
Gp 2: 2.4% 
Gp 3: 2.2% 
Gp 4: 4.6% 
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All treatments are effective in preventing pit 
and fissure caries in permanent molars. 
Chu et al. (2014/ Hong 
Kong)(Chu et al., 2014) 
Arrest  A 14-year-old Chinese 
boy/permanent (rampant 
caries) 
 Patient with rampant 
caries was treated with 
38% SDF, followed by 
provisional crown 
restoration. 
Good prognosis with pain relief. 
Duangthip et al. (2016/Hong 
Kong)(Duangthip et al., 2016) 
Arrest 304 children (3-4 years 
old)/primary 
18 
months 
Gp 1: annual 38% SDF 
Gp 2: 3 weekly 38% 
SDF  
Gp 3: 3 weekly 5% 
NaF 
(*10 sec)  
Caries arrest rates  
Gp 1: 40% 
Gp 2: 35% 
Gp 3: 27% 
Annual or 3-weekly applications of 38% SDF 
is more effective in caries arrest than 3-
weekly application of 5% NaF varnish. 
Fung et al. (2016/China)(Fung et 
al., 2016) 
Arrest 888 children (3-4 years 
old)/primary 
18 
months 
Gp 1: annual 12% SDF  
Gp 2: biannual 12% 
SDF  
Gp 3: annual 38% SDF 
Gp 4: biannual 38% 
SDF  
 
Caries arrest rates: 
Gp 1: 50% 
Gp 2: 55% 
Gp 3: 64% 
Gp 4: 74% 
SDF is more effective in cares arrest at 38% 
than 12% and when applied biannually 
rather than annually. 
Duangthip et al. (2017/Hong 
Kong)(Duangthip et al., 2017) 
Arrest 371 children (3-4 years 
old)/primary 
30 
months 
Gp 1: annual 38% SDF 
Gp 2: 3 weekly 38% 
SDF 
Gp 3: 3 weekly 5% 
NaF 
(*10 sec) 
Caries arrest rates  
Gp 1: 48% 
Gp 2: 33% 
Gp 3: 34% 
Annual application of 38% SDF is more 
eﬀective than 3-weekly applications of SDF 
or NaF varnish. 
Fung et al. (2018/China)(Fung et 
al., 2018) 
Arrest  888 children (3-4 years 
old)/primary 
30 
months 
Gp 1: annual 12% SDF  
Gp 2: biannual 12% 
SDF 
Gp 3: annual 38% SDF 
Gp 4: biannual 38% 
SDF 
Caries arrest rates: 
Gp 1: 55.2%, 
Gp 2: 58.6%, 
Gp 3: 66.9%, 
Gp 4: 75.7% 
SDF is more effective in cares arrest at 38% 
than 12% and when applied biannually 
rather than annually. 
and  
Milgrom et al. 
(2018/USA)(Milgrom et al., 2018) 
Arrest 66 children (2~6years 
old)/primary 
14 ~ 21 
days 
Gp 1: 38% SDF  
Gp 2: placebo 
Averaged proportion of arrested caries 
lesions: 
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 Gp 1: 72% 
Gp 2: 5%    
*no harms were observed. 
Topical 38% silver diamine fluoride is 
effective and safe in arresting cavities in 
preschool children. 
Clinical effects of SDF applications on root caries 
Studies (year/Sites) Caries 
effect 
studied  
Subjects/Dentitions Durations Groups compared Main findings 
Tan et al. (2010/ Hong Kong)(Tan 
et al., 2010) 
Prevention 306 elders (mean age 
78.8 ± 6.2 
years)/permanent roots 
3 years Gp 1: oral hygiene 
instruction (OHI)   
Gp 2: OHI + 3-monthly 
chlorhexidine (CHX) 
Gp 3: OHI + 3-monthly 
NaF (5%) 
Gp 4: OHI + annual 
38% SDF 
New root caries surfaces: 
Gp 1: 2.5   
Gp 2: 1.1 
Gp 3: 0.9 
Gp 4: 0.7 
CHX, 5% NaF and 38% SDF were all more 
effective than OHI alone. 
Zhang et al. (2013/ Hong 
Kong)(Zhang et al., 2013) 
Arrest and 
prevention 
277 elders (60-89 years 
old)/permanent roots 
24 
months 
Gp 1: OHI   
Gp 2: OHI + annual 
38% SDF 
Gp 3: OHI + annual 
38% SDF + biannual 
oral health education 
(OHE) 
 
New/arrested root caries surfaces: 
Gp 1: 1.33/0.04 
Gp 2: 1.00/0.28 
Gp 3: 0.70/0.33 
Annual 38% SDF together with biannual 
OHE is effective in preventing and arrest 
caries. 
Li et al. (2016/ Hong Kong)(Li et 
al., 2016) 
Arrest 83 elders (mean age 
72.2 ± 5.8 years) 
/permanent roots 
30 
months 
Gp 1: no treatment    
Gp 2: 38% SDF  
Gp 3: 38% SDF/KI 
Root caries arrest rates: 
Gp 1: 45%    
Gp 2: 90%  
Gp 3: 93% 
1. 38% SDF application with or without KI 
application is effective in root caries arrest. 
2. KI application does not reduce black 
staining of SDF in the long term. 
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Cariostatic Effects of SDF on Dental Mineral. 
Studies (year) Methodologies Main findings 
Chu et al. (2008)(Chu and Lo, 2008a) Carious primary teeth treated with either 38% SDF or 
5% NaF were extracted to undergo Knoop hardness 
number (KHN) measurement.  
The median KHN of arrested lesions (range, 20-46 or 
196-451 MPa) were greater than those of soft lesions 
(range, 5-20, or 49-196 MPa) in the outer 25-200 µm. 
Lou et al. (2011)(Lou et al., 2011) Hydroxyapatite (HAP) powders mixed with 38% SDF, 
NaF or AgNO3 were inspected with SEM, energy-
dispersive X-ray analysis (EDX), and electron 
diffraction (ED). 
Compounds formed on treated surfaces: 
SDF: CaF2 and Ag(s) 
NaF: NaF globules 
AgNO3: Ag3PO4 (turns black immediately) 
Liu et al. (2012)(Liu et al., 2012b) Sound premolars treated with AgF, KF, AgNO3 or 
water, were subjected to demineralisation for 7 days 
before being inspected with micro-computed 
tomography (Micro-CT). 
Topical applications of AgF and KF inhibited enamel 
demineralisation, while AgNO3 application did not. 
Mei et al. (2013)(Mei et al., 2013d) Dentin caries generated by multi-species biofilms 
(Streptococcus mutans, Streptococcus sobrinus, 
Lactobacillus acidophilus, Lactobacillus rhamnosus 
and Actinomyces naeslundii) were treated with either 
38% SDF or water, and were incubated in the 
artificial mouth for 21 days. 
1. 38% SDF inhibits multi-species cariogenic biofilm 
formation on dentin carious lesions. 2. 2. The 
hardness and percentages of calcium and 
phosphorus of SDF treated samples from the 
outermost 50µm were higher. 
Mei et al. (2014)(Mei et al., 2014b) Carious primary teeth treated with 38% SDF were 
inspected with Micro-CT, EDX, SEM, and 
transmission electron microscopy (TEM).  
A highly remineralised zone rich in calcium and 
phosphate was found on the 38% SDF treated 
cavitated dentinal lesion.  
Punyanirun et al. (2018)(Punyanirun et al., 2018) Incipient caries on proximal surfaces of premolars 
were treated with 38% SDF before undergoing 
bacterial pH-cycling for 5 days. Micro-CT then was 
used for mineral density evaluation. 
Compared to the use of 1000 ppm fluoride toothpaste 
alone, the adjunctive use of 38% SDF enhances the 
remineralization of initial carious lesions based on 
mineral density, depth, and remineralization 
percentage. 
. 
Mei et al. (2017)(Mei et al., 2017) Calcium phosphate with different SDF 
concentrations (0.38, 1.52, 2.66, 3.80 mg/mL) were 
incubated at 37 0C for 24 h. The shape and 
organization of the crystals were examined by bright-
field transmission electron microscopy and electron 
diffraction. Unit cell parameters of the obtained 
crystals were determined with powder X-ray 
diffraction. The vibrational and rotational modes of 
phosphate groups were analysed with Raman 
microscopy. 
The results suggested that SDF reacted with calcium 
and phosphate ions and produced 
fluorohydroxyapatite (FAH). 
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Cariostatic effects of SDF on cariogenic bacteria 
Studies (year) Methodologies Main findings 
Knight et al. (2005)(Knight et al., 2005) Demineralized dentine discs treated with 50.9% SDF, 
50.9% SDF/KI and KI were incubated in medium of S. 
mutans for 14 days. Afterwards, optical density of the 
medium chambers was measured to determine 
bacterial penetration and growth.  
S. mutans migrated through all dentine discs. 
However, the samples treated with 50.9% SDF and 
SDF/KI had significantly lower optical densities. 
Knight et al. (2007)(Knight et al., 2007) Dentin discs with or without demineralisation, were 
treated with 50.9% SDF/KI. Next, were incubated with 
S. mutans for 14 days. Electron probe microanalysis 
(EPMA) and SEM were then used to inspect the 
samples. Bacterial growth was monitored by taking 
optical density readings. 
SDF/KI can inhibit biofilm formation composed of S. 
mutans. 
Knight et al. (2009)(Knight et al., 2009) Demineralized dentin disks treated with either 50.9% 
SDF or 50.9% SDF/KI were incubated in S. mutans 
before being inspected by scanning microscopy 
(SEM) and electron probe microanalysis (EPMA). 
The inhibition of S. mutans might be due to the 
presence of silver and fluoride in the outer layer (up 
to 450 µm) of SDF and SDF/KI treated samples, 
which make it more resistant to demineralisation. 
de Almeida et al. (2011)(de Almeida Lde et al., 
2011) 
Antibacterial effects of different concentrations of 
SDF were studies using an agar diffusion method. 
Both 12% and 30% can inhibit S. mutans. 
Chu et al. (2012)(Chu et al., 2012) Demineralized dentine blocks were incubated with 
either S. mutans or A. naeslundii to be treated with 
38% SDF. Lesions were then assessed by 
microhardness testing (MHT), EDX and Fourier 
transform infrared spectroscopy (FTIR). 
1. 38% SDF possesses anti-microbial activity against 
cariogenic biofilm of S. mutans or A. naeslundii, 
which inhibit the demineralisation. 
2. The hardness and percentages of calcium and 
phosphorus of SDF treated samples. 
Mei et al. (2013)(Mei et al., 2013b) Carious lesions were created in dentine blocks by 
inoculating with dual-species biofilm (S. mutans and 
Lactobacillus acidophilus). They were then treated 
with either 38% SDF or water before being incubated 
at 370C for 7 days. The biofilms were evaluated by 
colony forming units (CFU), SEM, and confocal 
microscopy (CLSM), while the carious lesion was 
inspected with XRD, Fourier transform infrared 
spectroscopy (FTIR) and immune-labeling. 
38% SDF had antimicrobial activity against the 
cariogenic biofilms composed of S. mutans and 
Lactobacillus acidophilus. 
Shah et al. (2013)(Shah et al., 2013) S. mutans counts in the mouths of children treated 
with 38% SDF, fluoride varnish or APF gel. All 
subjects were evaluated at 72 h, 6th, 12th, and 18th 
months of follow-up. 
38% SDF is more effective in inhibiting S. mutans 
than fluoride varnish and APF gel in vivo.  
Targino et al. (2014)(Targino et al., 2014) Evaluate the antimicrobial and cytotoxic activity of 
38% SDF. The minimum inhibition concentration 
(MIC) was evaluated by the spectrophotometric 
The MIC and MBC for SDF were 33.33 ± 14.43 and 
50.0 µg/mL, respectively. 
266 
microdilution method and turbidity. The minimum 
bactericide concentration (MBC) was evaluated in 
brain heart infusion plates.  
Hamama et al. (2015)(Hamama et al., 2015) Dentine discs infected with S. mutans were treated 
with 50.9% SDF/KI. The discs were then fractured 
into two halves, stained with fluorescent LIVE/DEAD 
stain and observed using confocal laser scanning 
microscopy. 
The use of the SDF/KI is effective in reducing the 
numbers of S. mutans in dentinal tubules. 
Savas et al. (2015)(Savas et al., 2015) S.mutans biofilm demineralized enamels were 
treated with water, 38% SDF, acidulated phosphate 
fluoride (APF), ammonium hexafluorosilicate (AHF), 
ammonium hexafluorosilicate + cetylpyridinium 
chloride (AHF+CPC), or 0.2% chlorhexidine (CHX) 
before being incubated for two days.    Numbers of 
viable microorganisms  
in the  biofilms  were  counted. 
38% SDF showed the highest antibacterial activity 
over other treatments. 
Cariostatic effects of SDF on dentinal organic content 
Studies (year) Methodologies Main findings 
Mei et al. (2012)(Mei et al., 2012) The inhibitory effects of 12%, 30%, 38% SDF, NaF 
and AgNO3 on matrix metalloproteinases (MMPs) 
were studied using MMP assay kits. 
Inhibitory effect of SDF on MMPs increased with 
concentration. SDF had more inhibition on MMPs 
than solutions of NaF and AgNO3. 
Mei et al. (2013)(Mei et al., 2013c) Demineralized dentin blocks were treated with 38% 
SDF, 10% NaF, 42% AgNO3, and water. They were 
then subjected to pH cycling for 8 days before being 
inspected with SEM, X-ray diffraction (XRD), Micro-
CTand spectrophotometry with a hydroxyproline 
assay. 
1. Groups treated with 38% SDF and 42 % AgNO3 
had significantly less hydroxyproline liberated from 
the dentine matrix than groups F and W (p<0.01). 
2. 38% SDF can inhibit demineralisation and 
preserved collagen from degradation. 
Mei et al. (2014)(Mei et al., 2014a) The inhibitory effects of 12%, 30%, 38% SDF, NaF 
and AgNO3 on cathepsins were studied using 
cathepsin assay kits.  
1. The solutions containing Ag+ have significantly 
higher inhibitory effect than the solutions containing 
F- only (p<0.01). 
2. SDF solution at all 3 tested concentrations 
significantly inhibited the activity of cathepsin. 
Zhao et al. (2017)(Zhao et al., 2017b) Dentine discs treated with 25% AgNO3 followed by 
5% NaF, 38% SDF or water were subjected to pH-
cycling for 8 days before being inspected with SEM, 
X-ray diffraction (XRD), X-ray microtomography and 
spectrophotometry with a hydroxyproline assay. 
25% AgNO3 followed by 5% NaF or 38% SDF 
application can preserve dentinal collagen, and result 
in lower lesion depths.  
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Appendix B: QMUL Skills Points Record 
Type A B C D Total 
Conference Attendance (Five days) 15 10 0 0 25 
Conference Attendance (Four days) 24 16 0 0 40 
 Conference Attendance (One day) 3 2 0 0 5 
Conference Attendance (Three days) 18 12 0 0 30 
 Conference Attendance (Two days) 6 4 0 0 10 
Conference attendance sub-total 18 12 0 0 30 
Basic IT/Software course 1 0 0 0 1 
Doctoral College event/course 0 2 3 2 7 
E-Learning Course 0 0 0 2 2 
Other CPD course 0 1 0 0 1 
Other Teaching/demonstrating training 0 2.5 0 2.5 5 
Other course/event attendance 4 0 0.5 0 4.5 
Researcher Development Course 12 40.5 12 21.5 86 
Course/event attendance sub-total 17 46 15.5 28 106.5 
Conference Presentation (Oral) 9 9 0 12 30 
Conference Presentation (Poster) 9 9 0 12 30 
Internal Presentation (< or =30 mins) 2 2 0 4 8 
Journal Club/Reading Group/lab meeting 
Presentation 
3 0 0 3 6 
Giving presentations sub-total 23 20 0 31 74 
Journal Club/Reading Group/lab 
meeting/mentoring group - attendance 
16.5 0 0 0 16.5 
Meeting/club/reading group attendance sub-
total 
16.5 0 0 0 16.5 
Seminar attendance (series) 2 0 0 0 2 
Seminar attendance (single) 3 0 1 0 4 
Seminar attendance sub-total 5 0 1 0 6 
Mentoring/supervising of Project Student 8 4 0 8 20 
Teaching/demonstrating/marking/preparation 0 15 0 15 30 
Teaching sub-total 8 19 0 23 50 
Refereed Publication (Journal Paper, Book 
chapter, not abstract) acceptance 
2 0 0 8 10 
Refereed Publication (Journal Paper, Book 
chapter, not abstract) submission 
4 0 0 16 20 
Written publications sub-total 6 0 0 24 30 
Total (with caps applied) 93.5 97 16.5 106 313 
Target 60 20 15 30 210 
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Appendix C: Awards 
1. Third place of 2016 London Region Young Persons Lecture Competition  
2. 2017 IADR Cariology Research Group Science Award  
3. 2018 Armourers & Brasiers Travel Grant  
4. 2018 BSODR Student Bursary  
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Appendix D: Conference presentations 
 
2016 IADR in Seoul, Korea (poster presentation #1053):  
W. Huang*, T. Duminis, D. G. Gillam, P. Anderson, S. Shahid “Cariostatic 
Influence of Commercial SDF on Hydroxyapatite Disc Demineralisation Kinetics”
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2016 ORCA in Athens, Greece (poster and oral presentation #88):  
W. Huang*, T. Duminis, P. Anderson, S. Shahid “ISE Study of Effect of Silver Ions 
on Demineralisation of Hydroxyapatite Disc” (DOI: 10.1159/000445087) 
Abstract 
Silver has traditionally been used in dentistry as a bactericide. However, recently 
it has been suggested that Ag+ influences enamel demineralisation directly. The 
aim was to understand the chemical interactions of Ag+ with enamel’s mineral 
components during demineralisation using hydroxyapatite (HAP) discs as 
isotropic enamel analogues. Three HAP discs (PlasmaBiotal, UK; 20% porosity), 
14 mm (D) X 2 mm (H) were demineralised for 4 h in 50 ml, 1.0 M buffered pH 
4.0 acetic acid, 37 0C. The discs were then removed and treated with either 3.16 
M AgNO3 solution; saturated KI solution; or 3.16 M AgNO3+ saturated KI solution. 
The discs were then further demineralised for 4 h. ISEs (Ion Selective Electrodes) 
were used to monitor the rate of demineralisation by measuring Ca2+ 
concentration increases in the solutions at 1 min intervals. The changes in Ag+ 
concentrations were also monitored contemporaneously. Similarly treated HAP 
powder samples were analysed using 31P MAS-NMR (Magic-angle spinning 
Nuclear Magnetic Resonance) to detect formation of phosphate salts. The rate of 
Ca2+ release before and after treatments were:  
AgNO3: Initial increase in Ca2+ release rate from 0.11 mM/h to 0.17 mM/h for 1 h, 
reducing to 0.0266 mM/h thereinafter. Overall decrease 24 %. Staining observed.  
KI: Decrease in Ca2+ release rate from 0.095 mM/h to 0.045 mM/h. Overall 
decrease 47 %. No staining observed.  
AgNO3+KI: Decreased in Ca2+ release rate from 0.072 mM/h to 0.0175 mM/h. 
Overall decrease 24 %. No staining observed.  
 31P MAS-NMR indicated formation of Ag3PO4 for samples treated with AgNO3, 
but not for KI treated nor AgNO3+KI treated samples. Topical application of 
AgNO3 reduces demineralisation of HAP by forming a Ag3PO4 protective barrier, 
but stains the surface. Addition of KI prevents formation of Ag3PO4, and also 
staining. However, KI does not detriment protection, possibly due to formation of 
an AgI protective barrier. 
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 2016 ORCA poster 
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2017 IADR in San Francisco, USA (oral presentation #0066):  
W. Huang*, T. Duminis, P. Anderson, S. Shahid “Cariostatic Effects of 
Commercial Silver Diammine Fluoride Components on Enamel” 
Abstract 
Objectives: Silver Diammine Fluoride (SDF) has been used to manage dental 
caries for decades. Commercial SDF products contain silver and fluoride ions at 
high concentrations. However the mechanism behind its positive clinical outcome 
has not been clearly verified. The aim of this study was to investigate the 
cariostatic effects of the topical application of silver and fluoride ions individually, 
and in combination, on the demineralisation of human enamel.  
Methods: Human permanent molars were sectioned to provide 8 caries-free 
smooth surfaces. These were polished and then 5mm X 5mm windows were 
created using nail varnish. The samples were demineralised for 4 h in 50 mL 0.1 
M buffered acetic acid pH 4.0 at 37 0C. Ion selective electrodes (ISEs) were used 
to monitor Ca2+ concentration changes in real-time throughout the experiment as 
a proxy for demineralisation. After 4h, the samples were removed and topically 
treated with the cariostatic agents shown in Table 1 using a microbrush. The 
samples were then placed back into demineralisation solutions and Ca2+ release 
was recorded for a further 4 h period. Furthermore, 31P and 19F MAS-NMR was 
used to assess the interaction of fluoride ions and silver ions with the apatite 
phase. 
Results: The decrease in Ca2+ release following topical application of cariostatic 
agents is shown in Table 2. The fluoride ions had the greatest efficacy in reducing 
demineralisation, whereas silver ions had the least effect. 31P NMR results 
showed that silver reacts with apatite to form Ag3PO4. This was observed 
following application of SDF, AgF and AgNO3 but not NaF. 19F data showed 
formation of CaF2 in samples treated with SDF, NaF and AgF. 
Conclusions: SDF application inhibits the demineralisation process of enamel, 
which might be attributed to the establishment of a barrier consisting of Ag3PO4 
and CaF2 on the surface. The fluoride ions play the major role of the cariostatic 
function. 
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Table 1. – Four groups of cariostatic agents 
Cariostatic agents Concentration Sample size 
SDF 50.9 wt% (341280 ppm 
Ag, 60000 ppm F) 
2 
AgF 40.1 wt% (341280 ppm 
Ag, 60000 ppm F) 
2 
NaF 13.3 wt% (60000 ppm F) 2 
AgNO3 53.7 wt% (341280 ppm 
Ag) 
2 
 
Table 2. – Inhibition ability based on calcium ion release 
Group names Inhibition efficacy (% decrease in 
Ca2+ release) 
SDF 45.3+4.6 % 
AgF 52.8+5.2 % 
NaF 55.6+3.3 % 
AgNO3 11.9+3.7 % 
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2017 BSODR in Plymouth, UK (poster presentation #83):  
W. Huang*, P. Anderson, S. Shahid “Cariostatic Effect of Riva Star vs 
Conventional Silver Diammine Fluoride” 
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2018 IADR in London, USA (oral presentation #0454):  
W. Huang*, P. Anderson, S. Shahid “Dose-dependent Inhibitory Effects of Silver 
Compounds on Enamel Demineralisation” 
Abstract 
Objectives: To investigate the effects of different concentrations of AgNO3, AgF 
and Ag[NH3]2F (silver diamine fluoride, SDF) on enamel demineralisation.  
Methods: Fifty-four enamel samples were sectioned from caries-free permanent 
molars and polished using 600 grit sandpapers. Thereafter, samples were nail 
varnished, leaving a 3 mm X 4 mm window exposed. The samples were then 
allocated into nine groups (n = 6). These groups were treated with 3.16 M SDF, 
3.16 M AgF, 3.16 M AgNO3, 2.36 M SDF, 2.36 M AgF, 2.36 M AgNO3, 0.7453 M 
SDF, 0.7453 M AgF and 0.7453 M AgNO3, respectively. Initially all samples were 
individually demineralised by immersing into 50 mL, buffered pH 4.0 acetic acids 
for 4 h at 37 0C. Next, the samples were topically treated with their assigned 
application agents with micro-brush for 1 min and then return to the acids for 
further 4 h demineralisation. Calcium ion selective electrodes (ISEs) were used 
to monitor the ion concentrations at 1-min intervals during the demineralisation. 
The percentage reduction in the rate of calcium loss of enamel (PRCLenamel) was 
calculated, based on the change of Ca2+ release rate. Afterwards, enamel from 
each group was powdered and scanned with 19F and 31P magic angle spinning-
nuclear magnetic resonance (MAS-NMR).  
Results: The mean PRCLenamel of all groups is shown in Table 1. The PRCLenamel 
increased with concentration in the groups treated with SDF and AgF, while 
decreased in the groups treated with AgNO3. In the spectrums of MASNMR, CaF2 
and fluorapatite (FAP) were detected in the groups treated with SDF and AgF. 
Also, formation of CaF2 was predominant over FAP for every group except that 
treated with 0.7453 M SDF, for which FAP was predominant.  
Conclusions: Silver compounds have dose-dependent inhibitory effects on 
enamel demineralisation. The inhibitory mechanisms of SDF and AgF are 
associated with the formations of CaF2 and FAP. 
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Table 1. – PRCLenamel of the silver compounds in different concentrations 
Silver compound 
concentrations 
(M) 
3.16  2.36 0.7453 
SDF 65.2+3.3 % 60.9+4.5 % 41.6+2.2 % 
AgF 65.6+6.2 % 61.0+5.5 % 61.7+3.7 % 
AgNO3 0.0+5.3 % 4.5+5.9 % 21.9+3.2 % 
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Appendix E: Published paper and papers in preparation 
 
“Validation of a Real-Time ISE Methodology to Quantify the Influence of Inhibitors 
of Demineralisation Kinetics in vitro Using a Hydroxyapatite Model System”: 
Caries Res. 2018 May 25;52(6):598-603. 
Papers in preparation: 
“Inhibitory mechanisms of Silver Compounds on Hydroxyapatite 
Demineralisation”: Aimed to submit to JDR. (Drafting) 
“Dose-dependent Inhibitory Effects of Silver Compounds on Enamel 
Demineralisation”: Aimed to submit to JDR. (Drafting) 
 
